Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AAK1	"DKFZp686K16132, KIAA1048"	ENSG00000115977	"AP2 associated kinase 1"	Q2M2I8	2	69457997-69674349	"Enzymes, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 109.7"	"Cell type enhanced"	"Detected in all"	9	"Cone photoreceptor cells: 732.4;Rod photoreceptor cells: 621.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017931, HPA020289"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	No			"Vesicles, Plasma membrane"	Cytosol	"HPA017931: AB_1844406, HPA020289: AB_1844407"	"unprognostic (2.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.06e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.24e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.18e-1)"	5.1	5.9	11.0	5.7	11.9	7.8	6.9	25.2	26.5	4.8	4.2	3.9	6.3	3.8	4.7	7.1	3.8	4.9	4.3	7.9	14.4	12.8	7.2	3.1	7.5	6.8	9.4	11.6	3.3	6.7	109.7	10.3	6.9	10.2	5.0	4.6	4.7	3.6	12.3	6.8	3.7	3.7	5.4	9.3	5.5	5.4	4.1	6.9	4.7	16.0	2.1	5.3	4.9	5.8	1.0	0.8	4.1	3.9	2.8	5.6	1.3	16.8	10.1	9.3	9.0	8.9	9.9	29.9	13.7	10.9	8.3	7.4	10.2	6.7	0.6	3.4	17.9	11.4	7.9	7.1	7.1	17.0	12.5	3.0	9.1	6.1	6.9	8.1	6.4	21.7	8.5	6.3	15.6	20.3	6.8	17.6	8.6	1.9	9.5	14.4	2.8	5.9	3.4	4.4	3.1	5.6	3.9	10.0	1.4	6.6	35.3	3.1	4.9	7.9	6.1	7.1	6.4	3.6	9.1	17.5	18.7	12.5	13.4	13.5	9.3	2.4	1.0	15.6	10.9	12.7	2.5	1.4	0.6	4.5	0.6	4.2	0.4	4.0	3.0	0.8	1.0	5.6	4.5	4.1	2.8	3.9	0.7	3.1	1.3	11.0	11.9	25.2	26.5	14.4	12.8	9.4	11.6	10.2	6.9	32.8	38.8	3.0	17.4	14.2	235.7	71.2	99.3	10.7	23.9	136.1	732.4	65.1	36.5	37.7	19.2	43.8	67.4	23.3	57.5	45.9	24.0	51.4	20.7	30.1	51.9	289.2	69.3	93.9	98.0	23.3	35.4	45.1	10.1	50.5	26.9	42.5	48.8	26.4	43.9	53.7	621.3	19.4	29.2	45.9	51.3	8.7	178.4	135.1	14.6	50.6
AGAP1	"CENTG2, GGAP1, KIAA1099"	ENSG00000157985	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 1"	Q9UPQ3	2	235494089-236131800	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Bipolar cells: 268.5;Cone photoreceptor cells: 310.2;Horizontal cells: 112.8;Rod photoreceptor cells: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1;MAIT T-cell: 4.2"	"Lineage enriched"	"Detected in single"	42	"T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 40.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051405	Uncertain					NA	NA					"HPA051405: AB_2681471"	"unprognostic (1.69e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.42e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (1.36e-1)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (6.52e-5)"	"unprognostic (5.56e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.32e-2)"	5.7	6.1	28.3	4.1	28.0	2.2	10.3	16.5	29.6	7.8	13.4	31.7	8.2	8.5	6.6	11.3	8.4	8.6	7.0	7.2	25.6	20.6	9.7	3.4	6.9	2.2	29.3	15.1	7.5	8.1	9.3	6.5	8.2	20.1	6.2	14.0	11.9	4.8	6.9	9.0	4.7	10.3	13.0	19.9	2.5	6.8	8.1	30.2	0.0	11.3	3.1	2.5	8.0	8.6	0.0	0.0	0.0	0.0	0.0	4.2	0.2	8.3	6.7	10.6	5.0	7.8	5.1	6.5	4.3	4.6	5.0	3.9	6.9	15.6	0.0	1.8	7.3	19.1	2.2	7.8	10.2	6.2	0.1	4.0	12.9	6.4	5.0	3.1	0.0	8.9	7.4	10.0	10.3	8.2	3.7	3.4	3.0	6.6	0.5	6.3	10.8	0.2	1.4	4.6	7.2	3.0	1.8	5.4	8.1	5.5	10.0	40.2	10.2	3.6	8.7	4.9	6.1	4.8	2.0	3.3	6.0	6.1	5.0	5.8	2.9	0.0	0.4	9.4	0.1	6.4	0.0	0.0	0.0	2.1	0.0	4.2	0.0	0.6	1.2	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.2	28.3	28.0	16.5	22.4	25.6	20.6	29.3	15.1	20.1	30.2	6.0	16.2	0.0	3.2	3.7	268.5	19.5	2.5	12.0	9.1	10.4	310.2	8.5	3.3	15.2	7.6	8.8	17.4	0.0	12.7	1.3	7.1	4.0	19.7	5.5	1.2	112.8	15.6	9.2	0.3	1.8	4.6	3.1	1.7	2.8	17.4	30.2	15.1	20.1	12.7	12.9	120.3	25.8	12.5	2.8	23.4	3.8	5.5	1.0	19.3	4.3
AGFG1	"HRB, RAB, RIP"	ENSG00000173744	"ArfGAP with FG repeats 1"	P52594	2	227472152-227561214	"Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Transport"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 126.0;Late spermatids: 243.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008741	Approved		Supported	Vesicles		NA	NA		28000	Vesicles		"HPA008741: AB_1850752"	"unprognostic (5.76e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (8.73e-3)"	"unprognostic (6.31e-3)"	"prognostic favorable (6.10e-4)"	"unprognostic (9.30e-3)"	"prognostic unfavorable (7.31e-6)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.43e-5)"	"unprognostic (2.03e-2)"	"unprognostic (5.78e-2)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.24e-3)"	43.2	26.4	19.9	27.7	26.5	80.1	34.4	18.1	31.3	16.7	26.2	31.5	15.7	25.6	18.1	16.8	29.3	18.2	23.6	28.2	22.6	19.7	22.7	24.7	35.0	33.0	25.4	20.4	20.9	20.9	25.3	13.8	44.0	24.6	14.0	20.5	18.2	19.7	15.3	21.2	22.8	29.1	23.4	39.2	32.2	19.7	51.5	20.8	26.4	21.0	17.3	30.4	23.5	19.8	5.3	5.2	9.0	8.4	1.6	5.5	2.5	18.4	30.6	16.2	15.8	27.8	20.5	61.5	24.7	23.6	29.6	26.3	24.0	21.3	13.1	18.8	27.0	39.9	19.6	27.8	31.9	38.5	22.1	15.5	29.0	26.6	44.4	29.9	19.6	18.4	12.5	34.2	37.4	35.5	22.7	29.6	13.6	30.3	35.7	35.4	26.3	23.5	17.7	25.3	24.8	16.0	21.7	26.8	9.3	29.4	25.4	15.1	11.8	20.1	26.3	23.4	29.5	11.2	22.4	29.0	25.6	20.4	36.7	21.6	20.7	13.9	18.6	27.7	16.8	29.2	5.4	8.4	2.7	2.6	6.8	5.5	3.0	3.1	2.6	5.2	5.3	2.6	4.7	9.0	1.6	6.4	3.6	3.6	2.5	19.9	26.5	18.1	31.3	22.6	19.7	25.4	20.4	24.6	20.8	23.8	23.4	14.3	21.9	29.5	37.6	18.2	12.7	10.7	19.4	21.0	23.6	25.4	13.3	16.6	126.0	22.9	26.2	23.3	18.3	13.6	22.0	36.7	12.7	18.1	20.8	41.3	32.7	24.5	94.2	243.6	14.4	38.0	18.6	16.2	16.9	42.9	29.4	17.5	11.0	21.9	32.2	19.4	12.3	29.6	16.8	28.1	33.2	15.8	17.2	42.4
AHDC1	"DJ159A19.3, RP1-159A19.1"	ENSG00000126705	"AT-hook DNA binding motif containing 1"	Q5TGY3	1	27534035-27604431	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 59.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028648, HPA028685, HPA028691"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028648: AB_10599276, HPA028685: , HPA028691: AB_10601781"	"unprognostic (1.96e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (4.43e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (5.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	10.2	17.6	16.9	6.7	12.9	4.6	7.7	40.3	21.7	15.3	8.7	5.8	6.7	5.2	16.8	6.6	20.4	13.5	7.5	9.9	15.2	7.4	7.2	5.6	6.6	5.7	8.2	12.7	19.0	7.5	4.3	16.0	8.4	13.7	8.0	3.0	8.8	15.4	13.1	41.5	21.3	5.6	11.0	14.6	18.2	9.3	8.9	12.9	9.1	12.8	10.9	10.6	9.8	14.0	0.6	1.6	0.9	0.7	2.0	1.4	0.7	7.6	7.0	9.9	5.3	3.2	5.3	10.1	7.2	5.2	5.0	4.2	2.7	7.2	1.1	5.3	4.8	3.0	7.7	1.0	9.4	1.4	2.8	3.8	6.0	6.3	3.6	3.0	1.6	3.1	5.0	3.9	3.5	2.2	5.1	2.6	3.6	7.2	0.9	8.3	3.7	5.1	8.6	7.3	1.9	8.7	22.9	11.9	0.6	3.3	1.0	17.1	6.5	5.0	8.3	2.0	3.5	4.1	1.3	4.8	8.7	7.2	6.4	2.2	2.5	1.7	1.2	7.4	4.8	4.9	0.9	0.4	0.5	1.2	0.6	0.7	0.5	1.0	1.2	0.4	0.6	1.4	1.0	0.7	2.0	0.7	1.6	1.1	0.7	16.9	12.9	40.3	21.7	15.2	7.4	8.2	12.7	13.7	12.9	6.0	6.9	8.2	7.7	44.0	32.7	14.2	2.5	5.3	9.1	17.4	0.0	9.1	3.3	9.3	0.6	11.9	5.6	0.0	11.8	4.0	19.6	9.7	0.0	9.7	11.2	33.4	9.4	14.7	2.1	1.9	48.1	4.1	15.1	2.8	6.1	11.7	12.9	5.8	59.8	4.4	1.8	38.8	15.6	2.6	4.3	49.1	4.7	4.5	6.3	11.3
AL136454.1		ENSG00000231767			1	192716132-192716653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Ciliated cells: 13.4;Club cells: 30.7;Distal tubular cells: 36.5;granulocytes: 33.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 7.5;SK-MEL-30: 6.6;THP-1: 7.8"									"HPA041344, HPA049132, HPA054087"	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.78e-1)"	"unprognostic (5.09e-2)"	"unprognostic (7.80e-3)"	"prognostic favorable (5.72e-4)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (3.07e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.62e-2)"	1.7	0.9	0.3	2.3	0.6	1.9	2.6	0.9	0.9	1.3	0.7	0.0	3.9	2.8	1.8	2.5	0.8	0.7	1.8	0.8	0.5		1.2	0.4	1.3	3.3	1.7	0.2	2.6	7.3	0.0	0.0	0.6	0.8	1.5	0.0	0.4	5.9	4.2	3.4	0.1	1.6	0.6	0.7	3.0	1.2	0.4	1.0	0.2	0.6	2.5	0.8	3.0	2.3	6.1	2.6	1.3	1.9	4.5	7.4	6.4	1.7	0.7	0.5	1.1	0.5	0.0	4.4	0.2	1.0	0.0	0.6	0.0	1.3	0.4	4.4	0.0	0.3	1.8	0.3	0.5	0.0	1.4	0.9	0.8	0.9	3.3	0.4	1.2	2.3	0.5	0.8	0.3	0.0	0.1	0.3	0.4	0.2	1.3	0.0	0.9	1.5	7.5	1.9	0.2	0.4	1.7	0.5	1.0	0.6	2.2	1.4	2.7	0.3	2.7	6.6	0.2	1.7	7.8	0.9	1.1	2.1	1.4	4.0	2.6	1.8	1.5	1.4	1.2	0.2	1.3	1.4	0.7	3.2	1.9	4.6	6.1	5.7	3.5	2.6	5.8	7.4	7.0	0.4	4.5	1.4	2.4	3.6	6.4											8.9	8.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	30.7	1.8	0.0	0.0	36.5	1.4	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	2.8	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALOX5AP	FLAP	ENSG00000132965	"Arachidonate 5-lipoxygenase activating protein"	P20292	13	30713478-30764426	"Disease related genes, Predicted membrane proteins"	"Leukotriene biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 296.2;bone marrow: 121.8"	"Cell type enhanced"	"Detected in many"	12	"granulocytes: 589.5;Hofbauer cells: 445.6;Macrophages: 736.5;monocytes: 250.7;T-cells: 298.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 296.2;eosinophil: 148.4;neutrophil: 194.2;plasmacytoid DC: 136.1"	"Group enriched"	"Detected in all"	7	"dendritic cells: 136.1;granulocytes: 296.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 80.1;HL-60: 42.6;HMC-1: 137.8;THP-1: 53.6;U-937: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026592	Enhanced					NA	NA					"HPA026592: AB_10601115"	"unprognostic (1.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (7.83e-2)"	"unprognostic (6.63e-2)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.59e-1)"	16.7	12.7	9.6	27.9	17.0	121.8	8.3	1.9	10.7	6.3	7.5	17.1	0.0	6.4	7.7	3.3	6.4	11.5	11.7	10.4	8.0	9.0	10.6	5.8	55.8	33.4	22.0	2.7	5.1	7.9	1.7	3.3	10.6	14.2	5.9	6.6	5.1	9.9	4.9	2.4	2.8	10.9	12.1	23.0	57.6	7.8	5.2	15.5	42.2	4.3	3.7	29.2	11.9	6.5	18.4	136.1	296.2	12.6	3.6	33.2	24.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	19.1	0.2	0.0	0.6	0.1	0.0	0.5	0.0	80.1	0.0	2.3	0.0	0.1	0.1	42.6	137.8	0.1	0.0	0.0	4.8	1.0	0.1	4.1	0.0	0.4	0.2	0.0	2.3	1.5	0.0	0.0	0.0	0.3	0.5	1.5	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.3	0.0	53.6	0.1	0.0	0.4	0.0	0.3	8.5	0.0	12.7	0.1	39.4	0.1	296.2	12.6	148.4	22.3	0.6	33.2	16.9	22.3	18.2	7.6	18.4	11.3	11.1	194.2	3.6	0.4	136.1	30.9	24.1	9.6	17.0	1.9	10.7	8.0	9.0	22.0	2.7	14.2	15.5	38.7	140.9	78.7	2.7	21.1	0.0	2.5	17.8	20.1	43.3	0.0	0.0	2.6	13.3	1.9	4.4	5.6	2.8	0.0	0.9	2.8	8.0	1.1	589.5	1.0	445.6	0.0	25.3	9.2	168.8	3.1	4.4	736.5	40.5	250.7	1.0	0.0	3.7	1.5	3.9	1.4	0.0	32.3	4.3	0.3	1.0	21.7	4.1	298.1	1.2	1.3
ANKRD13A	"ANKRD13, NY-REN-25"	ENSG00000076513	"Ankyrin repeat domain 13A"	Q8IZ07	12	109999186-110039763	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 49.6;HBF TERT88: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039488, HPA043218"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA039488: AB_10673612, HPA043218: AB_2678367"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-3)"	"unprognostic (5.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (7.70e-6)"	"unprognostic (5.68e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (9.71e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.29e-2)"	11.1	12.3	7.0	19.8	12.6	18.3	10.2	6.8	12.8	10.6	13.8	23.3	8.6	7.9	12.0	6.9	19.9	9.8	13.1	9.1	9.2	6.4	12.8	14.0	15.1	28.7	13.1	8.3	11.1	10.6	6.5	5.3	39.4	9.5	12.6	13.0	17.1	21.7	15.1	6.2	21.1	16.8	31.0	12.3	24.2	12.7	45.8	13.8	13.3	19.1	8.0	36.5	21.5	13.0	3.9	2.5	8.9	4.2	1.4	2.9	1.3	38.1	1.7	4.2	3.8	6.5	6.4	5.1	38.4	36.8	37.2	19.9	5.1	2.5	25.4	3.0	49.6	4.7	4.6	5.3	5.8	50.2	28.4	4.3	9.4	3.9	4.2	5.7	10.9	11.3	5.6	6.2	15.8	9.2	9.4	5.6	6.2	7.2	4.2	16.5	1.3	9.6	4.8	2.2	2.8	7.9	8.3	11.7	10.1	5.4	5.0	8.7	4.1	7.1	14.2	4.9	3.0	6.4	9.3	7.0	27.9	4.9	15.3	20.6	9.0	5.3	34.0	13.7	7.7	4.0	2.6	1.9	8.9	0.9	4.2	2.9	3.9	2.4	1.1	2.5	1.9	1.4	1.8	6.0	1.4	2.0	1.9	1.0	1.3	7.0	12.6	6.8	12.8	9.2	6.4	13.1	8.3	9.5	13.8	44.7	33.3	22.3	16.2	26.1	20.0	11.7	25.5	25.4	31.8	54.1	13.7	13.2	18.3	25.5	73.7	14.6	14.0	0.0	15.1	17.2	15.3	13.6	12.7	14.9	13.2	23.8	18.0	15.4	34.8	116.0	10.9	19.7	13.5	19.8	10.0	10.5	21.6	8.6	20.5	6.8	13.3	32.3	15.0	43.4	13.5	33.1	31.5	17.8	14.4	20.1
ANXA4	ANX4	ENSG00000196975	"Annexin A4"	P09525	2	69644425-69827100	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 212.1;pancreas: 160.1"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 1936.3;Ductal cells: 852.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 68.0;Hep G2: 71.0;RPTEC TERT1: 99.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB005076, HPA007393, CAB017560"	Enhanced		Approved	Cytosol		NA	NA		580000	Cytosol		"CAB005076: AB_630869, CAB017560: AB_2227370, HPA007393: AB_1078168"	"prognostic unfavorable (8.55e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.82e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.57e-1)"	"unprognostic (3.21e-1)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (7.23e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.97e-2)"	18.7	5.9	4.2	12.2	4.3	4.1	9.7	1.3	3.0	16.9	32.7	5.3	12.9	43.2	22.8	11.5	16.1	11.9	212.1	6.8	4.3	3.1	36.2	30.9	19.2	5.9	5.1	2.4	12.3	160.1	5.8	3.3	50.9	11.8	18.1	14.9	10.3	11.7	11.4	6.9	12.9	85.7	12.3	6.5	7.2	16.9	5.6	3.6	4.0	24.7	12.9	8.3	11.0	13.2	17.6	21.3	27.6	23.7	3.6	10.3	8.9	10.8	39.4	0.5	4.9	30.3	26.2	1.8	10.5	15.9	4.3	6.1	5.9	19.5	3.5	68.0	17.1	12.9	16.8	3.8	16.9	4.5	10.0	3.2	5.4	3.6	71.0	21.5	1.8	7.0	15.5	16.7	5.8	14.2	10.2	11.1	1.7	0.3	3.2	11.8	9.8	2.8	3.4	0.9	44.1	5.4	2.9	1.1	4.3	99.5	15.7	0.8	3.7	11.6	16.1	15.8	6.0	5.3	24.5	16.0	8.0	3.9	10.6	5.8	1.3	1.4	0.1	12.4	9.3	5.4	27.6	14.8	11.9	10.3	17.4	7.8	17.6	5.3	7.7	21.3	15.9	0.9	5.8	2.0	3.6	23.7	6.4	5.9	8.9	4.2	4.3	1.3	3.0	4.3	3.1	5.1	2.4	11.8	3.6	190.6	117.9	20.5	84.8	65.9	7.2	9.8	1936.3	278.4	133.1	80.3	5.9	74.2	187.3	852.8	12.6	41.2	479.2	0.0	308.4	326.2	105.4	51.9	108.6	59.2	193.0	7.9	17.9	27.0	44.2	6.5	59.8	61.9	87.7	107.4	167.5	40.5	315.1	293.7	86.7	253.0	56.9	6.5	52.0	11.5	3.6	69.5	367.6	32.5	132.9	90.2
AP2A1	"ADTAA, CLAPA1"	ENSG00000196961	"Adaptor related protein complex 2 alpha 1 subunit"	O95782	19	49766968-49807113	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 15.8"	"Lineage enriched"	"Detected in all"	4	"monocytes: 15.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004306	Approved		Supported	Vesicles		NA	NA		300000	Vesicles		"CAB004306: AB_2274034"	"unprognostic (4.33e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (5.85e-3)"	"unprognostic (4.84e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.82e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (2.83e-9)"	"unprognostic (2.63e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.72e-3)"	26.5	37.8	23.7	21.7	34.3	40.9	19.8	32.2	58.6	18.4	15.9	22.2	11.5	22.3	25.2	13.1	23.0	23.0	17.9	23.7	21.5	22.0	15.2	31.7	15.3	23.7	20.1	28.2	26.1	22.5	10.3	15.1	29.4	37.6	15.3	9.7	16.5	16.5	18.8	39.6	26.2	22.8	19.8	18.1	22.8	15.8	48.5	14.6	15.5	13.2	14.3	13.5	20.1	18.0	1.1	3.9	3.4	15.8	2.0	1.8	3.0	23.5	34.1	11.8	27.2	21.2	26.0	24.1	28.0	19.2	17.4	18.3	17.5	15.0	10.6	10.7	28.9	14.7	21.5	8.9	20.2	7.4	16.6	20.1	15.6	22.9	18.8	23.4	12.5	26.3	40.8	14.7	19.3	10.1	15.6	20.6	17.7	38.9	14.8	16.4	18.6	13.7	16.6	12.1	22.4	35.2	15.6	27.8	13.4	10.3	30.0	9.0	12.1	30.8	21.4	11.6	13.2	18.0	17.8	28.3	45.4	25.2	18.9	19.8	22.1	27.1	11.1	31.9	18.4	19.0	0.2	3.9	2.6	1.8	10.9	1.3	1.1	1.1	1.1	3.9	0.9	0.9	1.1	3.4	2.0	15.8	1.2	1.5	3.0	23.7	34.3	32.2	58.6	21.5	22.0	20.1	28.2	37.6	14.6	0.0	2.9	15.7	14.9	12.2	41.4	2.6	20.4	0.0	3.4	14.0	41.2	70.4	10.0	14.6	99.3	14.7	36.5	70.0	25.5	27.7	28.2	13.1	9.2	33.4	27.7	47.7	2.4	41.1	43.1	126.6	49.5	20.9	18.6	22.6	13.0	29.2	22.9	17.5	58.0	39.5	27.5	58.2	26.8	43.5	56.7	12.2	202.1	27.1	19.5	19.0
ARID1B	"6A3-5, BAF250b, DAN15, ELD/OSA1, KIAA1235, p250R"	ENSG00000049618	"AT-rich interaction domain 1B"	Q8NFD5	6	156777374-157210779	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016511, HPA075291"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016511: AB_1845008, HPA075291: AB_2686743"	"prognostic unfavorable (1.04e-4)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-1)"	18.3	15.0	20.2	18.8	20.9	25.8	19.3	42.1	32.8	20.0	17.4	26.3	21.7	15.3	23.0	14.2	18.6	20.7	15.9	16.8	20.4	11.3	14.2	10.6	17.0	18.3	19.4	16.7	30.2	18.5	47.4	29.2	12.2	17.7	17.7	13.3	24.0	20.0	20.2	30.6	27.3	17.8	21.7	14.9	21.1	15.0	10.7	24.6	24.0	23.8	13.3	26.3	23.5	21.0	9.5	11.9	5.6	3.0	2.7	5.6	1.6	7.2	11.1	16.4	22.3	13.5	12.4	11.2	7.7	10.1	10.0	10.0	9.8	10.5	22.8	4.8	13.0	12.3	9.2	14.0	12.5	9.9	22.9	9.8	16.5	11.2	11.6	9.5	13.7	12.1	14.0	10.1	15.2	13.6	10.9	13.8	14.9	19.4	17.8	7.1	8.5	15.9	15.5	8.3	9.6	5.9	36.3	7.0	12.3	6.9	13.4	15.0	19.2	15.4	16.2	9.0	9.0	10.9	21.6	14.2	12.6	13.4	11.6	15.0	12.3	11.0	29.2	11.0	16.5	16.9	5.6	3.0	2.5	5.4	2.4	5.0	6.8	4.7	3.8	2.3	9.5	4.0	5.6	5.5	2.7	2.6	11.9	4.6	1.6	20.2	20.9	42.1	32.8	20.4	11.3	19.4	16.7	17.7	24.6	44.7	46.7	59.6	18.3	42.2	35.6	27.8	28.1	28.1	36.4	120.4	27.5	10.8	6.6	33.6	12.1	27.8	19.2	0.0	29.8	6.4	27.7	23.2	38.1	23.3	12.3	44.5	39.2	37.4	29.2	13.0	52.6	28.8	28.7	72.1	38.0	23.8	39.9	21.0	59.1	12.2	30.1	45.3	28.2	6.3	14.9	48.7	14.6	23.2	34.9	20.2
ARRDC2	"CLONE24945, PP2703"	ENSG00000105643	"Arrestin domain containing 2"	Q8TBH0	19	18001132-18014102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.7"	"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 53.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053788, HPA074216"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053788: AB_2682262, HPA074216: "	"unprognostic (8.10e-2)"	"prognostic favorable (5.93e-4)"	"unprognostic (2.20e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.81e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.87e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (6.91e-4)"	"prognostic favorable (2.92e-4)"	26.7	5.3	10.4	12.5	34.6	39.3	27.7	3.2	19.5	10.9	9.6	28.3	7.3	6.9	7.6	4.7	8.1	8.5	13.1	8.5	14.1	8.2	10.7	9.8	22.6	19.0	47.5	9.0	4.9	6.2	18.7	5.7	8.1	20.1	10.1	7.2	6.0	15.3	11.6	60.7	9.4	13.3	6.7	16.8	18.7	12.1	3.2	32.9	10.5	14.3	4.9	19.1	9.3	11.3	5.9	3.1	3.7	6.3	7.2	16.0	4.7	5.8	10.7	0.2	5.4	4.5	4.1	4.2	3.4	9.8	2.9	2.9	2.4	11.6	11.0	9.8	2.9	4.7	4.0	4.3	3.1	2.3	7.1	6.3	8.4	8.3	3.3	4.1	6.3	12.4	4.4	5.0	3.3	5.1	5.4	4.9	7.1	9.6	0.3	2.7	9.1	4.8	17.5	1.3	13.2	17.7	28.3	0.1	8.2	4.2	5.5	2.6	2.6	5.6	5.7	5.7	0.9	3.4	16.3	10.4	5.0	3.9	16.9	4.3	0.8	0.0	12.4	8.1	24.2	3.9	3.7	6.3	3.7	4.0	5.2	2.8	3.9	6.7	5.1	3.1	5.9	16.0	8.4	2.4	7.2	5.4	2.0	5.0	4.7	10.4	34.6	3.2	19.5	14.1	8.2	47.5	9.0	20.1	32.9	14.9	16.2	24.9	14.4	5.7	0.4	6.2	53.5	16.0	7.9	8.7	0.0	0.6	1.7	8.3	0.7	27.0	6.6	0.0	5.6	7.1	7.8	19.7	26.5	5.4	16.7	0.0	17.7	15.4	24.0	1.0	4.4	39.6	5.0	8.2	8.7	0.9	10.8	7.8	7.1	0.3	0.4	12.9	14.6	0.5	3.7	6.1	1.0	20.8	5.2	23.1
ARRDC3	"KIAA1376, TLIMP"	ENSG00000113369	"Arrestin domain containing 3"	Q96B67	5	91368724-91383359	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 283.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 43.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.28e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.25e-8)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.15e-1)"	40.4	37.9	9.3	12.3	14.6	68.7	40.8	17.9	13.8	25.6	18.6	14.8	9.4	4.5	30.0	14.6	28.5	13.3	17.4	16.0	9.5	8.6	23.5	33.4	32.3	14.6	14.6	5.7	57.9	14.4	20.5	15.4	44.7	13.4	26.7	12.6	17.8	43.2	18.1	58.4	24.6	10.3	16.6	19.9	16.0	11.7	12.7	15.2	15.6	59.0	17.2	24.1	47.7	26.0	4.7	3.4	43.1	7.7	5.3	15.4	6.4	2.9	4.8	5.5	7.6	8.7	14.7	18.6	7.1	6.7	4.3	7.6	2.3	12.2	3.5	6.0	7.3	12.1	6.6	6.1	6.0	3.9	3.6	0.6	1.7	19.3	3.7	6.8	12.2	0.7	6.3	9.8	3.7	9.7	26.2	11.9	3.4	5.0	17.3	6.6	1.6	13.0	1.8	1.9	1.2	5.1	10.9	7.0	18.2	27.9	5.3	9.8	6.5	21.8	1.7	1.2	14.6	8.2	5.8	12.7	3.6	5.3	5.7	4.2	13.2	17.6	7.5	21.3	7.3	4.0	9.7	5.8	7.2	11.6	4.8	8.3	4.7	7.4	9.0	3.4	3.8	9.9	15.4	43.1	5.3	7.7	0.8	7.9	6.4	9.3	14.6	17.9	13.8	9.5	8.6	14.6	5.7	13.4	15.2	47.6	175.7	38.2	11.5	99.6	29.7	27.7	20.4	22.7	69.4	92.5	29.5	74.8	131.0	56.1	17.7	99.2	13.6	23.3	68.5	41.4	76.6	42.9	35.9	84.9	42.2	30.2	70.2	32.5	91.9	16.8	19.5	79.5	114.7	36.1	27.4	91.1	50.7	14.4	14.2	41.0	63.5	19.4	36.4	4.9	6.6	103.4	283.9	49.8	14.3	14.7
ASAP3	"CENTB6, DDEFL1, FLJ20199, UPLC1"	ENSG00000088280	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 3"	Q8TDY4	1	23428563-23484568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.6;ASC TERT1: 18.6;HSkMC: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020537, HPA020546"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA020537: AB_2670467, HPA020546: AB_2670470"	"unprognostic (2.51e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-3)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (3.87e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-3)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (5.12e-5)"	"unprognostic (3.39e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.27e-2)"	10.6	15.5	8.7	5.9	9.9	0.7	15.2	2.6	8.3	11.0	8.9	6.6	13.5	2.4	7.9	7.7	12.9	8.7	7.8	20.7	6.9	5.1	10.7	7.4	7.9	2.3	9.2	6.1	29.6	13.7	13.7	7.4	12.4	16.3	12.0	6.8	8.2	14.6	25.5	24.2	32.5	3.7	9.9	15.4	1.9	8.9	9.4	6.7	0.2	12.0	12.0	6.2	7.0	17.7	0.1	0.0	0.0	1.6	0.0	0.4	0.4	1.0	1.0	10.6	6.9	19.6	18.6	13.1	1.9	2.3	3.0	3.8	0.7	0.0	5.4	2.2	3.7	1.7	5.0	7.3	1.7	1.7	0.2	0.9	0.3	2.8	6.8	10.6	0.0	0.5	23.7	2.7	4.7	4.3	8.9	2.3	0.8	3.6	0.0	1.8	2.2	0.7	0.0	1.8	2.9	2.5	2.8	1.1	0.0	2.0	2.1	0.4	3.6	8.3	2.1	2.1	5.5	7.9	0.0	0.8	1.2	3.2	3.6	0.1	2.3	2.3	0.6	0.5	0.0	0.7	0.0	0.2	0.0	0.0	0.7	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.4	8.7	9.9	2.6	8.3	6.9	5.1	9.2	6.1	16.3	6.7	8.9	7.0	0.0	1.7	1.8	1.0	11.6	0.0	2.7	2.3	3.5	0.0	1.6	3.3	4.0	3.5	3.1	2.1	0.0	5.2	32.0	6.7	3.3	1.1	3.4	1.6	0.0	1.2	3.7	0.0	5.6	11.5	0.4	0.0	0.0	7.0	7.5	4.0	0.0	12.7	4.9	0.5	0.0	1.9	6.0	8.1	3.8	1.1	0.0	3.7	1.1
ATP1A3	DYT12	ENSG00000105409	"ATPase Na+/K+ transporting subunit alpha 3"	P13637	19	41966582-41997497	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Deafness, Disease mutation, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 146.4;heart muscle: 78.3"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 387.3;Cone photoreceptor cells: 161.0;Horizontal cells: 201.8;Late spermatids: 93.3;Rod photoreceptor cells: 178.0"	"Group enriched"	"Detected in many"	6	"glioma: 21.6;testis cancer: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2;memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 20.7;JURKAT: 13.5;Karpas-707: 13.2;REH: 13.0;SCLC-21H: 49.1;SH-SY5Y: 21.1"									"CAB033630, HPA045367, HPA056446"	Enhanced	Approved				NA	NA					"CAB033630: AB_781528, HPA045367: AB_2679297, HPA056446: AB_2683136"	"unprognostic (1.90e-1)"	"unprognostic (8.65e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.16e-2)"	"unprognostic (7.66e-2)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (3.44e-4)"	"prognostic favorable (6.15e-5)"	"unprognostic (4.02e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.27e-1)"	1.9	12.8	34.0	2.5	30.8	2.1	1.8	42.8	146.4	1.8	2.4	4.8	0.0	2.4	1.8	1.8	2.0	1.8	1.9	78.3	48.3	54.6	1.8	1.8	1.9	2.3	39.9	42.6	1.8	2.3	1.8	3.0	1.8	94.4	1.8	2.3	17.3	2.2	1.8	1.8	2.0	2.7	2.2	18.5	2.1	2.0	18.6	6.9	0.0	1.8	0.0	2.1	1.9	0.1	0.3	0.1	0.0	0.0	0.1	2.2	0.3	0.0	0.8	0.3	8.7	0.0	0.0	0.0	0.1	0.0	0.6	0.6	0.3	1.6	20.7	0.9	0.1	2.0	0.2	6.1	0.0	0.2	3.9	1.1	1.8	0.0	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.1	0.1	0.0	13.5	0.0	13.2	0.1	0.3	3.7	0.0	1.1	2.9	5.3	13.0	7.1	0.6	0.0	0.2	49.1	21.1	0.1	1.6	0.0	0.0	1.3	0.9	0.0	1.1	1.1	0.0	0.4	1.3	0.9	4.7	1.9	7.2	0.2	0.0	0.0	0.0	2.2	0.0	0.2	0.3	0.6	1.7	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.1	0.7	0.3	34.0	30.8	42.8	66.6	48.3	54.6	39.9	42.6	94.4	6.9	0.0	7.9	0.5	0.3	0.2	387.3	15.7	0.0	0.0	0.0	0.0	161.0	0.0	0.0	0.0	33.6	0.3	0.0	0.0	0.0	0.1	0.6	0.2	1.1	0.0	0.2	201.8	0.0	0.0	0.0	93.3	1.7	0.2	0.0	0.0	0.0	25.9	0.0	0.0	0.4	0.0	178.0	0.0	0.0	21.3	3.2	0.3	0.2	1.9	0.0	0.4
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.8"	"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 131.1;Kupffer cells: 223.6;Macrophages: 162.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 75.8"	"Group enriched"	"Detected in many"	42	"granulocytes: 75.8;monocytes: 20.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 6.0;HMC-1: 7.5;U-87 MG: 9.0;U-937: 9.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"CAB002720: , HPA014520: AB_1846337, HPA048012: "	"unprognostic (5.95e-2)"	"prognostic favorable (4.71e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.54e-2)"	33.7	8.0	1.9	34.9	7.0	46.2	8.7	0.7	3.0	5.6	6.0	3.7	1.6	1.0	4.1	4.9	3.5	14.3	16.5	11.7	7.6	3.2	5.3	9.1	38.1	26.9	3.8	1.2	7.6	3.6	1.3	27.9	12.8	10.9	4.2	1.9	7.8	2.9	1.1	7.0	1.1	3.0	11.4	11.2	48.8	4.2	6.3	1.3	2.3	2.5	1.7	3.4	12.2	2.7	0.1	1.1	75.8	20.5	0.1	0.1	2.6	1.4	5.4	0.3	0.5	1.0	0.4	1.1	1.0	0.6	0.3	0.1	0.2	6.0	0.5	1.1	1.2	0.7	2.0	0.7	0.8	0.2	1.0	0.7	0.2	5.0	0.8	0.7	2.7	7.5	0.8	3.0	0.6	0.9	0.9	0.0	0.3	0.3	2.6	0.2	1.5	0.3	3.4	1.9	0.3	0.9	0.3	0.2	0.4	1.8	1.3	0.0	0.1	0.5	0.6	0.8	0.9	0.4	3.1	0.0	0.1	3.2	0.4	0.3	0.4	0.4	0.3	9.0	9.1	0.3	7.0	8.9	6.9	0.1	15.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	75.8	0.1	20.5	0.2	0.0	2.6	1.9	7.0	0.7	3.0	7.6	3.2	3.8	1.2	10.9	1.3	3.0	33.4	11.3	0.6	4.5	0.8	2.0	2.5	52.2	26.1	1.8	2.0	0.8	3.3	0.0	0.6	1.7	1.1	0.0	0.0	0.9	2.6	0.5	23.3	3.4	131.1	0.0	0.0	3.1	223.6	0.0	0.6	162.7	5.0	14.4	0.7	0.4	0.1	0.0	0.0	1.1	4.2	12.9	1.7	0.5	1.1	2.6	1.3	0.0	0.9	0.3
C6orf120	bA160E12.4	ENSG00000185127	"Chromosome 6 open reading frame 120"	Q7Z4R8	6	169702190-169704856	"Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 93.3;Late spermatids: 214.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039626	Uncertain				"Secreted to blood"	NA	NA					"HPA039626: AB_10673361"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (1.78e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-3)"	22.1	23.5	18.4	14.8	20.8	7.0	16.8	12.3	25.1	15.5	18.9	16.0	8.9	17.4	15.2	13.2	14.9	14.2	14.4	21.2	15.5	11.3	21.3	29.9	13.8	16.0	16.2	17.0	20.9	20.0	12.2	11.6	23.7	15.3	14.1	16.0	14.0	15.4	14.1	17.1	11.4	23.5	14.8	13.0	20.2	16.7	16.5	16.2	17.0	12.3	10.8	16.2	16.6	11.4	7.1	9.0	9.6	10.6	4.1	9.6	4.7	5.8	4.7	11.6	17.6	32.3	27.0	13.1	12.3	17.8	10.3	12.1	6.3	5.5	5.0	10.0	15.0	17.2	9.0	7.5	11.3	17.4	8.4	18.2	7.1	4.4	13.3	22.9	11.8	11.4	33.1	9.3	12.3	14.3	18.2	12.5	11.6	18.7	14.4	17.7	10.6	6.4	8.1	9.8	10.3	5.5	4.7	6.3	13.4	12.8	6.6	4.7	10.6	10.2	6.5	8.2	13.7	10.9	15.6	13.7	4.4	8.5	23.0	8.3	18.7	28.6	7.2	14.5	11.0	11.4	8.1	10.6	9.6	4.9	10.6	6.6	4.7	7.2	8.5	9.0	7.1	9.6	7.7	5.9	4.1	8.2	3.1	4.7	4.7	18.4	20.8	12.3	25.1	15.5	11.3	16.2	17.0	15.3	16.2	14.9	4.0	8.2	8.2	8.8	12.7	7.7	2.5	8.1	9.1	14.0	23.6	23.7	8.3	9.2	93.3	7.3	18.3	23.3	13.9	27.1	15.5	11.6	9.2	15.5	14.6	7.9	13.7	9.8	16.8	214.1	16.4	9.0	18.6	11.8	9.0	25.6	10.2	11.6	11.0	11.0	22.8	0.0	8.3	5.2	14.5	8.9	24.3	7.5	10.3	10.9
CAB39L	"bA103J18.3, FLJ12577, MO2L"	ENSG00000102547	"Calcium binding protein 39 like"	Q9H9S4	13	49308650-49444126	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 123.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 28.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 24.4;RT4: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003686, HPA045954, HPA076632"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB003686: AB_426084, HPA045954: AB_2679512, HPA076632: "	"unprognostic (3.90e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.13e-1)"	"unprognostic (5.01e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (3.08e-2)"	"prognostic favorable (7.91e-4)"	"prognostic favorable (1.94e-13)"	"unprognostic (6.59e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.96e-2)"	"unprognostic (8.05e-3)"	19.6	32.1	18.4	5.6	18.2	2.1	32.6	17.6	22.6	12.9	33.2	13.1	19.0	5.5	11.5	14.8	25.6	12.5	13.6	14.5	22.2	16.3	12.8	5.0	12.2	3.7	29.6	19.5	17.6	10.2	17.9	10.7	10.3	26.4	35.8	10.2	7.6	13.8	20.7	4.9	10.6	8.0	21.1	23.3	3.8	18.8	24.1	24.9	2.5	8.9	9.1	4.6	21.3	13.0	3.8	3.9	9.9	3.8	2.7	5.3	3.2	1.0	1.0	6.7	1.9	6.6	6.6	9.2	6.0	12.8	3.7	3.0	24.4	3.5	8.3	0.8	4.0	4.2	1.9	3.5	4.3	7.0	2.9	3.2	2.2	1.5	1.7	3.4	1.8	1.0	4.9	3.8	3.0	4.7	5.2	4.7	1.4	0.3	2.0	5.7	1.6	1.9	1.6	5.2	3.2	1.7	1.6	0.9	1.3	5.8	25.5	0.8	2.6	3.2	7.2	7.8	7.8	11.2	3.4	4.8	1.7	1.7	3.4	4.9	1.5	1.4	9.6	1.9	1.8	4.0	9.9	3.8	7.9	4.4	3.5	3.2	3.8	5.2	5.3	3.9	2.9	4.0	3.7	8.4	2.7	2.9	0.5	5.2	3.2	18.4	18.2	17.6	22.2	22.2	16.3	29.6	19.5	26.4	24.9	14.9	11.0	0.0	11.2	2.7	5.6	13.7	5.1	24.1	11.4	10.4	5.9	22.7	10.0	8.3	123.2	2.9	1.0	0.0	9.4	10.1	12.0	23.2	4.6	1.9	5.6	1.6	2.4	5.5	2.2	17.0	14.4	4.3	11.8	7.2	2.3	11.5	7.7	0.0	11.0	3.7	5.0	6.5	11.7	8.2	3.0	3.9	24.3	1.8	1.9	20.0
CAVIN1	"cavin-1, CGL4, PTRF"	ENSG00000177469	"Caveolae associated protein 1"	Q6NZI2	17	42402452-42423517	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"RNA-binding, rRNA-binding"	"Congenital generalized lipodystrophy, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 399.0;Alveolar cells type 2: 119.0;Club cells: 93.3;Cytotrophoblasts: 122.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 112.6;fHDF/TERT166: 80.4;TIME: 93.4;U-138 MG: 95.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049838, HPA074213"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		29000	"Plasma membrane"	Vesicles	"HPA049838: AB_2680907, HPA074213: AB_2686674"	"unprognostic (1.59e-1)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.76e-3)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (7.18e-3)"	"unprognostic (2.36e-1)"	"unprognostic (3.44e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (5.87e-4)"	105.6	12.7	4.7	26.4	5.4	0.7	111.2	4.5	7.6	68.6	52.0	15.3	31.9	7.1	65.6	45.6	60.3	37.1	74.0	37.3	6.4	4.6	12.1	6.6	47.0	15.6	7.7	6.1	57.8	6.8	7.5	6.9	47.7	13.6	51.8	12.4	34.0	17.4	53.8	45.4	28.6	18.6	115.4	14.7	23.9	27.0	24.3	5.2	3.3	30.4	47.9	12.6	80.6	57.9	0.9	0.6	2.7	0.5	0.7	1.2	0.2	31.2	26.8	0.5	7.1	36.3	43.8	0.7	112.6	49.0	45.0	35.7	13.5	2.0	0.0	22.6	80.4	18.5	51.8	4.8	33.7	36.9	0.1	0.9	13.7	16.4	6.5	23.0	0.0	0.1	30.0	12.5	35.4	12.1	24.1	60.7	0.0	9.3	0.1	19.2	0.5	0.7	0.1	2.6	4.8	0.1	0.0	18.0	0.0	19.2	0.1	0.0	0.2	37.8	0.6	9.0	15.8	3.1	0.2	93.4	95.7	45.0	34.2	40.8	0.0	0.0	0.1	28.4	0.0	10.7	2.7	0.5	0.3	0.5	0.4	0.3	0.3	1.2	0.3	0.2	0.9	0.6	0.3	2.3	0.7	0.4	0.6	0.3	0.2	4.7	5.4	4.5	7.6	6.4	4.6	7.7	6.1	13.6	5.2	399.0	119.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	93.3	22.7	0.0	122.7	3.3	43.9	0.0	0.0	0.0	0.0	3.9	8.9	0.0	0.0	58.1	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	65.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	64.5	0.0	0.0	0.0
CCNE1	CCNE	ENSG00000105173	"Cyclin E1"	P24864	19	29811898-29824308	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.3;placenta: 46.7"	"Cell type enriched"	"Detected in many"	14	"Extravillous trophoblasts: 1526.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 81.6"	"Low region specificity"	"Detected in all"							"CAB000308, CAB016682, HPA018169"	Approved		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384"	"unprognostic (2.90e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (5.78e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (3.89e-5)"	"unprognostic (1.26e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.29e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.11e-16)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	1.6	6.8	2.4	4.5	2.9	23.3	0.6	6.3	3.3	0.8	3.0	1.7	1.1	2.3	1.2	0.6	4.7	0.7	2.2	4.4	2.3	2.8	1.2	0.7	1.1	4.6	1.9	1.9	0.9	1.4	1.7	1.0	46.7	2.8	1.1	3.8	1.5	3.2	1.2	2.2	4.4	2.5	3.0	1.7	4.6	2.0	12.3	1.6	4.1	1.6	2.1	5.9	2.7	2.5	2.7	1.6	1.6	1.9	0.0	1.4	0.5	4.1	8.6	6.6	9.4	1.4	1.6	81.6	6.6	1.4	2.9	3.6	8.7	8.4	3.5	15.7	2.9	3.8	1.3	7.8	3.4	4.2	11.1	4.8	2.9	8.4	9.1	1.1	11.5	7.9	1.7	1.9	4.0	0.5	0.9	3.5	3.5	11.8	1.6	4.4	6.2	6.3	3.3	11.0	9.4	2.0	9.5	7.7	2.6	2.2	6.6	5.6	4.7	9.5	11.7	1.0	10.1	2.6	8.6	2.0	6.9	25.9	4.1	4.4	6.6	4.6	23.9	3.9	1.4	3.7	0.0	0.1	0.0	0.6	1.9	1.1	2.7	0.5	0.4	1.6	0.2	0.1	0.9	1.6	0.0	1.9	0.0	1.4	0.5	2.4	2.9	6.3	3.3	2.3	2.8	1.9	1.9	2.8	1.6	0.0	1.1	0.8	1.0	4.2	2.4	2.8	0.0	0.0	2.3	0.0	0.0	112.5	0.0	0.4	7.1	1.1	1.7	0.0	0.6	1526.8	4.8	1.9	0.0	0.0	37.5	3.2	2.9	1.3	0.3	2.6	1.1	1.1	1.7	0.0	2.7	1.8	1.0	2.9	2.1	0.2	0.8	6.5	3.1	14.1	19.5	5.3	96.8	2.2	3.8	2.4
CCNH	"CycH, p34, p37"	ENSG00000134480	"Cyclin H"	P51946	5	87318416-87413019	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 169.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019416, HPA044138"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB019416: AB_2259936, HPA044138: AB_2678828"	"unprognostic (5.65e-2)"	"unprognostic (3.94e-3)"	"unprognostic (4.01e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.93e-2)"	"unprognostic (6.43e-2)"	"unprognostic (8.79e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (4.16e-2)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (3.92e-5)"	"unprognostic (1.48e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.62e-2)"	32.4	25.8	18.7	16.1	25.2	28.9	25.5	40.9	29.9	16.3	14.7	19.2	16.9	16.0	15.5	23.7	17.4	14.9	23.2	20.3	23.4	19.4	22.6	33.8	21.7	19.6	20.8	21.4	24.3	21.0	24.3	32.5	14.8	27.3	25.3	19.0	16.6	17.9	20.5	24.4	13.7	18.8	15.7	22.1	17.2	16.3	46.9	22.3	28.4	25.7	13.9	23.6	19.7	16.4	19.9	23.1	33.5	25.7	16.7	22.8	19.0	19.3	9.2	9.1	6.0	13.4	9.5	9.3	14.0	18.3	25.0	34.7	15.7	11.0	13.2	4.9	21.8	26.1	9.9	11.5	22.9	23.6	14.4	14.5	23.4	16.7	15.1	24.1	18.8	19.0	13.2	8.5	13.0	31.7	12.8	21.9	12.4	15.5	22.5	20.7	11.6	13.2	15.6	3.7	5.1	36.3	11.0	21.4	19.3	20.9	10.5	9.1	5.8	7.8	7.0	16.9	5.6	17.1	14.8	15.0	24.4	9.3	14.1	12.4	7.2	6.8	19.6	15.6	17.8	10.8	20.1	21.8	33.5	15.3	24.9	22.7	19.9	20.3	20.6	23.1	16.6	21.0	20.1	18.2	16.7	25.7	13.7	22.8	19.0	18.7	25.2	40.9	29.9	23.4	19.4	20.8	21.4	27.3	22.3	32.8	31.8	40.7	55.2	33.2	25.9	12.0	22.9	28.1	20.5	17.4	15.7	17.7	34.9	29.2	169.8	34.1	17.3	70.0	30.3	23.0	26.8	33.8	56.5	16.9	39.8	17.5	23.1	28.3	46.3	18.0	27.3	72.7	45.5	15.4	14.4	42.4	24.8	14.0	23.7	37.5	29.3	51.8	55.5	90.7	54.1	30.2	25.2	99.7	17.4	34.9
CD163	"M130, MM130, SCARI1"	ENSG00000177575	"CD163 molecule"	Q86VB7	12	7470813-7503893	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Acute phase, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 113.6"	"Cell type enriched"	"Detected in many"	7	"Kupffer cells: 1509.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 28.2;myeloid DC: 25.3"	"Group enriched"	"Detected in many"	40	"dendritic cells: 25.3;monocytes: 28.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.8;CACO-2: 1.7;GAMG: 5.4;HSkMC: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB002432, HPA046404, HPA051974"	Enhanced		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	903000000	1600000000	"Plasma membrane"		"CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678"	"unprognostic (1.13e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-2)"	66.7	23.8	2.1	44.6	7.2	4.1	23.2	2.8	4.9	11.3	25.3	1.6	1.4	3.5	7.2	16.8	11.3	20.1	13.2	15.7	2.8	1.8	43.9	38.9	81.0	99.8	6.9	0.5	10.3	6.7	3.1	11.7	31.9	9.9	6.8	6.5	9.8	8.6	2.2	15.2	4.0	12.5	37.2	5.7	113.6	10.2	19.6	4.3	3.4	15.5	2.9	3.5	20.1	8.3	0.0	25.3	0.6	28.2	0.0	0.0	6.3	0.0	0.0	0.0	0.0	1.8	1.0	0.4	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	5.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.5	0.3	5.3	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.5	0.1	0.0	0.1	0.9	0.1	0.0	0.0	0.2	0.5	0.1	0.1	0.0	0.5	0.0	0.3	0.0	0.9	0.3	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.5	28.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	6.3	2.1	7.2	2.8	2.4	2.8	1.8	6.9	0.5	9.9	4.3	3.0	8.8	9.3	0.2	1.3	0.0	3.4	10.2	2.7	9.1	0.0	2.0	1.3	0.0	0.0	2.5	1.9	0.0	0.0	0.0	1.5	1.6	0.1	4.7	5.9	221.9	0.0	0.0	28.3	1509.4	3.9	4.6	104.2	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.1	116.4	0.3	3.9	1.7	0.9	2.5	5.0	0.0	0.0
CERCAM	"CEECAM1, CerCAM, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.1"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 48.9;Fibroblasts: 70.1;Melanocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 5.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.6;ASC TERT1: 59.3;fHDF/TERT166: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: AB_2681545"	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (3.30e-5)"	12.7	5.1	40.0	7.2	65.5	1.6	9.0	10.0	62.1	19.1	6.9	61.2	5.0	4.8	11.4	10.9	8.2	6.0	17.3	8.8	72.8	34.7	4.9	1.8	5.3	2.3	59.5	28.1	14.1	18.8	15.8	21.6	27.4	31.4	11.1	5.2	3.5	13.2	13.6	4.3	8.9	6.0	27.7	78.1	3.3	5.4	5.2	62.1	0.0	6.7	2.4	2.7	15.1	6.6	0.3	2.0	0.3	1.6	1.1	5.3	2.2	9.5	6.1	6.9	7.3	55.6	59.3	5.9	30.9	29.2	8.1	6.1	2.2	0.4	0.0	12.7	50.4	6.9	6.5	3.0	4.1	3.1	2.4	4.9	0.5	5.6	3.3	17.0	1.1	17.3	32.8	2.2	8.8	2.1	33.5	9.1	0.6	2.8	7.6	10.5	18.1	0.4	11.7	0.4	0.4	4.7	0.9	4.8	1.3	3.8	3.6	1.0	1.9	6.9	8.4	3.5	2.3	6.8	2.3	10.1	21.6	5.9	29.6	4.7	8.9	6.9	0.1	20.4	3.4	4.2	0.3	1.1	0.1	3.8	1.6	0.3	0.3	0.3	4.7	1.5	0.1	0.1	5.3	0.3	1.1	0.1	2.0	0.0	2.2	40.0	65.5	10.0	24.5	72.8	34.7	59.5	28.1	31.4	62.1	6.0	13.0	0.0	6.2	7.9	1.1	3.2	0.0	6.7	21.6	10.4	0.0	14.3	0.0	10.7	2.0	7.1	0.0	0.0	2.9	48.9	70.1	3.9	8.1	0.0	5.9	6.4	0.0	18.4	0.6	1.5	22.5	4.7	38.8	1.0	0.0	0.1	6.9	0.0	24.8	0.5	0.7	6.5	15.6	1.0	19.0	3.6	16.4	2.5	0.0	2.0
CILP2	MGC45771	ENSG00000160161	"Cartilage intermediate layer protein 2"	Q8IUL8	19	19538248-19546659	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 9.4;testis: 10.1"	"Cell type enhanced"	"Detected in some"	19	"Early spermatids: 20.5;Late spermatids: 15.9;Sertoli cells: 6.5;Spermatogonia: 4.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.9;HEK 293: 5.2;NB-4: 3.9;THP-1: 5.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA041847	Uncertain				"Secreted to extracellular matrix"	NA	NA		11000000			"HPA041847: AB_10795599"	"unprognostic (6.51e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.42e-4)"	"prognostic unfavorable (3.22e-6)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.13e-3)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.41e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.59e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.36e-2)"	2.8	0.1	0.9	1.1	1.0	3.1	3.6	0.3	1.1	3.1	0.7	0.0	0.8	0.1	0.7	1.1	0.8	0.9	5.6	1.0	0.8	1.4	0.2	0.7	0.9	2.5	0.3	0.0	9.4	0.2	1.4	0.9	2.4	0.4	1.2	0.2	3.0	2.8	0.9	4.0	0.7	0.3	0.5	0.1	0.7	0.2	10.1	0.0	0.0	7.8	0.4	1.8	1.1	0.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.2	0.3	0.2	8.9	0.3	1.2	1.1	0.0	0.5	0.1	2.4	0.9	0.1	2.3	0.4	0.1	1.0	0.2	0.0	0.1	0.6	5.2	0.0	0.2	0.3	0.3	0.0	0.6	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.8	0.0	3.9	3.3	2.7	1.6	0.6	0.0	0.0	0.1	0.0	0.1	2.2	0.5	2.8	0.3	0.5	0.5	5.0	0.0	0.1	1.1	0.4	0.2	0.7	2.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.3	1.1	0.8	1.4	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.5	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.3	3.7	4.5	0.5	0.0	0.0	0.0	0.4
CLDN4	"CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8"	ENSG00000189143	"Claudin 4"	O14493	7	73799542-73832693	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 141.0"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 2545.0;Glandular cells: 2415.4;Urothelial cells: 7943.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 43.3;BEWO: 51.0;CAPAN-2: 95.4;MCF7: 48.6;OE19: 49.3;PC-3: 62.1;RT4: 42.0;SK-BR-3: 80.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002610	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB002610: "	"unprognostic (1.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (2.16e-3)"	"unprognostic (5.11e-1)"	"prognostic favorable (3.46e-10)"	"unprognostic (5.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.63e-2)"	0.7	0.2	0.4	17.1	0.4	0.0	17.1	0.4	0.5	17.5	53.7	0.7	23.2	25.0	5.1	15.9	62.3	15.4	15.4	0.5	0.4	0.3	30.2	2.0	28.8	0.4	0.4	0.4	5.5	32.4	2.7	3.5	78.1	1.3	31.8	24.7	0.7	52.0	25.7	0.6	35.3	93.3	2.7	0.4	0.4	2.7	2.5	0.4	3.8	141.0	60.9	55.7	38.5	21.0	0.1	0.1	0.2	0.1	0.1	0.6	0.0	43.3	0.5	0.0	0.2	0.0	0.0	51.0	0.4	0.0	0.0	0.0	22.7	95.4	0.0	3.5	0.0	0.3	24.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	15.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	48.6	0.0	0.2	0.0	49.3	62.1	0.0	0.8	1.0	11.6	42.0	10.1	0.2	0.0	80.9	0.1	2.9	31.6	0.1	0.0	0.1	1.8	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.4	0.4	0.4	0.5	0.4	0.3	0.4	0.4	1.3	0.4	256.1	182.2	2.2	2545.0	14.3	0.2	0.6	242.0	323.9	224.1	207.6	0.0	586.9	11.6	821.2	0.0	2.9	1686.2	0.0	388.8	629.5	21.8	2415.4	27.6	0.8	67.0	0.0	648.6	0.0	0.3	0.0	2.3	10.6	13.5	27.1	955.9	0.9	781.5	1557.1	0.0	10.2	0.0	0.0	2.1	0.0	0.2	47.2	799.6	1.7	627.6	7943.2
CLEC5A	"CLECSF5, MDL-1"	ENSG00000258227	"C-type lectin domain containing 5A"	Q9NY25	7	141927357-141947007	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.8"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 18.6;Macrophages: 57.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"classical monocyte: 11.5"	"Lineage enriched"	"Detected in many"	8	"monocytes: 11.5"	"Group enriched"	"Detected in some"	23	"HL-60: 15.2;U-937: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA054137			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA054137: AB_2732582"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.33e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.58e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.64e-1)"	1.4	3.2	1.8	7.3	2.4	35.8	0.8	0.8	2.5	1.7	0.4	1.9	0.6	0.4	0.8	0.5	1.4	1.2	2.0	3.8	7.6	3.1	2.9	2.1	13.9	0.3	2.4	0.5	2.7	2.6	1.4	1.1	2.7	8.2	0.9	0.5	0.8	2.7	0.8	0.3	2.7	0.3	1.5	4.8	2.1	0.4	0.9	4.8	1.1	1.4	4.9	1.4	1.9	1.1	0.0	0.5	1.4	11.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.7	0.0	0.0	11.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	1.9	1.8	2.4	0.8	2.5	7.6	3.1	2.4	0.5	8.2	4.8	0.0	7.4	0.0	0.0	1.6	0.0	0.3	2.5	5.3	9.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	2.3	0.0	18.6	0.0	0.0	0.0	3.8	0.2	0.0	57.4	1.7	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.3	0.2	0.0	0.0	0.0
CNNM4	"ACDP4, KIAA1592"	ENSG00000158158	"Cyclin and CBS domain divalent metal cation transport mediator 4"	Q6P4Q7	2	96760902-96811891	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Biomineralization, Ion transport, Sensory transduction, Transport, Vision"		"Amelogenesis imperfecta, Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 106.0;Enterocytes: 53.8;Rod photoreceptor cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 29.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017732	Enhanced		Uncertain	"Plasma membrane,Actin filaments"		NA	NA			"Actin filaments"	"Plasma membrane"	"HPA017732: AB_1847395"	"unprognostic (1.98e-3)"	"unprognostic (8.95e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (3.42e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.72e-1)"	"unprognostic (8.14e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	3.7	4.0	4.8	17.0	9.6	4.5	7.4	24.1	11.1	6.8	31.2	11.3	8.3	6.3	10.4	5.2	7.7	10.8	7.3	11.5	5.4	5.0	5.9	4.9	8.1	4.3	6.0	6.6	6.1	11.4	9.0	10.6	17.1	5.5	7.4	33.5	13.9	10.8	11.3	21.3	7.4	11.1	5.7	5.2	6.1	12.6	11.8	6.1	4.6	9.7	6.1	9.3	6.5	7.4	3.7	2.2	2.8	2.3	0.8	3.2	1.1	6.9	4.6	3.7	6.8	3.9	2.6	10.2	3.0	4.3	4.5	6.1	8.3	7.5	5.0	8.8	3.1	6.2	9.0	9.5	5.2	4.2	10.1	7.5	4.0	3.1	4.5	5.4	1.9	4.0	2.5	6.5	7.2	4.4	3.0	2.4	5.1	2.0	14.4	2.3	9.8	4.0	2.8	4.9	12.9	6.3	6.0	1.7	5.8	4.5	5.4	17.4	5.2	5.8	29.6	4.3	10.8	14.4	3.3	2.2	2.6	5.9	5.7	3.4	5.0	4.0	2.6	3.8	3.8	4.6	2.8	1.6	0.5	3.2	1.8	1.1	3.7	1.7	1.7	2.2	2.1	1.1	2.1	0.7	0.8	2.3	1.7	0.8	1.1	4.8	9.6	24.1	11.1	5.4	5.0	6.0	6.6	5.5	6.1	35.7	7.7	4.7	3.8	5.0	38.8	11.8	7.6	5.3	14.8	7.0	106.0	4.7	0.0	2.6	4.1	2.9	53.8	0.0	3.6	1.4	2.8	3.4	1.1	3.0	3.0	31.8	9.7	3.1	5.4	1.0	0.9	2.4	0.0	0.0	26.3	7.7	3.8	20.9	1.1	1.2	46.8	0.0	4.7	5.5	2.0	3.6	5.6	2.9	21.7	4.9
COG3	SEC34	ENSG00000136152	"Component of oligomeric golgi complex 3"	Q96JB2	13	45464898-45536630	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040353, HPA054470"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA040353: AB_10794027, HPA054470: AB_2732585"	"unprognostic (1.75e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.04e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.71e-1)"	12.5	17.4	8.7	17.1	14.0	10.9	17.0	19.7	14.5	16.9	17.1	13.0	22.4	13.2	16.9	20.6	14.4	14.0	12.8	12.5	8.9	9.4	16.5	46.2	12.1	11.7	9.3	10.0	17.9	29.4	10.9	22.6	32.9	11.5	20.9	20.7	12.9	28.3	25.2	12.5	14.7	18.8	13.3	10.1	14.8	15.6	9.9	11.2	17.4	18.5	8.7	18.5	14.8	14.8	5.1	7.2	7.4	4.6	4.9	8.0	3.8	5.4	4.9	9.5	8.6	12.6	14.5	9.1	9.1	13.0	10.6	8.9	7.2	10.1	7.5	4.1	10.8	7.9	12.0	7.8	9.2	16.2	5.8	6.4	8.4	6.0	12.6	15.6	12.3	8.1	10.8	13.9	7.0	25.1	12.9	10.3	7.4	5.4	4.6	12.7	8.4	6.8	11.6	7.8	27.4	6.0	8.0	5.6	7.0	9.9	8.9	4.7	8.6	5.9	11.6	12.1	9.4	7.9	12.8	9.6	5.1	4.0	9.5	5.8	6.5	3.5	7.8	9.8	6.2	9.1	7.4	4.1	7.3	7.5	4.6	8.0	5.1	5.8	6.4	3.1	4.9	6.6	6.1	3.7	4.9	2.9	7.2	6.2	3.8	8.7	14.0	19.7	14.5	8.9	9.4	9.3	10.0	11.5	11.2	8.9	31.8	15.2	12.2	14.1	9.4	16.9	20.4	9.4	23.9	12.2	13.7	12.4	13.3	9.4	12.9	12.1	27.1	23.3	32.9	15.5	10.8	25.6	16.2	73.3	9.8	9.5	21.4	20.3	20.8	7.4	13.0	14.6	10.1	6.4	43.3	5.2	18.0	34.5	12.7	11.9	10.4	6.5	9.9	11.5	6.6	14.1	27.5	17.5	21.4	19.0
COL8A2	"FECD, FECD1, PPCD, PPCD2"	ENSG00000171812	"Collagen type VIII alpha 2 chain"	P25067	1	36095236-36125220	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"		"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 39.4"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 9.8;Fibroblasts: 13.4;Hofbauer cells: 6.5;Melanocytes: 6.8;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.0;intermediate monocyte: 1.2;myeloid DC: 2.8;plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	15	"dendritic cells: 2.8;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ: 5.6;fHDF/TERT166: 4.1;HHSteC: 14.2;hTERT-RPE1: 18.1;THP-1: 4.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA049788	Uncertain		Uncertain	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA			"Golgi apparatus"		"HPA049788: AB_2680882"	"unprognostic (9.98e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.41e-3)"	"unprognostic (8.76e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.35e-5)"	"unprognostic (1.08e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.16e-3)"	4.4	1.2	1.7	8.1	3.4	0.3	7.2	6.0	1.3	9.6	4.8	4.5	1.0	1.4	5.2	3.1	6.4	3.4	6.3	11.1	1.7	1.4	1.1	0.4	4.8	2.9	3.8	0.9	4.2	1.8	0.1	3.7	13.7	7.6	5.5	2.1	39.4	6.5	13.4	1.4	4.6	1.8	16.3	4.8	7.5	9.6	1.9	2.5	1.9	7.7	4.7	3.5	10.1	5.5	0.0	2.8	0.1	1.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	1.0	0.1	5.6	1.6	1.5	0.9	0.2	0.1	0.0	0.8	4.1	0.0	0.3	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	14.2	0.0	0.0	1.7	0.1	0.7	0.0	18.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.5	0.5	0.5	0.0	0.2	0.4	0.0	4.5	0.1	2.3	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	0.2	2.4	0.0	0.2	1.7	3.4	6.0	1.3	1.7	1.4	3.8	0.9	7.6	2.5	0.0	2.6	0.0	1.6	1.9	0.0	9.8	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.3	0.0	0.7	0.0	0.0	0.2	0.2	13.4	0.7	2.3	0.0	6.5	0.0	0.0	0.6	1.9	0.0	2.8	5.1	6.8	0.0	0.0	0.3	0.4	0.0	5.6	0.0	0.0	6.5	2.3	0.0	0.1	1.1	0.7	0.0	0.0	0.4
CST4		ENSG00000101441	"Cystatin S"	P01036	20	23685640-23689040	"Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	94	"salivary gland: 705.3"	"Cell type enriched"	"Detected in single"	9	"Collecting duct cells: 8.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 6.8;RT4: 16.7"									"HPA043706, HPA044763"	Supported				"Secreted to digestive system"	NA	NA		2700000			"HPA043706: AB_2678627, HPA044763: AB_2679080"	"unprognostic (2.80e-1)"		"unprognostic (7.88e-2)"	"unprognostic (2.48e-1)"		"unprognostic (1.09e-1)"		"unprognostic (2.59e-1)"		"prognostic unfavorable (4.98e-5)"	"unprognostic (1.00e-2)"	"unprognostic (9.52e-2)"		"unprognostic (2.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.95e-2)"	"prognostic favorable (2.88e-4)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	2.5	0.1	0.1	0.0	1.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.0	0.1	0.1	0.1	7.5	0.0	0.1	705.3	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	4.7	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	6.8	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	16.7	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3
DAGLB	"DAGLBETA, KCCR13L"	ENSG00000164535	"Diacylglycerol lipase beta"	Q8NCG7	7	6409126-6484190	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069377			Supported	"Nucleoplasm,Plasma membrane"		No	No			"Plasma membrane"	Nucleoplasm	"HPA069377: AB_2686132"	"unprognostic (2.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (7.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-2)"	20.1	28.2	12.6	12.7	20.3	25.8	29.8	18.4	26.1	19.1	18.0	11.4	19.4	15.1	14.3	17.5	16.2	12.5	26.6	18.9	12.4	13.8	24.0	88.0	18.4	25.2	11.6	5.8	22.5	47.0	14.2	19.0	45.7	7.5	14.6	10.6	14.6	34.1	22.3	22.0	22.1	31.3	16.0	13.2	15.1	14.0	27.1	7.9	7.2	23.1	15.1	16.8	15.6	20.8	5.6	18.9	13.6	14.7	2.4	8.4	7.5	10.9	12.5	5.4	7.0	8.2	6.4	4.3	15.4	10.5	13.3	14.4	6.6	12.0	5.9	6.7	7.4	32.5	16.2	8.8	8.1	7.6	2.7	6.1	3.1	14.3	4.5	8.8	8.9	5.0	5.7	13.5	8.9	8.8	5.3	5.7	7.6	8.9	2.9	7.8	7.7	3.1	12.6	19.7	5.4	9.5	27.4	6.2	12.7	8.4	4.0	7.0	4.2	8.7	13.4	2.5	9.0	9.3	16.7	7.0	11.5	21.9	14.4	7.1	3.1	5.6	5.0	5.7	14.0	13.9	6.2	14.7	13.6	4.4	13.9	3.9	5.6	3.5	2.9	18.9	3.6	8.4	4.8	7.3	2.4	12.2	3.2	2.9	7.5	12.6	20.3	18.4	23.4	12.4	13.8	11.6	5.8	7.5	7.9	8.9	13.0	3.9	2.8	14.9	4.2	2.4	2.5	2.7	3.4	5.2	2.0	4.4	0.0	6.2	0.4	6.7	10.9	0.0	5.3	7.7	4.6	4.6	3.5	6.2	14.7	0.0	2.4	8.0	15.4	0.9	5.8	15.3	5.0	11.8	4.7	0.9	9.2	5.8	2.1	1.8	4.5	0.0	5.7	7.2	6.8	11.7	10.4	5.3	6.3	3.2
DHRS7	"retDSR4, SDR34C1"	ENSG00000100612	"Dehydrogenase/reductase 7"	Q9Y394	14	60144120-60169856	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 123.5"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"prostate cancer: 199.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031121, HPA078401"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No		63000	"Nucleoplasm, Mitochondria"		"HPA031121: AB_10600803, HPA078401: "	"prognostic favorable (6.42e-4)"	"unprognostic (5.20e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.92e-10)"	"unprognostic (8.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	15.0	24.6	12.3	10.1	10.9	10.5	17.9	10.6	12.4	11.1	30.6	10.7	57.3	20.7	11.7	19.4	12.3	9.9	15.3	17.4	11.0	11.4	22.6	27.9	13.1	13.9	14.1	8.8	13.4	17.2	40.2	17.2	6.1	17.8	83.4	13.4	9.1	113.7	93.0	123.5	9.8	48.7	9.6	15.5	11.1	32.6	4.9	11.0	6.4	24.8	16.7	10.1	12.4	15.6	26.0	56.6	121.4	32.2	37.3	50.8	54.0	52.6	15.9	9.2	20.2	47.7	18.7	11.7	17.0	43.8	6.2	13.8	8.8	35.7	5.5	10.2	15.9	15.8	22.7	12.0	23.9	9.1	38.3	11.2	13.6	7.8	14.4	25.1	16.1	0.4	13.9	28.8	9.8	33.3	11.1	11.9	14.0	4.1	11.9	15.5	15.9	9.3	15.3	4.3	31.1	16.1	9.7	12.4	6.4	27.7	18.0	19.8	24.8	17.2	26.1	37.7	11.8	18.3	7.1	8.3	30.9	10.5	8.4	9.7	4.2	1.9	9.8	16.8	15.6	21.2	80.1	32.2	71.6	50.8	22.6	49.9	26.0	36.0	43.9	27.1	21.8	20.2	38.9	121.4	37.3	29.0	56.6	29.0	54.0	12.3	10.9	10.6	12.4	11.0	11.4	14.1	8.8	17.8	11.0	50.6	96.5	40.4	57.0	30.2	23.6	16.5	147.7	46.8	59.1	82.0	78.5	22.0	16.6	184.7	1.5	65.9	155.6	0.0	145.2	76.8	60.2	242.6	172.3	147.5	88.2	39.7	44.6	30.1	58.9	2.0	76.2	101.1	102.9	178.5	77.9	88.0	174.5	89.2	79.2	41.6	54.4	84.1	70.6	1.1	3.1	22.2	17.4	135.7	66.0	41.6
DSE	"DS-Epi1, DSEPI, SART2"	ENSG00000111817	"Dermatan sulfate epimerase"	Q9UL01	6	116254173-116444860	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 85.3;Macrophages: 81.1;monocytes: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 8.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA014764, HPA052151"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA014764: AB_1856587, HPA052151: AB_2681746"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.19e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-2)"	32.3	10.6	7.4	22.3	10.7	13.1	34.8	5.4	7.7	16.0	12.8	4.9	9.9	5.3	11.7	18.5	13.5	15.3	12.9	16.1	8.1	4.3	11.2	10.4	17.7	13.1	9.8	4.5	21.0	4.0	15.4	20.9	21.7	13.1	13.0	7.1	14.3	9.3	9.4	8.5	16.9	10.7	12.8	16.1	24.9	7.6	10.9	9.0	8.3	8.7	10.9	8.3	14.6	29.4	3.6	8.9	2.5	3.9	0.2	1.1	1.2	10.5	2.3	7.9	7.4	21.5	14.2	9.0	12.5	29.4	15.7	23.1	0.0	3.0	0.3	1.1	21.8	15.8	20.3	1.1	29.4	20.6	10.9	4.8	0.7	3.4	0.1	24.0	0.5	0.5	30.1	12.7	17.4	17.1	8.2	9.2	2.7	0.2	4.8	7.5	0.3	1.4	0.6	4.2	0.0	0.6	1.8	7.3	5.0	10.4	0.7	2.6	2.0	12.1	0.0	0.3	5.7	0.1	1.2	3.4	15.9	4.6	3.9	10.0	1.0	0.3	0.5	8.4	1.3	1.8	0.7	3.1	0.1	1.0	3.9	0.6	3.2	0.9	0.4	8.9	3.6	1.1	0.4	2.5	0.2	2.2	4.2	0.2	1.2	7.4	10.7	5.4	7.7	8.1	4.3	9.8	4.5	13.1	9.0	14.9	2.6	18.6	20.6	46.1	4.1	7.0	5.1	18.7	18.2	3.5	0.0	2.0	6.6	4.0	39.9	11.9	0.0	0.0	7.5	3.7	35.5	14.2	22.0	3.8	39.5	1.6	1.2	57.7	85.3	19.2	50.9	81.1	10.1	97.4	0.7	3.9	9.5	0.0	28.3	6.1	3.0	32.3	29.2	2.6	5.1	34.9	4.1	6.5	1.0	42.4
EBPL	EBRP	ENSG00000123179	"Emopamil binding protein like"	Q9BY08	13	49660723-49691475	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 285.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA049891	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA049891: AB_2680937"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (7.18e-8)"	"unprognostic (1.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.95e-2)"	10.2	32.6	5.8	13.4	5.7	11.1	17.1	4.5	8.6	21.5	13.9	4.7	8.8	10.1	21.1	7.0	32.9	13.0	7.2	6.8	4.8	7.1	12.8	64.8	14.5	17.9	6.1	5.0	21.8	46.4	6.6	5.9	7.3	9.4	22.4	11.7	8.2	21.0	14.6	4.9	15.5	8.8	13.5	6.0	13.7	13.6	8.4	3.7	11.1	22.2	21.8	19.7	14.7	22.6	7.0	6.7	9.3	4.8	5.5	10.4	1.7	14.3	11.6	7.5	30.8	9.5	23.1	12.2	14.9	11.1	11.4	8.3	22.4	21.0	17.6	6.9	8.1	9.8	30.3	13.7	15.9	15.5	13.9	39.0	15.2	8.1	31.8	26.8	22.1	11.4	26.9	33.0	8.3	23.5	17.5	18.5	20.9	10.8	7.7	14.0	9.6	8.6	41.9	24.5	51.4	24.3	18.1	4.3	28.3	22.8	4.8	6.5	17.0	5.8	20.9	6.8	8.0	18.0	17.9	9.1	7.8	7.9	6.6	12.4	4.8	11.9	14.8	3.4	22.1	7.2	2.8	4.0	1.1	3.4	4.7	10.0	5.8	7.3	7.2	6.7	7.0	10.4	5.8	9.3	5.5	4.8	4.5	4.9	1.7	5.8	5.7	4.5	8.6	4.8	7.1	6.1	5.0	9.4	3.7	32.8	17.2	59.6	137.3	96.5	6.8	3.8	76.5	5.3	14.8	22.7	7.9	26.0	34.9	55.4	11.6	57.3	12.7	0.0	44.5	33.3	44.2	104.1	18.4	285.3	33.1	1.6	26.8	65.7	45.6	8.4	87.2	31.9	43.9	3.6	79.1	13.6	42.9	21.0	65.7	52.5	8.0	19.4	53.6	31.6	14.1	135.1	12.7	39.8	112.1	100.9
EHD2	PAST2	ENSG00000024422	"EH domain containing 2"	Q9NZN4	19	47713343-47743134	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Leydig cells: 91.7;Peritubular cells: 100.8;Sertoli cells: 232.8;Smooth muscle cells: 117.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 59.6;ASC TERT1: 45.4;fHDF/TERT166: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047394, HPA049890, HPA049986, HPA066751"	Approved		Supported	"Plasma membrane"		NA	NA		580000	"Plasma membrane"		"HPA047394: AB_2680026, HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.33e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.70e-3)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (5.49e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (6.59e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.06e-3)"	82.2	17.8	6.7	14.5	6.1	0.6	62.0	4.3	7.5	35.2	29.1	5.0	10.0	6.7	40.2	21.2	33.0	20.7	34.3	19.3	5.4	2.9	8.3	4.5	28.1	13.5	5.4	3.4	34.0	11.1	3.1	3.8	22.8	6.4	28.2	7.3	11.6	9.7	25.1	17.3	15.3	14.3	40.7	4.5	19.0	17.5	12.9	5.7	1.8	15.0	24.6	8.3	35.0	52.6	0.6	0.4	2.4	0.6	0.2	0.5	0.9	11.3	26.6	0.0	0.3	59.6	45.4	0.0	44.4	21.0	16.1	13.1	1.7	5.7	0.0	0.0	46.9	3.8	14.4	0.2	23.1	9.8	0.0	0.1	1.5	15.5	0.1	37.7	0.0	3.1	43.9	20.4	13.5	13.3	21.4	31.0	0.1	4.7	0.0	16.9	2.0	2.3	0.1	0.3	1.6	4.8	0.2	1.8	0.0	12.8	0.5	0.0	0.1	38.9	1.5	1.1	3.7	3.7	0.7	35.3	24.2	5.4	21.2	9.5	0.0	0.0	0.0	22.5	0.6	5.1	1.0	0.4	0.6	0.3	0.3	0.3	0.5	0.3	0.4	0.1	0.6	0.5	0.5	2.4	0.2	0.6	0.4	0.3	0.9	6.7	6.1	4.3	7.5	5.4	2.9	5.4	3.4	6.4	5.7	56.6	22.3	0.0	24.5	18.0	3.2	7.3	12.7	1.4	17.0	5.2	0.0	0.9	0.0	17.5	0.6	58.5	0.0	0.0	11.9	1.3	39.2	11.6	2.3	2.1	1.7	0.0	0.0	42.4	1.0	1.9	91.7	3.2	8.5	1.0	0.0	1.7	25.4	0.0	100.8	0.0	0.8	232.8	117.3	0.7	3.4	11.8	1.3	0.0	0.0	26.5
ELK3	"ERP, NET, SAP2"	ENSG00000111145	"ELK3, ETS transcription factor"	P41970	12	96194382-96269835	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 91.0;Endothelial cells: 133.8;Ito cells: 151.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001600	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA001600: AB_1078752"	"unprognostic (3.11e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.38e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-3)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.05e-2)"	36.9	9.3	5.0	20.9	6.7	8.3	23.5	12.9	4.5	29.2	12.6	7.3	12.0	4.6	45.2	15.6	25.7	15.0	16.3	15.5	4.8	5.1	13.3	8.2	17.1	20.6	6.1	2.8	13.3	5.8	6.6	6.0	15.9	8.9	18.1	7.5	15.7	14.1	8.6	10.5	8.7	11.1	20.8	13.1	32.7	9.1	8.6	6.3	17.4	19.7	25.1	32.1	15.9	20.9	11.3	9.4	4.1	12.8	10.5	24.1	6.3	12.9	7.8	8.0	4.2	20.4	38.4	2.0	16.5	31.7	13.2	10.2	0.4	9.7	2.1	5.7	18.5	9.9	4.6	0.9	26.5	23.3	5.6	3.0	0.6	3.3	2.9	6.2	6.3	1.5	22.5	5.0	27.2	20.6	26.9	31.5	1.6	1.5	8.7	44.5	2.0	1.2	4.2	9.8	1.8	10.4	10.3	13.5	2.3	11.3	3.4	0.4	8.5	5.4	2.4	8.2	12.7	1.3	3.4	19.3	36.3	14.2	22.3	14.3	16.7	13.9	0.5	12.8	7.4	25.1	3.3	12.8	0.3	6.2	6.9	24.1	11.3	14.7	8.4	9.4	9.9	8.9	6.5	4.1	10.5	5.9	3.8	23.4	6.3	5.0	6.7	12.9	4.5	4.8	5.1	6.1	2.8	8.9	6.3	6.0	30.6	17.6	31.5	29.0	0.5	4.8	5.1	91.0	54.6	5.2	3.9	0.9	5.0	18.1	0.6	133.8	0.7	0.0	13.5	3.1	34.2	29.1	16.2	3.6	20.8	0.0	1.2	151.0	36.0	1.3	10.6	22.2	11.8	3.6	3.0	4.7	36.9	2.9	9.9	0.0	0.4	12.9	24.3	0.0	14.7	23.6	0.9	15.9	2.9	67.8
ELMSAN1	"C14orf117, C14orf43, LSR68"	ENSG00000156030	"ELM2 and Myb/SANT domain containing 1"	Q6PJG2	14	73715122-73790285	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003111	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003111: AB_1078329"	"unprognostic (1.54e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.36e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.96e-1)"	17.8	8.1	11.2	18.7	10.1	18.8	17.4	17.8	9.9	17.3	13.7	14.5	9.7	11.2	16.8	11.1	14.0	12.7	15.8	11.2	8.3	6.3	7.7	7.8	13.9	12.9	7.6	8.2	18.6	8.7	21.4	7.6	12.8	9.4	14.2	6.0	16.8	13.1	13.1	13.4	26.1	14.1	13.9	7.6	18.8	12.6	8.2	11.8	8.8	11.0	9.5	20.0	16.1	15.0	2.9	4.4	3.1	1.9	2.1	1.8	1.3	6.8	7.7	2.8	5.2	2.6	4.5	5.4	2.8	4.8	3.9	3.5	6.7	8.2	10.0	3.2	3.8	4.1	10.6	4.6	7.9	1.6	13.2	2.8	16.0	6.6	2.4	4.3	2.7	34.9	5.9	4.9	3.4	4.3	3.4	6.2	3.5	8.2	9.3	1.9	16.0	6.3	4.4	0.9	3.4	6.4	7.4	15.2	2.6	5.9	7.4	3.6	3.0	10.6	14.7	5.9	1.6	11.3	5.9	12.3	8.1	9.4	6.0	3.0	7.3	3.4	11.1	6.6	3.4	9.4	2.1	1.9	0.7	1.2	0.9	1.8	1.8	0.6	1.3	2.1	2.9	0.7	0.8	3.1	2.1	1.1	4.4	1.4	1.3	11.2	10.1	17.8	9.9	8.3	6.3	7.6	8.2	9.4	11.8	23.8	22.4	64.8	25.5	78.6	20.9	18.6	20.4	13.4	10.3	17.4	49.1	32.2	13.3	17.8	1.6	26.4	41.7	0.0	14.9	23.4	29.6	22.2	22.0	17.1	23.3	11.1	39.2	43.6	34.2	2.2	25.0	22.4	69.2	28.9	30.4	17.8	17.2	28.8	29.4	12.9	33.8	32.3	25.0	1.1	18.8	54.5	24.6	26.7	20.2	5.8
EMP1	"CL-20, TMP"	ENSG00000134531	"Epithelial membrane protein 1"	P54849	12	13196716-13219939	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 240.9;lymphoid tissue: 129.3"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 616.6;Fibroblasts: 489.5;Melanocytes: 448.7;Suprabasal keratinocytes: 601.1;Urothelial cells: 926.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 28.6"	"Cell type enriched"	"Detected in some"	7	"myeloid DC: 7.0"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 7.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 132.0;fHDF/TERT166: 91.8;HaCaT: 82.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA051931, HPA056250"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051931: , HPA056250: "	"unprognostic (1.40e-2)"	"unprognostic (7.30e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.41e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (2.26e-8)"	"prognostic unfavorable (7.46e-4)"	"unprognostic (2.98e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (9.69e-8)"	63.3	5.0	2.7	8.0	10.4	2.1	20.8	0.8	3.9	51.3	11.6	5.5	4.0	4.6	14.0	10.4	240.9	9.9	25.2	16.1	7.3	2.8	8.9	4.4	18.1	5.9	5.3	0.9	5.7	10.2	2.9	2.8	10.6	28.6	6.3	6.9	17.8	45.4	2.8	12.0	16.8	10.7	17.6	9.7	8.5	6.0	5.2	3.0	0.6	22.5	99.1	129.3	14.1	80.6	0.0	7.0	0.0	0.5	0.1	0.1	0.0	38.9	2.0	1.0	0.2	63.1	132.0	0.1	28.8	52.9	14.9	19.0	0.2	66.0	0.2	20.6	91.8	6.5	82.1	1.1	3.8	20.2	0.7	0.0	0.1	6.9	0.0	15.2	0.2	0.2	41.4	5.6	47.3	13.9	11.8	34.0	0.0	0.2	0.6	35.0	0.1	0.0	0.8	0.7	7.3	6.7	0.1	4.0	0.3	43.5	0.4	0.0	0.0	12.9	1.9	21.5	7.7	0.3	0.2	37.2	33.5	11.8	31.4	15.5	0.1	0.4	0.2	48.8	0.2	39.3	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.1	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	2.7	10.4	0.8	3.9	7.3	2.8	5.3	0.9	28.6	3.0	190.6	90.0	2.7	198.6	616.6	0.0	9.5	2.5	87.0	247.9	17.4	0.0	0.8	13.3	17.9	0.7	293.7	59.6	0.0	3.9	1.5	489.5	352.1	46.5	2.0	41.5	0.0	45.6	127.7	32.1	0.5	64.5	93.9	448.7	7.2	4.0	2.5	37.6	27.1	102.9	0.2	0.0	6.5	173.1	0.7	0.5	601.1	0.9	5.1	5.6	926.6
EPB41L2	4.1-G	ENSG00000079819	"Erythrocyte membrane protein band 4.1 like 2"	O43491	6	130839347-131063322	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	18	"Muller glia cells: 499.6;Rod photoreceptor cells: 1331.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005730, HPA006642"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		170000	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA005730: AB_1848195, HPA006642: AB_1848194"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.19e-2)"	50.2	16.5	29.6	17.3	42.8	3.9	21.1	6.5	40.1	20.5	23.1	32.3	7.2	12.3	23.0	13.7	13.2	25.6	18.0	22.8	33.4	24.6	11.5	12.1	24.4	15.4	50.5	33.1	44.4	9.1	8.2	8.4	26.2	34.8	11.2	23.2	52.0	10.1	15.8	16.0	7.1	21.4	20.6	59.5	25.3	11.7	32.2	51.9	6.8	15.2	14.6	11.6	15.2	16.6	10.5	8.6	0.5	8.8	1.0	2.5	1.3	8.3	8.8	20.0	27.4	13.9	22.3	6.1	14.2	18.0	14.5	20.3	16.8	11.9	10.2	26.7	19.5	11.8	4.3	7.6	13.1	29.0	43.3	17.7	18.3	10.5	9.6	8.2	0.0	22.3	10.9	0.2	25.6	9.9	23.5	22.3	15.6	49.5	29.3	9.2	2.1	14.3	3.1	18.5	35.8	9.6	22.3	24.0	0.9	24.4	8.0	2.1	0.0	5.9	0.1	11.5	21.4	3.0	19.1	27.0	17.1	32.3	28.9	42.7	24.3	0.4	9.5	11.7	0.1	26.0	0.1	3.1	0.5	1.0	8.8	0.9	2.9	1.0	1.2	8.6	10.5	1.7	0.7	0.0	1.0	3.3	2.3	2.5	1.3	29.6	42.8	6.5	39.6	33.4	24.6	50.5	33.1	34.8	51.9	6.0	11.8	15.4	12.1	13.7	52.8	12.6	22.9	20.1	28.4	1.8	212.1	2.8	0.0	28.2	273.7	47.2	31.6	0.0	14.3	5.1	74.8	3.3	42.8	3.4	29.8	27.0	9.8	39.3	104.6	245.3	67.6	61.1	10.1	17.2	36.8	499.6	37.8	21.0	43.5	9.8	1331.8	116.4	56.7	54.3	79.8	8.9	2.1	5.0	21.6	6.8
EPHA4	"Hek8, TYRO1"	ENSG00000116106	"EPH receptor A4"	P54764	2	221418027-221574202	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 25.0;Pancreatic endocrine cells: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 3.0;gdT-cell: 3.4;MAIT T-cell: 3.4;memory B-cell: 2.5;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.3;naive B-cell: 1.8;naive CD4 T-cell: 1.9;NK-cell: 6.0;T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 35.8;ASC diff: 15.8;CACO-2: 26.2;U-2197: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB028368	Enhanced					NA	NA		8400000			"CAB028368: AB_2099353"	"unprognostic (1.28e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.05e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.66e-2)"	7.1	1.8	8.1	1.9	18.3	3.5	5.2	14.7	29.6	4.9	5.9	3.1	3.2	1.1	6.5	3.1	5.0	6.6	3.3	16.7	19.9	4.4	5.2	0.9	3.7	2.5	2.4	16.4	11.7	1.2	2.0	1.2	1.7	4.9	5.9	4.7	0.8	3.7	6.7	3.1	12.8	4.1	8.2	2.1	3.3	4.0	11.4	2.6	0.5	9.8	3.7	3.2	4.6	4.9	2.5	0.2	3.0	0.0	6.0	5.0	0.7	1.1	1.1	35.8	0.0	15.8	9.8	0.0	8.5	3.7	7.7	2.8	26.2	0.4	0.0	0.0	11.8	0.0	3.1	5.5	0.0	3.2	4.2	3.0	0.0	0.3	0.0	0.4	0.0	0.6	3.9	1.9	2.4	0.0	4.8	7.2	0.0	0.0	0.0	2.0	4.2	0.1	0.0	2.5	2.6	0.8	0.0	3.9	0.0	12.0	1.9	6.3	0.0	2.8	0.6	0.6	3.0	1.3	0.0	0.0	0.8	1.5	17.5	0.4	0.0	0.0	0.0	3.2	0.0	1.6	3.0	0.0	0.0	3.4	0.0	3.4	2.5	5.0	3.3	0.0	1.8	1.9	0.3	0.2	6.0	0.0	0.2	2.1	0.7	8.1	18.3	14.7	29.6	19.9	4.4	2.4	16.4	4.9	2.6	0.0	5.4	0.8	0.4	5.5	10.2	25.0	7.6	1.4	3.4	8.7	0.0	0.0	6.6	0.2	2.0	11.7	0.1	0.0	0.2	0.0	3.9	1.2	1.1	0.0	0.3	1.6	3.4	12.3	0.0	4.3	1.1	0.2	6.8	0.0	14.0	6.3	18.0	0.0	8.1	1.5	2.7	0.0	7.2	6.7	1.3	10.9	0.0	1.0	6.8	1.8
FAM120B	"CCPG, KIAA1838, PGCC1"	ENSG00000112584	"Family with sequence similarity 120B"	Q96EK7	6	170290703-170407065	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	32	"Early spermatids: 546.2;Late spermatids: 1520.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037518, HPA037519"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037518: AB_10671626, HPA037519: AB_10696935"	"unprognostic (7.99e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.87e-2)"	"prognostic unfavorable (1.60e-4)"	"prognostic favorable (2.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	18.4	20.6	18.5	21.1	28.7	10.7	20.5	28.4	27.7	20.5	16.6	28.5	16.3	15.8	28.3	24.1	16.5	26.8	18.1	18.4	18.1	22.8	17.3	15.6	18.3	16.7	20.6	19.5	23.4	17.0	24.7	32.0	19.5	26.1	22.4	18.6	19.1	21.4	21.2	25.7	18.4	16.2	20.1	21.1	16.9	16.9	20.7	20.4	24.7	22.3	15.3	22.0	19.8	16.3	7.4	9.2	14.7	13.6	15.9	10.2	8.5	5.9	6.1	9.3	11.1	13.4	13.0	5.5	10.0	11.7	8.9	8.9	5.4	4.6	8.4	6.0	14.3	10.4	7.1	9.6	11.5	11.7	12.1	5.9	8.9	5.7	7.1	12.0	8.8	7.2	15.7	12.3	8.2	10.9	15.6	13.7	9.4	9.8	6.9	14.9	12.2	6.4	7.9	4.6	12.3	4.2	5.5	8.7	8.7	9.2	5.3	6.6	10.1	8.6	7.7	3.0	12.0	7.6	17.6	11.6	3.8	6.3	10.0	6.9	8.5	7.1	8.9	10.4	7.3	13.9	14.7	8.1	10.0	8.3	9.0	9.5	6.6	7.9	8.9	9.2	7.4	10.2	8.1	13.9	15.9	13.6	5.3	8.4	8.5	18.5	28.7	28.4	27.7	18.1	22.8	20.6	19.5	26.1	20.4	20.8	14.5	2.7	4.7	3.2	15.0	15.7	15.3	14.7	13.6	14.0	31.4	8.9	0.0	8.3	546.2	15.3	8.6	0.0	8.0	6.4	6.5	11.1	9.3	7.6	9.5	6.4	9.2	11.1	8.2	1520.1	17.8	8.7	18.6	1.8	13.9	6.6	7.9	8.5	13.4	4.9	11.5	32.3	5.3	16.1	11.5	5.1	11.2	5.1	7.4	5.5
FAM20C	"DKFZp547D065, DMP4, G-CK, IMAGE:4942737"	ENSG00000177706	"FAM20C, golgi associated secretory pathway kinase"	Q8IXL6	7	192969-260745	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	Biomineralization	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 80.6"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 52.4;Hepatocytes: 80.0;Hofbauer cells: 49.0;Peritubular cells: 53.0;Proximal tubular cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HSkMC: 50.3;hTERT-RPE1: 39.1;U-87 MG: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019823			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted in other tissues"	NA	NA		160000000	"Golgi apparatus"	Nucleoplasm	"HPA019823: AB_1848389"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (9.40e-6)"	"unprognostic (1.97e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.83e-3)"	27.5	10.2	10.8	19.3	16.6	3.3	25.6	7.4	14.9	8.3	20.1	13.5	15.1	12.9	9.5	6.9	11.1	9.7	15.0	15.0	8.8	7.2	31.8	31.6	12.7	5.1	16.9	5.6	11.8	14.8	2.6	9.2	7.2	15.8	15.0	4.6	8.8	80.6	11.8	20.4	6.8	16.5	17.0	17.0	6.9	20.0	5.9	14.8	0.4	9.6	8.4	4.4	20.5	17.5	0.0	0.6	0.0	1.6	0.2	0.0	0.0	13.3	6.5	0.2	9.3	11.9	19.7	0.0	11.9	20.2	6.5	5.2	0.7	8.2	0.0	6.6	17.8	8.8	11.6	1.0	0.5	1.6	2.8	0.6	0.0	3.1	3.5	9.0	0.0	0.9	50.3	1.5	0.2	0.7	39.1	4.5	0.0	0.0	0.1	1.7	1.8	0.0	0.7	6.3	0.1	0.4	1.5	0.3	0.0	4.8	0.0	3.1	0.1	12.4	0.0	1.8	1.2	8.8	6.1	12.5	8.1	4.0	6.9	3.6	0.0	0.0	0.0	31.0	0.8	23.1	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.8	16.6	7.4	14.9	8.8	7.2	16.9	5.6	15.8	14.8	6.0	3.2	2.4	1.9	9.0	20.6	8.1	33.1	5.3	0.0	52.4	0.0	0.5	5.0	1.3	0.0	2.4	3.5	0.0	4.1	0.6	13.5	6.8	3.5	80.0	49.0	1.6	11.3	9.8	15.6	1.1	15.0	14.7	1.7	11.8	4.2	16.6	6.5	3.5	53.0	46.8	8.0	12.9	15.3	0.2	0.7	7.0	0.5	0.0	7.3	1.4
FAM98C	FLJ44669	ENSG00000130244	"Family with sequence similarity 98 member C"	Q17RN3	19	38403135-38409088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040930, HPA041730"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli"	Cytosol	"HPA040930: AB_10795484, HPA041730: AB_10804114"	"unprognostic (3.01e-2)"	"unprognostic (6.44e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (8.51e-5)"	"unprognostic (2.82e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (5.53e-4)"	10.8	8.9	18.3	9.3	16.9	11.0	9.8	17.0	19.9	8.7	14.2	12.8	9.0	19.6	9.9	7.2	14.3	13.8	9.1	11.6	16.0	13.1	9.1	13.4	8.7	9.5	12.3	16.9	10.2	22.4	10.6	8.1	7.6	13.0	12.5	7.0	8.2	17.7	9.5	2.5	17.0	22.2	6.8	12.7	10.1	19.2	5.4	9.7	5.3	11.8	7.7	11.2	9.4	9.5	6.0	3.2	12.6	3.4	3.3	5.6	1.6	10.9	11.9	1.4	6.9	1.5	5.2	6.1	6.4	5.4	6.3	6.7	2.0	8.0	10.0	7.2	3.7	2.2	5.3	2.7	4.6	1.0	16.1	5.6	3.2	2.0	4.6	6.8	2.8	6.0	5.0	9.6	3.2	5.8	3.5	3.7	16.4	9.0	11.0	3.7	12.1	4.0	2.1	1.0	18.2	12.8	8.3	2.9	5.9	7.7	5.8	2.4	7.1	6.4	11.4	3.8	0.7	8.6	8.7	4.8	2.8	7.8	8.8	7.6	11.9	6.0	4.2	7.4	6.5	4.5	0.0	2.3	12.6	3.1	3.3	4.2	2.6	5.6	4.6	3.2	6.0	4.3	3.4	2.0	3.3	3.4	1.2	4.4	1.6	18.3	16.9	17.0	19.9	16.0	13.1	12.3	16.9	13.0	9.7	8.9	9.9	17.1	21.7	19.2	13.2	4.3	10.2	6.7	5.7	22.7	11.8	10.3	18.3	17.4	5.0	9.3	43.8	0.0	28.7	9.4	10.0	14.8	15.0	11.9	9.9	11.1	24.6	10.4	10.5	2.1	17.3	14.7	21.9	12.6	32.7	11.1	19.7	34.5	17.3	15.9	11.6	12.9	11.4	27.3	41.1	26.1	5.1	20.3	33.5	22.0
FANCD2	"FA-D2, FACD, FAD, FANCD"	ENSG00000144554	"Fanconi anemia complementation group D2"	Q9BXW9	3	10026414-10101930	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.4;testis: 23.3"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 46.7;Spermatocytes: 55.1;Spermatogonia: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 46.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016117, HPA063742"	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		No	No			Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB016117: AB_2278211, HPA063742: AB_2685110"	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.08e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-3)"	"prognostic unfavorable (5.00e-5)"	"unprognostic (1.23e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.41e-10)"	"unprognostic (9.11e-3)"	"unprognostic (3.99e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.89e-2)"	2.0	1.3	0.8	10.3	2.6	12.2	2.4	1.6	2.7	1.7	2.9	1.1	1.0	2.2	2.2	1.8	4.7	2.4	2.5	1.1	0.8	0.9	2.3	1.0	2.4	9.5	1.3	1.2	3.5	3.5	0.6	1.1	5.3	1.4	2.2	4.9	1.6	3.3	0.4	3.0	3.3	6.2	1.2	2.0	7.3	2.4	23.3	1.6	24.4	1.6	5.6	14.6	2.2	2.4	6.8	3.7	5.3	2.6	2.1	2.9	1.0	8.7	9.3	17.8	5.0	0.9	1.4	46.0	8.0	3.6	11.5	9.4	6.9	8.7	17.1	3.8	2.6	9.5	7.6	18.3	6.2	11.5	8.1	12.4	23.3	14.3	6.6	0.1	17.3	14.6	0.4	1.0	13.0	7.2	1.6	6.9	14.7	14.2	19.6	8.7	10.0	14.4	6.7	21.4	6.7	6.5	15.8	14.5	12.1	4.0	9.8	4.9	9.8	9.8	7.7	3.1	13.5	11.8	11.0	4.0	9.6	11.0	5.8	11.6	8.3	16.3	28.9	5.5	17.8	16.3	5.3	1.4	3.7	1.5	1.0	1.3	4.9	2.0	1.2	0.9	6.8	2.5	1.9	3.3	2.1	2.6	3.7	2.9	1.0	0.8	2.6	1.6	2.7	0.8	0.9	1.3	1.2	1.4	1.6	0.0	0.3	9.7	2.8	4.0	2.8	1.6	0.0	1.4	1.2	1.8	9.8	6.6	0.0	1.6	4.4	1.5	0.7	46.7	2.9	12.7	1.3	2.2	1.1	1.0	5.0	0.0	1.2	3.7	3.4	5.6	2.0	5.2	3.3	7.2	2.0	0.8	1.4	2.8	1.4	0.5	5.8	19.4	0.8	55.1	32.4	2.4	5.8	3.8	5.0	2.3
FBXL20	"Fbl2, Fbl20, MGC15482"	ENSG00000108306	"F-box and leucine rich repeat protein 20"	Q96IG2	17	39252644-39402523	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"SK-BR-3: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044748, HPA050397"	Uncertain		Supported	Microtubules		NA	NA			Microtubules		"HPA044748: AB_2679072, HPA050397: AB_2681112"	"unprognostic (7.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-2)"	9.1	12.9	12.7	11.0	13.3	15.4	9.9	23.6	13.9	10.3	10.4	11.1	9.3	7.6	9.6	8.0	9.8	9.2	8.1	8.0	12.7	11.7	9.4	9.9	8.7	7.4	10.1	10.2	11.0	9.4	12.2	12.3	11.6	10.1	8.5	9.2	8.7	8.2	10.2	10.8	11.7	8.0	11.0	10.7	9.1	8.2	25.1	11.3	15.2	8.7	4.2	8.5	9.4	9.8	4.2	3.6	18.7	4.2	5.4	5.3	1.5	2.3	4.9	4.9	5.1	6.3	4.5	2.8	3.2	4.5	3.8	4.7	1.6	5.6	3.7	7.4	4.3	7.7	5.6	5.6	3.9	5.6	7.0	7.5	3.9	4.3	4.6	4.6	5.5	5.0	3.8	4.6	3.8	4.4	5.5	4.6	4.7	7.7	2.7	3.7	3.4	5.4	3.9	1.3	4.8	2.0	2.7	9.7	2.5	2.0	3.7	3.1	2.4	6.3	40.1	4.2	6.7	6.2	5.3	3.5	4.3	4.3	3.2	3.1	4.8	5.0	3.1	5.4	2.5	3.3	15.4	3.8	11.8	3.0	3.1	2.7	2.5	2.9	2.7	2.8	4.2	2.6	2.6	18.7	5.4	4.2	3.6	5.3	1.5	12.7	13.3	23.6	13.9	12.7	11.7	10.1	10.2	10.1	11.3	17.9	17.8	11.1	6.4	3.5	27.1	5.6	10.2	12.0	9.1	12.2	55.0	11.6	1.7	8.3	11.9	9.0	16.2	0.0	5.3	6.8	7.1	11.2	8.1	9.0	9.6	19.1	9.2	17.2	13.0	10.6	16.7	12.0	1.7	14.4	12.4	15.1	12.8	10.5	10.6	4.5	36.7	6.5	7.6	34.4	25.6	4.8	20.3	10.2	9.0	6.2
FCGBP	FC(GAMMA)BP	ENSG00000275395	"Fc fragment of IgG binding protein"		19	39863323-39934626	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	5	"cervix, uterine: 13.9;gallbladder: 46.6;intestine: 43.3;stomach 1: 17.0;thyroid gland: 20.9"	"Cell type enriched"	"Detected in many"	10	"Mucus-secreting cells: 4433.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 9.8;JURKAT: 3.3;RH-30: 11.0;RPMI-8226: 3.8;U-266/70: 3.6"					"Not detected"	"Not detected"			"HPA003517, HPA003564"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytokinetic bridge"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytokinetic bridge"	"HPA003517: AB_1078838, HPA003564: AB_2231648"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.28e-5)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (9.70e-6)"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.92e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (2.08e-1)"	1.7	0.6	1.7	5.9	1.8	0.0	2.7	0.2	1.6	13.9	43.3	0.8	0.7	15.2	0.2	0.4	0.2	0.0	46.6	0.7	0.6		0.6	0.2	0.6	0.2	0.9	0.6	0.6	0.2	0.0	1.2	1.5	1.1	0.4	16.7	0.3	1.3	1.2	0.2	2.8	16.9	0.2	2.1	0.2	17.0	0.4	0.9	0.5	20.9	0.2	0.5	0.2	0.2	0.6	2.3	0.0	0.9	1.3	3.2	0.6	0.0	9.8	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.3	0.1	0.3	1.0	0.2	0.0	0.0	0.0	0.0	3.3	0.1	0.4	0.0	0.4	2.8	1.2	0.3	3.2	0.7	0.2	11.0	3.8	0.2	1.3	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.6	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.9	0.3	0.0	0.7	1.4	2.3	0.6	0.9	3.2	0.0	1.3	0.5	0.0	0.2	0.6											3.0	3.2	2.7	0.7	3.3	1.2	3.1	114.7	5.3	21.6	24.4	0.0	0.6	0.0	3.5	6.2	0.7	445.8	0.0	0.8	0.2	1.1	18.9	16.1	0.8	33.7	0.0	77.9	0.6	21.7	7.1	0.9	10.0	8.5	0.0	4433.7	0.0	2.4	241.9	0.0	1.3	1.0	58.2	0.4	0.7	2.4	5.9	0.3	2.9	169.3	4.7
FSTL3	"FLRG, FSRP"	ENSG00000070404	"Follistatin like 3"	O95633	19	676365-683399	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Osteogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"placenta: 201.0"	"Cell type enriched"	"Detected in many"	4	"Extravillous trophoblasts: 2939.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 36.2;hTCEpi: 40.0;SiHa: 73.8;U-2197: 38.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB024899, HPA045378"	Approved		Supported	Nucleoplasm	"Secreted in other tissues"	NA	Yes		6800000	Nucleoplasm		"CAB024899: , HPA045378: AB_2679300"	"unprognostic (9.86e-3)"	"unprognostic (1.32e-3)"	"prognostic unfavorable (3.01e-4)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (2.19e-3)"	"unprognostic (1.51e-3)"	"unprognostic (8.64e-3)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (3.50e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.03e-3)"	"unprognostic (7.22e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.89e-3)"	19.9	29.1	4.0	10.7	6.2	5.6	24.7	1.3	4.2	13.1	14.9	3.8	8.1	3.8	12.8	15.6	12.7	14.1	13.1	27.0	5.0	2.0	13.7	5.1	26.9	8.7	7.3	4.5	16.8	11.7	1.4	5.3	201.0	6.0	14.3	3.1	12.0	4.5	11.0	4.1	6.2	6.5	20.6	10.4	3.9	9.1	34.5	4.9	0.7	7.2	5.5	1.4	16.7	18.3	0.9	2.2	0.1	4.4	0.6	2.6	2.0	1.9	15.9	1.1	0.8	5.0	12.8	36.2	27.0	4.0	6.8	2.5	5.8	3.1	0.8	10.9	18.2	3.9	13.9	0.9	23.0	2.2	1.6	1.9	0.7	22.2	4.7	21.6	1.4	2.6	16.0	40.0	7.5	31.3	17.6	1.2	0.8	1.7	1.1	10.2	7.0	0.5	0.8	1.3	13.1	5.5	1.5	0.7	1.8	9.4	0.3	0.7	1.2	73.8	1.5	0.8	1.4	1.3	0.7	16.2	6.8	23.5	38.1	9.9	1.8	0.8	0.4	1.0	4.2	3.1	0.0	4.4	0.0	1.0	4.4	0.2	0.3	1.4	1.1	2.2	0.9	2.6	1.6	0.1	0.6	3.2	0.9	0.2	2.0	4.0	6.2	1.3	4.2	5.0	2.0	7.3	4.5	6.0	4.9	17.9	3.4	2.2	19.6	12.9	1.6	12.8	30.6	2.7	1.2	8.7	0.0	22.7	6.6	69.7	5.6	4.5	0.9	0.0	56.0	2939.6	52.2	21.7	0.0	0.9	68.4	3.2	1.2	22.1	3.8	6.5	56.7	4.0	5.0	11.8	0.9	7.8	198.1	0.0	25.1	5.6	0.5	45.3	32.5	2.3	7.7	6.8	662.4	2.9	1.7	20.7
GAL3ST4	FLJ12116	ENSG00000197093	"Galactose-3-O-sulfotransferase 4"	Q96RP7	7	100159244-100168750	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.8"	"Cell type enriched"	"Detected in some"	6	"Hofbauer cells: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 4.4;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.5;plasmacytoid DC: 4.3"	"Group enriched"	"Detected in many"	26	"dendritic cells: 4.3;T-cells: 15.0"	"Cell line enhanced"	"Detected in many"		"WM-115: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038137, HPA038138"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038137: AB_10697239, HPA038138: AB_2675854"	"unprognostic (4.22e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.44e-4)"	"unprognostic (8.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (3.98e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.36e-2)"	3.9	5.4	8.4	4.2	9.4	1.0	4.1	1.5	10.9	7.8	6.5	18.6	0.4	4.1	9.0	3.7	8.4	6.3	5.9	4.9	8.0	3.8	1.8	1.0	5.3	2.9	11.9	4.7	7.6	1.5	1.6	4.6	9.8	8.1	6.5	7.0	4.2	24.9	4.3	1.9	27.8	8.9	10.6	14.9	2.7	2.8	4.4	10.2	37.8	2.0	2.4	3.9	7.3	10.6	0.1	4.3	0.3	0.1	0.2	15.0	2.2	0.0	0.6	4.0	1.8	3.6	7.1	7.6	2.2	2.2	1.3	1.8	0.4	0.2	0.7	0.5	7.4	2.3	8.6	0.2	1.3	0.4	0.0	0.4	0.2	0.1	0.2	2.4	0.4	2.4	8.7	3.4	3.9	0.4	2.8	2.5	3.1	1.1	0.1	2.4	0.3	2.7	0.1	1.3	8.2	0.9	2.2	1.8	0.1	0.0	0.3	0.2	1.7	0.6	0.0	4.6	0.7	0.0	0.2	2.2	0.2	1.2	0.3	0.1	0.1	0.1	1.7	1.4	0.4	29.6	0.0	0.1	0.0	0.5	0.0	0.0	0.0	4.4	0.3	0.0	0.1	15.0	4.5	0.3	0.2	0.1	4.3	1.1	2.2	8.4	9.4	1.5	10.9	8.0	3.8	11.9	4.7	8.1	10.2	0.0	0.3	0.0	2.0	3.8	0.0	0.8	2.5	0.0	1.2	0.0	0.0	0.3	0.0	0.5	0.1	0.5	0.0	0.0	0.0	0.2	6.0	0.3	0.0	0.0	38.9	0.0	0.0	1.8	0.3	0.0	4.4	0.7	5.0	1.0	0.6	0.5	0.5	2.9	4.9	0.0	0.0	0.0	2.2	0.4	0.2	7.0	0.7	0.0	6.0	0.9
GALNT10	GalNAc-T10	ENSG00000164574	"Polypeptide N-acetylgalactosaminyltransferase 10"	Q86SR1	5	154190730-154420984	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 43.7"	"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 74.0;TIME: 40.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007525	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		830000	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA007525: AB_1849443"	"unprognostic (6.99e-2)"	"unprognostic (4.33e-2)"	"unprognostic (9.85e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.63e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (2.88e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.08e-1)"	9.5	13.5	8.4	15.4	9.1	10.1	8.7	3.2	6.2	15.9	10.6	14.4	1.0	8.8	4.9	11.5	5.9	9.2	17.8	7.7	6.9	7.5	6.8	3.4	10.1	11.5	7.2	5.2	43.7	9.2	14.1	9.7	5.2	10.1	8.3	9.4	31.6	11.6	2.4	5.6	4.0	12.4	14.1	7.7	16.7	13.8	4.3	9.2	5.6	10.6	4.2	9.3	7.5	10.0	4.7	3.1	5.7	3.8	3.9	7.5	2.1	6.2	21.4	5.2	4.5	11.1	9.9	4.0	18.1	10.1	7.2	6.9	3.0	14.4	4.1	12.8	30.4	12.9	1.1	2.4	14.1	6.6	10.6	1.7	11.2	4.1	4.0	8.5	2.4	10.9	12.3	3.3	5.8	8.6	74.0	13.8	3.1	2.5	13.0	12.3	6.5	0.2	1.6	2.0	17.6	4.4	1.2	2.7	4.1	10.0	4.3	0.7	1.7	8.0	30.0	2.3	8.0	11.6	1.8	40.5	17.6	4.2	4.3	19.2	3.7	3.6	2.2	11.5	4.8	5.3	3.4	2.7	5.3	7.5	3.6	6.6	4.5	4.3	4.8	3.1	4.7	1.9	5.3	5.7	3.9	3.8	2.7	3.5	2.1	8.4	9.1	3.2	6.2	6.9	7.5	7.2	5.2	10.1	9.2	8.9	36.1	12.3	3.5	4.2	3.5	4.1	5.1	0.0	12.5	14.0	3.9	0.6	8.3	9.3	10.6	13.4	15.5	23.3	26.2	1.2	9.1	9.9	10.3	4.7	7.2	0.0	2.9	19.0	15.4	16.0	35.4	9.7	0.0	6.4	16.1	20.8	26.5	11.5	47.0	2.9	11.4	6.5	7.3	1.7	3.1	3.1	0.7	13.8	9.3	2.8
GHDC	LGP1	ENSG00000167925	"GH3 domain containing"	Q8N2G8	17	42188799-42194532	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031650	Uncertain				"Intracellular and membrane"	NA	NA					"HPA031650: AB_10601014"	"unprognostic (2.30e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (3.21e-4)"	"prognostic unfavorable (6.81e-5)"	"unprognostic (5.13e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.18e-2)"	"prognostic favorable (2.00e-6)"	"unprognostic (2.08e-1)"	"unprognostic (7.93e-2)"	"unprognostic (9.66e-2)"	"unprognostic (4.02e-2)"	14.8	22.4	6.6	10.3	8.3	9.8	10.2	11.5	12.2	12.6	13.7	13.0	28.4	15.1	10.5	11.7	10.2	10.8	15.5	9.2	6.5	9.4	21.5	20.0	10.3	14.8	11.8	5.9	15.7	17.2	10.9	11.5	10.1	10.0	14.5	5.2	15.9	22.4	17.2	5.5	6.1	17.2	8.8	8.4	21.6	13.3	8.4	8.0	8.5	30.0	6.5	12.7	10.6	8.8	7.7	5.3	3.3	7.3	2.1	4.7	4.0	3.2	11.6	0.8	9.2	3.1	2.8	7.3	4.4	3.5	2.3	2.9	3.7	15.8	5.0	15.9	4.0	2.7	0.3	2.6	0.1	0.5	8.1	9.4	7.5	5.1	7.7	8.2	6.0	32.2	4.2	2.4	6.2	1.9	2.8	3.5	3.1	7.2	22.6	1.1	4.0	3.8	11.8	2.0	12.3	0.0	3.8	4.3	21.4	6.1	2.6	1.8	6.3	0.1	20.8	14.8	0.2	14.3	9.6	3.0	10.7	4.3	9.3	2.0	17.0	13.2	3.3	9.0	7.6	4.3	1.4	5.9	3.3	4.7	5.9	2.2	5.3	3.2	4.7	5.3	7.7	3.3	3.6	3.3	2.1	7.3	4.7	2.8	4.0	6.6	8.3	11.5	12.2	6.5	9.4	11.8	5.9	10.0	8.0	0.0	8.1	7.5	6.8	2.6	7.5	1.6	17.8	10.7	4.5	15.7	5.9	11.0	3.3	11.0	0.8	9.0	7.4	0.0	16.6	9.9	8.7	8.4	12.7	14.8	23.9	7.9	13.2	25.8	21.3	1.1	10.6	7.6	8.5	1.8	8.3	17.3	10.0	3.5	13.1	15.0	4.0	0.0	3.9	0.6	0.7	1.6	6.1	9.2	8.1	5.0
GPAT4	"AGPAT6, DKFZp586M1819, LPAAT-zeta, TSARG7"	ENSG00000158669	"Glycerol-3-phosphate acyltransferase 4"	Q86UL3	8	41577187-41625001	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016471	Approved					NA	NA					"HPA016471: AB_1844649"	"unprognostic (3.05e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (7.45e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.08e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.98e-2)"	"prognostic favorable (4.15e-4)"	"unprognostic (1.73e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.04e-2)"	"prognostic favorable (5.65e-4)"	15.7	27.4	14.4	17.8	17.2	16.6	28.1	43.8	21.9	16.9	14.0	23.1	22.7	13.0	22.8	12.0	13.1	14.6	15.8	14.1	14.0	13.1	20.8	26.7	18.7	13.8	18.5	13.6	16.6	17.3	35.7	22.3	23.3	20.5	15.1	15.1	21.0	20.8	15.5	42.1	14.5	14.6	23.0	18.0	17.5	17.8	15.5	16.6	15.2	14.5	12.4	19.4	16.6	14.9	9.1	18.9	10.8	15.0	4.9	12.1	11.1	14.7	16.4	19.7	15.4	21.6	26.3	17.3	32.2	27.7	24.4	25.6	11.0	29.8	20.6	22.6	26.5	30.1	8.6	23.0	14.5	31.7	22.0	12.7	24.0	18.3	10.1	12.6	2.5	34.7	16.5	10.7	25.4	9.2	21.0	25.1	20.6	17.9	24.3	25.0	6.3	22.4	6.5	21.0	27.3	8.8	13.2	19.7	11.1	14.8	22.2	12.9	17.8	12.5	17.3	34.5	23.6	24.0	16.3	18.2	25.3	17.8	28.9	24.0	13.1	17.6	22.5	20.8	14.2	24.7	10.8	15.0	6.6	12.1	14.3	11.3	8.3	9.3	11.9	18.9	9.1	8.5	8.2	3.5	4.9	12.0	7.1	8.7	11.1	14.4	17.2	43.8	21.9	14.0	13.1	18.5	13.6	20.5	16.6	3.0	37.7	8.0	11.2	0.0	15.6	0.0	30.6	10.7	25.0	10.4	9.8	29.1	3.3	35.3	36.6	18.0	10.2	70.0	34.4	34.1	9.3	25.6	2.3	53.8	22.9	14.3	16.4	20.9	29.5	44.4	11.8	16.4	0.0	37.9	19.7	12.7	36.5	14.0	9.9	23.5	12.1	6.5	0.0	3.0	13.4	0.0	33.8	10.2	13.3	13.6
GRB7		ENSG00000141738	"Growth factor receptor bound protein 7"	Q14451	17	39737927-39747291	"Cancer-related genes, Predicted intracellular proteins"		"Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.9"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 79.7;Glandular cells: 69.7;Syncytiotrophoblasts: 82.5;Urothelial cells: 65.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"cerebellum: 7.4"	"Cell type enriched"	"Detected in single"	20	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Cell line enriched"	"Detected in some"	5	"OE19: 193.7"	"Region enhanced"	"Detected in some"		"cerebellum: 9.3"	"Low region specificity"	"Detected in all"			"CAB005226, HPA057084, CAB073538"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330"	"unprognostic (8.46e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.60e-7)"	"unprognostic (7.06e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (3.10e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (2.59e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (5.49e-3)"	"unprognostic (4.01e-2)"	2.9	0.1	0.1	2.8	0.6	0.0	16.1	7.4	1.2	6.7	12.7	0.3	25.0	6.7	2.6	8.1	53.9	14.5	16.3	0.8	0.2	0.1	23.4	5.2	12.3	0.1	0.1	0.4	3.1	20.5	5.8	3.7	42.6	1.6	10.2	6.4	0.7	14.0	25.5	0.5	19.1	12.4	2.0	0.1	0.3	7.2	2.3	0.3	0.5	8.5	6.5	17.2	7.2	11.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.6	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	4.9	2.8	0.0	0.4	0.0	0.1	2.6	0.0	1.8	0.0	0.0	0.2	0.0	0.6	4.3	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.5	193.7	0.4	0.0	0.0	1.9	2.2	1.6	1.1	0.0	2.1	42.8	0.0	2.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	7.4	1.2	0.2	0.1	0.1	0.4	1.6	0.3	20.8	10.0	0.0	79.7	34.0	0.0	2.0	15.3	17.4	7.9	21.0	0.0	27.0	8.3	29.6	0.0	0.5	18.0	0.0	16.9	18.8	1.9	69.7	1.1	4.0	2.5	0.0	13.8	0.0	0.0	0.0	2.6	0.9	5.0	2.8	16.8	0.3	20.5	24.6	1.1	8.6	0.0	0.0	1.0	0.4	0.2	36.6	82.5	0.9	22.1	65.1
HDAC4	"BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288"	ENSG00000068024	"Histone deacetylase 4"	P56524	2	239048168-239401654	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Autism spectrum disorder, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.6"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 73.9;Late spermatids: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 10.5;classical monocyte: 7.4;neutrophil: 28.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 28.3;monocytes: 7.4"	"Cell line enhanced"	"Detected in many"		"JURKAT: 30.4;MOLT-4: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048723, HPA071448"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA048723: AB_2680501, HPA071448: "	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-3)"	"unprognostic (3.06e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.33e-4)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.40e-1)"	"unprognostic (4.82e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.04e-2)"	7.9	6.8	6.1	6.8	5.2	17.1	4.6	6.4	12.3	11.3	21.4	4.6	4.3	2.5	10.2	6.4	8.8	9.0	24.6	5.2	5.0	6.0	3.2	3.1	4.2	4.3	6.1	5.4	8.5	5.8	4.9	8.3	2.5	5.2	7.5	4.8	8.3	3.7	7.3	54.6	6.9	6.5	15.8	4.2	5.4	7.0	8.1	4.3	6.5	4.8	13.2	5.6	10.2	4.6	0.5	1.7	28.3	7.4	2.1	1.2	0.4	3.8	3.8	4.9	5.9	2.8	4.7	5.8	4.0	2.7	3.2	3.1	1.7	7.0	1.8	1.6	3.4	4.6	3.8	3.4	1.6	1.6	10.6	1.8	2.8	4.7	5.6	3.7	4.3	2.6	3.2	4.1	5.9	4.7	1.6	3.4	30.4	4.0	4.1	1.5	4.7	28.1	5.9	3.8	4.8	2.0	7.3	9.2	2.8	3.7	4.9	3.9	6.9	5.6	2.5	9.8	2.9	1.3	11.9	5.4	3.7	0.3	6.4	5.4	2.9	2.7	3.5	5.4	6.0	7.4	10.5	7.4	1.1	0.9	2.4	1.1	0.5	0.9	0.8	0.8	0.5	0.5	1.0	28.3	2.1	1.0	1.7	1.2	0.4	6.1	5.2	6.4	7.5	5.0	6.0	6.1	5.4	5.2	4.3	3.0	9.0	3.7	2.2	7.0	11.5	10.1	7.6	0.0	3.4	10.4	2.0	1.2	0.0	2.4	73.9	5.8	4.5	0.0	1.8	1.5	8.0	5.0	2.3	5.8	2.9	15.9	5.8	13.5	22.7	47.3	10.9	5.5	5.0	0.0	5.5	10.1	1.7	0.0	11.7	1.2	7.1	0.0	5.6	2.2	2.1	8.4	1.1	8.7	5.7	2.2
HOXB4	"HOX2, HOX2F"	ENSG00000182742	"Homeobox B4"	P17483	17	48575513-48580111	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 13.3"	"Cell type enhanced"	"Detected in many"	15	"Collecting duct cells: 61.1;Cytotrophoblasts: 18.4;Spermatogonia: 21.8"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 23.4;HEK 293: 11.3;HMC-1: 14.4;K-562: 11.4"	"Region enriched"	"Detected in single"	36	"pons and medulla: 3.7"	"Region enriched"	"Detected in single"	23	"pons and medulla: 7.5"	HPA057432	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA057432: AB_2683437"	"unprognostic (2.71e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.97e-3)"	"unprognostic (5.39e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.41e-3)"	4.4	2.4	0.0	1.5	0.0	0.0	2.9	0.0	0.0	4.2	8.1			1.2	2.3	13.3	2.7	8.5	1.5	0.4	0.0	0.0	5.7	0.7	3.6	0.6	0.0		0.0	0.7	1.8	0.0	1.0		0.6	1.1		0.0	4.8	0.8	0.9	4.3	2.0	2.4	3.0	3.9	0.5			0.6		0.2	1.3	1.7	0.3	2.4	0.0	0.1	0.6	0.7	0.1	0.1	0.3	0.0	0.1	4.9	3.9	1.9	0.0	0.0	0.2	0.1	2.2	2.0	3.1	23.4	1.5	0.4	0.1	4.1	0.0	0.0	8.0	11.3	7.6	0.7	0.0	5.0	0.0	14.4	3.8	0.0	5.7	0.0	0.8	6.6	5.2	11.4	0.2	5.6	0.0	1.8	0.0	0.0	2.1	0.0	0.0	4.4	1.6	4.6	1.9	0.0	0.0	0.6	0.0	2.9	1.6	0.4	1.5	2.5	0.3	0.2	0.8	0.2	1.9	4.0	0.7	1.6	0.0	2.2	0.0	0.1	0.0	0.7	0.0	0.1	0.3	0.2	0.5	0.0	0.1	0.2	0.1	0.0	0.6	0.0	2.4	0.0	0.1											0.0	0.0	1.7	0.9	3.4	0.0	0.8	0.0	1.4	0.0	61.1	0.0	18.4	10.0	0.1	0.0	7.1	0.8	0.0	0.0	11.0	9.7	0.4	3.5	0.0	3.2	0.0	0.0	15.4	1.8	0.0	0.3	1.9	5.0	0.0	2.0	0.0	0.0	1.9	0.0	1.4	0.0	0.0	5.2	0.2	21.8	1.6	5.0	10.5	1.5	2.6
JADE2	"JADE-2, KIAA0239, PHF15"	ENSG00000043143	"Jade family PHD finger 2"	Q9NQC1	5	134524312-134583230	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025959, HPA055789"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA025959: AB_1855289, HPA055789: AB_2682922"	"unprognostic (8.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (1.58e-2)"	"unprognostic (3.49e-2)"	"prognostic favorable (5.36e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.87e-2)"	15.6	19.8	16.7	16.1	22.0	9.7	13.9	22.8	21.7	16.0	13.4	15.3	9.2	12.7	13.9	8.4	11.8	20.6	13.2	13.4	17.8	14.5	14.8	4.7	15.0	25.8	30.8	16.0	28.4	14.0	30.9	14.4	8.5	20.1	12.8	8.2	16.4	15.0	16.9	12.0	11.5	17.8	13.0	16.8	22.9	12.9	8.1	30.8	13.0	20.6	6.0	19.2	20.0	22.7	7.3	2.0	6.8	3.0	3.1	6.2	2.4	28.7	20.5	0.6	0.8	7.2	8.7	9.4	5.2	13.7	9.6	11.3	15.6	22.4	31.7	11.6	6.7	9.7	6.1	3.6	27.5	4.8	19.1	1.4	7.4	14.3	4.2	7.2	8.1	1.1	5.8	13.3	11.7	14.8	7.6	7.2	9.5	4.6	11.9	5.8	10.3	14.0	7.3	6.8	8.8	10.7	12.6	0.6	12.4	9.0	8.0	4.4	2.9	12.8	0.4	18.4	5.8	5.6	10.1	10.1	6.8	6.1	19.1	12.9	5.5	23.0	29.3	10.5	14.6	9.5	6.8	1.2	4.4	6.2	1.1	6.0	7.3	5.7	5.6	2.0	5.5	5.6	5.6	1.3	3.1	3.0	1.2	5.8	2.4	16.7	22.0	22.8	21.7	17.8	14.5	30.8	16.0	20.1	30.8	8.9	9.1	20.8	6.1	3.8	21.4	10.1	10.2	6.7	4.5	7.0	33.4	6.4	6.6	4.6	0.2	9.2	8.4	0.0	14.6	8.4	8.1	4.3	2.3	3.0	4.0	9.5	11.1	15.4	30.1	0.0	19.0	8.0	1.7	22.6	9.7	6.0	8.8	3.5	18.0	9.1	21.8	0.0	10.8	0.2	1.5	3.1	6.1	20.2	11.9	3.4
JMY	"FLJ37870, WHAMM2"	ENSG00000152409	"Junction mediating and regulatory protein, p53 cofactor"	Q8N9B5	5	79236189-79327215	"Predicted intracellular proteins"	"DNA damage, DNA repair"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 17.4;Karpas-707: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037508, HPA043308"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037508: , HPA043308: AB_10806502"	"unprognostic (1.87e-2)"	"unprognostic (2.12e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.03e-5)"	"unprognostic (7.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.15e-1)"	8.6	9.2	13.4	5.8	17.0	14.8	10.3	21.7	15.8	13.6	17.8	10.1	13.0	5.8	20.3	12.9	10.0	9.2	8.4	8.5	11.2	8.9	11.5	9.1	7.1	7.6	13.6	13.4	24.7	15.9	24.8	12.5	5.8	11.7	13.5	7.9	9.2	11.9	11.0	15.4	11.9	8.2	13.0	9.7	8.1	9.5	12.0	14.1	10.4	17.7	5.1	7.2	13.5	10.2	0.9	0.8	0.4	0.4	3.7	1.7	0.1	2.4	2.4	1.8	4.8	5.2	4.7	6.5	2.4	6.1	2.2	3.6	1.1	2.7	1.7	17.4	2.6	2.5	2.7	6.5	3.1	3.5	7.5	6.0	3.4	3.8	2.4	7.9	1.5	2.2	4.4	8.5	1.0	9.6	4.5	2.7	4.7	2.0	29.8	1.8	3.3	3.2	3.2	3.0	0.5	1.6	3.2	5.9	7.2	4.7	2.6	7.4	4.0	3.0	3.3	5.5	3.3	2.7	3.2	2.8	0.9	1.6	0.5	1.5	8.5	7.3	1.7	1.9	1.5	1.6	0.0	0.4	0.1	1.4	0.4	0.9	0.9	1.4	1.4	0.1	0.8	1.7	1.2	0.4	3.7	0.3	0.8	1.2	0.1	13.4	17.0	21.7	15.8	11.2	8.9	13.6	13.4	11.7	14.1	8.9	12.2	7.5	10.3	26.6	32.0	32.7	17.8	20.1	14.8	15.7	41.2	5.1	1.7	6.5	23.3	13.0	4.7	0.0	8.5	4.7	16.9	16.5	8.1	13.9	4.0	38.1	23.0	4.9	5.4	15.4	22.5	9.9	21.9	1.0	8.4	17.3	13.0	10.4	33.6	6.5	38.4	12.9	25.5	22.9	41.1	34.8	16.9	17.0	7.3	9.2
JUNB		ENSG00000171223	"JunB proto-oncogene, AP-1 transcription factor subunit"	P17275	19	12791496-12793315	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Smooth muscle cells: 2844.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 101.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 101.1;monocytes: 27.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 106.6;U-266/70: 45.7;U-266/84: 67.8"	"Group enriched"	"Detected in many"	5	"amygdala: 25.2;basal ganglia: 16.8;cerebral cortex: 31.3;hippocampal formation: 24.3;olfactory region: 15.1"	"Region enriched"	"Detected in single"	20	"cerebellum: 17.1"	"CAB004464, HPA019149"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004464: AB_2130023, HPA019149: AB_1852053"	"unprognostic (1.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.79e-1)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.02e-1)"	83.4	95.3	8.7	57.2	16.6	153.1	29.0	8.3	16.0	57.6	33.1	29.2	13.0	20.7	26.6	23.7	84.8	128.6	103.5	46.4	10.2	9.9	20.4	54.5	76.2	23.1	10.3	7.1	108.1	25.0	10.5	43.8	44.4	21.5	63.8	9.7	47.3	37.8	84.3	54.3	66.0	32.9	33.6	15.7	25.7	39.7	15.3	11.6	12.2	27.1	71.9	53.3	71.7	37.9	4.7	12.7	101.1	27.0	2.6	6.5	12.7	8.9	1.8	0.5	1.1	2.0	5.0	1.8	3.9	3.4	1.9	1.8	1.1	5.3	3.1	13.8	1.4	5.9	17.0	0.4	5.9	0.2	106.6	1.7	3.0	6.8	1.5	2.7	4.1	14.3	6.3	17.4	1.7	1.3	3.9	0.9	2.2	8.0	5.7	0.6	26.9	2.8	24.9	0.3	6.1	7.0	3.8	1.3	6.4	1.3	11.3	4.2	6.4	17.1	10.5	4.9	0.3	1.8	4.6	3.0	5.7	3.3	11.4	4.9	45.7	67.8	2.8	6.7	10.6	1.5	3.5	17.4	18.5	5.2	27.0	5.3	4.7	5.7	6.5	12.7	4.4	4.1	4.3	101.1	2.6	24.7	1.1	5.5	12.7	8.7	16.6	8.3	16.0	10.2	9.9	10.3	7.1	21.5	11.6	107.2	621.9	699.4	682.5	1300.3	80.0	296.2	231.8	71.0	126.3	146.5	37.3	100.9	41.4	570.4	6.9	1195.0	682.0	70.0	486.4	175.7	1823.6	1011.1	495.7	64.4	1063.7	20.6	1445.6	268.2	528.1	10.3	754.8	1027.7	848.6	461.7	904.4	381.1	718.1	736.4	247.5	63.6	159.5	1144.8	2844.2	7.1	9.8	1577.0	368.2	643.4	570.8	396.1
KCNS1	Kv9.1	ENSG00000124134	"Potassium voltage-gated channel modifier subfamily S member 1"	Q96KK3	20	45092310-45101112	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 27.0"	"Cell type enriched"	"Detected in some"	6	"Cholangiocytes: 10.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 6.1"	"Region enhanced"	"Detected in many"		"cerebral cortex: 27.0"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HBF TERT88: 3.2;HHSteC: 4.9;hTEC/SVTERT24-B: 2.7;THP-1: 4.1;U-87 MG: 7.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.46e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.11e-4)"	"unprognostic (8.91e-3)"	"unprognostic (6.01e-3)"	"unprognostic (7.47e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (6.74e-2)"	"unprognostic (4.65e-2)"	"unprognostic (6.35e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.39e-1)"	0.3	0.8	1.4	0.2	4.6	0.4	0.7	0.4	27.0	0.6	0.3	0.0	5.9	0.2	0.2	0.2	0.4	0.3	5.2	0.4	2.1	1.1	0.5	0.3	0.7	0.3	1.0	7.2	0.2	0.3	0.1	0.4	0.3	0.0	0.9	0.2	0.0	3.4	7.0	0.2	2.6	0.3	0.2	0.4	0.3	0.3	2.0	0.0	0.0	0.3	0.0	0.5	0.4	0.6	0.6	0.2	2.5	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.1	0.5	0.0	0.3	0.3	1.0	0.9	0.1	0.4	1.4	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.2	0.9	0.0	2.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.3	1.8	0.0	2.1	0.5	0.0	4.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	7.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.2	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.4	4.6	0.4	27.0	2.1	1.1	1.0	7.2	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.9	10.2	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.1
KCTD11	"C17orf36, KCASH1, REN"	ENSG00000213859	"Potassium channel tetramerization domain containing 11"	Q693B1	17	7351889-7354944	"Predicted intracellular proteins"	"Cell cycle, Growth regulation, Ubl conjugation pathway"	"Developmental protein, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 29.2;hTCEpi: 21.5"	"Not detected"	"Not detected"							HPA052035	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052035: AB_2681704"	"unprognostic (1.98e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (9.55e-4)"	"unprognostic (6.78e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (7.93e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-2)"	7.4	5.7	4.7	5.3	6.5	0.9	16.2	5.8	5.7	20.1	6.9	7.6	5.1	5.2	8.9	7.5	32.9	8.0	9.8	4.9	3.6	3.6	5.2	5.1	8.6	9.4	10.2	3.4	8.6	10.5	8.2	5.2	15.2	6.0	10.5	5.2	6.5	11.1	9.8	4.3	23.0	6.5	7.1	5.0	8.1	7.9	4.0	5.5	1.5	17.2	23.3	17.0	19.2	22.0	1.8	2.5	8.8	6.0	1.6	2.3	2.5	10.2	4.1	3.1	2.3	13.3	7.8	3.3	6.6	10.7	7.2	6.3	3.7	4.5	1.5	3.7	11.2	6.7	17.9	0.4	29.2	6.1	6.1	1.2	0.1	2.9	0.6	7.0	0.1	5.9	6.1	21.5	7.7	4.2	14.4	2.2	1.2	1.3	1.7	5.3	4.4	0.9	1.4	1.0	4.5	2.4	1.3	2.8	1.4	7.3	4.0	0.1	1.7	4.7	4.7	0.7	4.0	6.7	0.6	4.3	5.8	5.2	3.9	3.4	1.2	0.6	0.4	7.1	3.3	4.3	8.8	3.6	2.4	2.3	6.0	0.8	1.8	1.1	1.0	2.5	1.4	0.6	1.6	0.5	1.6	4.3	0.1	0.2	2.5	4.7	6.5	5.8	5.7	3.6	3.6	10.2	3.4	6.0	5.5	8.9	0.6	1.7	16.0	1.5	3.3	0.4	2.5	10.7	4.5	5.2	2.0	4.2	3.3	11.3	12.7	2.7	7.7	0.0	8.4	5.3	11.4	7.7	4.6	2.4	4.2	1.6	6.9	6.7	3.7	5.3	16.4	5.4	1.7	8.2	4.3	3.9	21.3	4.8	20.5	2.7	1.4	19.4	17.2	0.7	1.0	3.9	8.2	4.3	3.3	17.4
KIAA0141	DELE	ENSG00000081791	KIAA0141	Q14154	5	141923808-141942047	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036548, HPA061490"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA036548: AB_10673356, HPA061490: "	"unprognostic (1.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.15e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (2.28e-3)"	26.2	35.7	17.9	28.5	21.0	31.0	27.4	39.6	26.8	24.8	27.2	28.1	33.5	27.3	32.9	29.0	23.5	26.1	29.4	66.5	17.9	16.2	27.0	35.2	28.9	35.6	21.7	25.8	26.2	28.4	25.2	25.2	28.2	22.0	26.2	28.6	23.1	22.1	38.8	40.9	20.1	24.6	27.5	23.2	43.0	26.0	19.0	21.2	19.9	26.9	26.5	24.8	27.6	24.9	10.2	26.2	8.8	28.8	10.9	12.3	10.7	10.0	13.6	20.0	29.3	15.8	21.0	13.3	13.2	21.5	23.1	25.7	19.5	23.7	23.8	15.2	14.3	13.4	15.7	12.0	27.7	12.9	13.6	10.6	14.4	15.8	15.1	20.1	20.4	28.5	25.5	13.9	20.2	16.6	20.8	24.1	5.1	9.1	32.5	11.9	13.1	5.4	11.2	7.7	12.5	21.2	18.6	13.3	26.4	16.7	15.0	11.3	14.3	15.3	24.1	31.2	13.6	31.1	18.4	19.3	17.7	10.8	9.2	11.7	9.1	9.7	14.5	14.4	16.4	19.4	7.7	20.3	6.5	10.4	26.4	9.8	10.2	8.4	10.2	26.2	9.4	7.2	9.2	8.8	10.9	28.8	10.6	12.3	10.7	17.9	21.0	39.6	26.8	17.9	16.2	21.7	25.8	22.0	21.2	11.9	27.4	12.8	15.2	7.2	7.4	0.0	28.1	14.7	10.3	0.0	27.5	22.7	0.0	0.0	0.7	29.7	19.2	0.0	0.0	11.4	12.3	13.8	18.5	25.9	24.6	33.4	20.8	28.3	26.1	1.1	14.7	18.7	15.1	0.0	20.9	4.8	0.0	10.5	8.5	0.0	19.5	12.9	7.2	3.0	5.5	9.4	21.5	15.2	25.0	17.2
KIF26B	FLJ10157	ENSG00000162849	"Kinesin family member 26B"	Q2KJY2	1	245154985-245709431	"Predicted intracellular proteins"		"Developmental protein, Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	7	"Collecting duct cells: 7.0;Cone photoreceptor cells: 3.9;Exocrine glandular cells: 4.4;Pancreatic endocrine cells: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	58	"plasmacytoid DC: 6.3"	"Lineage enriched"	"Detected in single"	58	"dendritic cells: 6.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 10.6;REH: 18.9;SH-SY5Y: 10.3;U-937: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027709, HPA028478, HPA028561, HPA028562"	Enhanced		Approved	"Plasma membrane,Microtubules"		NA	NA			"Plasma membrane, Microtubules"		"HPA027709: AB_10600215, HPA028478: AB_10601231, HPA028561: AB_10601960, HPA028562: AB_10602417"	"unprognostic (3.66e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (8.30e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.17e-4)"	"unprognostic (7.22e-3)"	0.7	3.9	7.1	3.0	6.3	0.7	2.1	10.2	9.7	5.2	1.7	8.7	6.0	1.2	3.7	2.9	1.3	2.1	4.2	1.3	5.6	7.2	3.2	1.1	2.7	1.7	7.8	4.6	1.2	1.8	1.4	1.4	7.6	9.6	3.7	0.8	1.1	1.2	7.7	0.9	2.7	1.1	2.3	4.9	1.1	2.9	2.9	3.7	1.3	3.4	1.2	1.4	4.0	0.8	0.0	6.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	2.6	0.5	0.8	1.9	2.1	1.5	0.1	0.1	3.2	0.0	0.0	3.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.3	0.3	10.6	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	18.9	0.1	0.0	1.9	0.0	2.6	10.3	0.0	0.0	0.0	1.8	0.0	1.0	0.3	2.0	0.1	0.0	0.8	0.0	0.0	0.1	0.3	9.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	0.0	0.0	7.1	6.3	10.2	9.7	5.6	7.2	7.8	4.6	9.6	3.7	0.0	0.3	0.0	0.1	0.8	0.8	2.2	0.0	2.7	0.0	7.0	3.9	1.8	0.0	1.8	1.7	0.0	0.0	0.0	4.4	2.0	0.9	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.6	0.4	3.3	1.0	0.0	0.3	5.5	0.0	0.0	0.0	0.1	0.0	0.4	0.5	1.0	1.1	2.1	0.0	0.0	0.0
KRT4	"CK4, CYK4, K4"	ENSG00000170477	"Keratin 4"	P19013	12	52806549-52814551	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 637.8;lymphoid tissue: 403.6;tongue: 174.6"	"Cell type enhanced"	"Detected in some"	24	"Alveolar cells type 1: 20.8;Ciliated cells: 56.2;Club cells: 112.6;Urothelial cells: 43.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"HaCaT: 96.5;SK-BR-3: 39.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002154, HPA034881"	Enhanced		Supported	"Intermediate filaments"		NA	NA		540000000	"Intermediate filaments"		"CAB002154: AB_563803, HPA034881: AB_2674370"	"unprognostic (4.04e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (8.52e-3)"		"unprognostic (1.20e-1)"		"unprognostic (2.64e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.85e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.58e-11)"	"unprognostic (1.64e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (6.26e-4)"	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	25.5	0.1	0.0	0.0	0.1	2.5	0.1	637.8	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	48.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	174.6	403.6	0.2	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	96.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	3.5	0.0	4.5	0.0	0.0	0.3	0.0	56.2	112.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.0
KRT7	"CK7, K2C7, K7, SCL"	ENSG00000135480	"Keratin 7"	P08729	12	52232520-52252186	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 156.6;salivary gland: 142.6;thyroid gland: 199.7"	"Cell type enhanced"	"Detected in many"	9	"Ductal cells: 3055.9;Exocrine glandular cells: 1910.6;Extravillous trophoblasts: 3534.8;Pancreatic endocrine cells: 3941.8;Urothelial cells: 1796.1"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 560.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 3.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 120.3;HBEC3-KT: 267.7;hTERT-HME1: 108.0;RT4: 319.2;SiHa: 251.7;SK-BR-3: 147.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000028, HPA007272, HPA007315"	Enhanced		Supported	"Intermediate filaments,Cytosol"		NA	NA		350000000	"Intermediate filaments"	Cytosol	"CAB000028: AB_2134589, HPA007272: AB_1079181, HPA007315: "	"unprognostic (2.71e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-3)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (9.42e-5)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.77e-9)"	"unprognostic (2.82e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.98e-3)"	3.5	0.2	0.2	0.6	0.2	0.0	43.1	0.2	0.2	7.8	0.5	0.1	18.0	0.0	1.7	9.6	14.4	11.7	27.1	1.2	0.2	0.2	35.0	4.3	63.2	0.0	0.2	0.2	3.3	15.1	1.7	2.1	156.6	0.6	23.1	0.0	0.1	142.6	67.3	0.4	10.7	0.3	4.3	0.3	0.2	2.3	4.3	0.0	0.4	199.7	6.1	16.3	58.2	22.3	0.0	0.8	0.0	3.8	0.0	0.0	0.2	0.1	101.9	0.0	0.0	0.1	0.0	120.3	21.9	0.0	11.5	1.0	0.3	72.7	0.0	0.0	7.5	0.0	80.2	0.0	267.7	0.5	0.1	0.0	0.0	54.7	0.3	2.5	0.0	0.0	0.0	16.7	0.0	108.0	0.0	11.5	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.0	0.1	0.0	0.2	1.6	66.1	319.2	0.1	0.1	251.7	147.0	0.0	1.2	5.6	0.0	87.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0	607.4	92.0	0.0	937.0	3.2	0.0	0.8	743.9	127.2	357.2	342.0	0.0	1328.4	114.4	3055.9	12.2	11.7	0.2	0.0	1910.6	3534.8	10.3	851.4	3.5	0.9	166.7	0.0	6.3	7.4	5.2	97.2	3.4	6.2	124.9	61.3	2.1	0.0	3941.8	0.0	0.4	2.8	0.0	0.0	7.2	0.7	0.5	1.9	1206.3	1.8	0.6	1796.1
LMTK2	"AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100"	ENSG00000164715	"Lemur tyrosine kinase 2"	Q8IWU2	7	98106885-98209633	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010657, HPA041836"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Nuclear speckles, Centriolar satellite"	"Plasma membrane, Cytosol"	"HPA010657: AB_1079259, HPA041836: AB_2677698"	"unprognostic (7.36e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.96e-1)"	"prognostic unfavorable (8.03e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.38e-3)"	5.1	10.3	13.7	5.6	21.3	17.3	5.6	16.6	34.3	7.3	13.8	6.1	5.6	12.6	6.1	6.3	12.7	6.4	7.9	16.9	11.0	10.1	10.1	8.5	10.0	5.1	7.5	18.9	8.0	21.0	22.2	10.0	4.8	13.2	7.9	11.8	5.4	10.5	6.5	17.5	11.5	13.8	5.7	5.5	6.8	9.4	8.0	6.9	7.2	8.7	5.7	7.4	8.3	8.1	0.6	0.7	4.8	0.9	0.3	1.6	0.5	9.8	11.6	9.0	9.2	4.8	3.9	8.4	4.1	4.5	4.0	4.9	9.1	9.0	5.2	11.8	5.2	15.3	10.8	10.4	6.3	6.3	7.4	7.3	3.5	10.4	9.1	5.9	6.2	6.3	2.6	8.7	8.3	11.3	4.1	6.0	6.0	9.1	10.9	3.6	13.3	6.6	3.7	11.0	13.5	5.7	7.2	6.1	10.2	6.7	17.3	6.5	12.9	8.2	15.0	6.0	9.5	4.1	2.5	7.3	8.4	13.8	16.8	9.3	4.9	8.5	10.3	5.7	4.9	10.0	1.2	0.6	0.5	0.8	0.3	0.5	0.6	0.9	0.9	0.3	0.6	1.1	1.6	4.8	0.3	0.9	0.7	0.8	0.5	13.7	21.3	16.6	34.3	11.0	10.1	7.5	18.9	13.2	6.9	26.8	10.5	0.0	4.2	8.7	14.0	18.7	17.8	10.7	9.1	1.8	13.7	2.3	1.7	5.0	0.8	3.1	26.2	0.0	7.9	1.6	3.5	6.2	2.3	6.8	1.8	6.4	11.5	3.1	2.6	2.1	1.7	2.3	1.7	0.0	13.5	5.8	8.6	13.1	4.2	2.4	9.9	0.0	3.8	6.3	4.7	9.5	2.5	2.9	12.6	13.2
LOXL4	"FLJ21889, LOXC"	ENSG00000138131	"Lysyl oxidase like 4"	Q96JB6	10	98247690-98268250	"Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 29.1"	"Cell type enhanced"	"Detected in many"	15	"Club cells: 9.1;Collecting duct cells: 29.6;Ductal cells: 8.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 44.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.3;plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 60.1;CAPAN-2: 72.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033876, HPA037609"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"CAB033876: AB_2135101, HPA037609: AB_2675579"	"unprognostic (9.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (7.71e-2)"	"unprognostic (1.75e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (2.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.40e-3)"	6.3	1.8	1.1	1.1	4.2	0.1	10.7	1.0	1.7	20.7	7.3	4.6	1.4	1.4	8.0	4.6	2.3	7.4	4.6	1.8	1.6	0.3	4.4	29.1	3.1	0.6	1.1	1.2	6.1	14.5	1.7	1.4	5.1	8.2	5.1	1.5	3.2	15.7	10.7	14.7	3.1	2.5	7.1	3.0	1.8	2.3	10.8	1.0	1.4	5.7	1.9	1.7	3.1	6.0	0.8	1.2	0.1	0.2	2.3	0.0	0.0	0.0	0.4	0.0	0.0	1.7	7.4	0.2	7.6	60.1	0.6	6.5	1.2	72.2	0.0	6.9	5.9	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	3.1	1.6	0.0	0.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.1	0.1	0.0	13.6	0.8	0.2	0.0	0.0	0.0	0.1	0.0	8.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	2.3	0.0	1.2	0.0	0.0	1.1	4.2	1.0	1.7	1.6	0.3	1.1	1.2	8.2	1.0	6.0	1.0	0.0	1.9	0.8	0.2	1.1	5.1	4.0	9.1	29.6	0.0	0.2	0.0	8.6	0.2	0.6	0.0	0.0	0.5	0.3	5.1	2.0	1.1	0.2	0.2	0.0	0.0	3.7	0.0	0.0	3.7	0.0	0.0	0.0	0.0	4.9	3.3	0.0	1.4	0.5	0.0	0.0	1.6	0.0	0.2	0.6	0.3	0.0	0.0	1.6
LPIN3	"LIPN3L, SMP2"	ENSG00000132793	"Lipin 3"	Q9BQK8	20	41340920-41360582	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 49.1"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 49.9;Late spermatids: 82.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 6.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.8;NK-cells: 6.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA051466, HPA052667, HPA070640"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA051466: , HPA052667: AB_2681908, HPA070640: AB_2686288"	"unprognostic (2.31e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-3)"	11.6	3.7	3.0	8.1	5.2	0.1	23.4	1.5	3.0	10.9	29.2	2.8	13.5	26.8	12.8	21.6	16.3	7.5	11.2	8.8	3.6	0.7	28.2	14.4	4.5	1.6	2.8	3.7	7.9	7.4	8.1	6.7	4.4	4.2	10.1	8.8	8.7	11.0	15.1	1.8	26.1	49.1	5.5	2.4	2.7	7.4	2.5	1.5	1.2	14.2	10.6	9.0	8.0	12.5	0.9	0.7	1.8	0.9	6.3	0.8	0.2	6.9	6.8	0.4	4.1	11.2	17.5	5.3	4.3	6.0	5.3	7.2	12.7	6.2	0.3	5.4	9.4	5.6	17.7	2.1	11.2	3.3	0.1	4.0	0.3	9.6	6.4	1.8	0.0	4.8	12.6	14.3	8.9	3.5	6.2	1.3	0.1	1.8	0.2	6.6	14.9	0.0	0.1	0.6	4.3	7.1	0.0	0.1	0.5	18.4	8.8	0.5	0.1	5.7	7.4	3.6	3.5	8.6	3.5	0.4	0.3	1.7	5.9	0.0	3.4	1.8	0.0	0.1	0.1	0.3	1.8	0.5	0.7	0.5	0.5	0.8	0.6	0.7	0.4	0.3	0.9	0.7	0.6	1.8	6.3	0.9	0.7	0.5	0.2	3.0	5.2	1.5	3.0	3.6	0.7	2.8	3.7	4.2	1.5	6.0	10.5	0.8	8.2	12.8	0.0	0.6	10.2	1.4	4.5	10.4	0.0	2.3	5.0	7.4	10.4	2.1	49.9	0.0	3.3	2.2	7.7	3.5	1.1	33.7	2.7	0.0	14.3	4.3	1.3	82.8	2.8	1.5	10.1	0.0	16.6	7.5	5.5	21.6	2.5	5.9	0.3	32.3	6.4	0.9	2.1	11.0	2.2	1.3	16.2	3.9
LRCH1	"CHDC1, KIAA1016"	ENSG00000136141	"Leucine rich repeats and calponin homology domain containing 1"	Q9Y2L9	13	46553168-46753040	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 46.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021536	Approved		Approved	"Nucleoli,Actin filaments,Cytosol"		NA	NA			"Actin filaments, Cytosol"	Nucleoli	"HPA021536: AB_1853258"	"unprognostic (7.13e-3)"	"prognostic unfavorable (6.24e-4)"	"unprognostic (3.59e-2)"	"unprognostic (8.93e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.04e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.98e-2)"	17.9	5.0	6.5	20.3	5.9	7.2	15.2	46.4	7.2	17.5	14.6	4.6	11.5	7.0	24.6	9.8	10.6	11.9	14.1	8.0	6.3	5.9	13.8	10.9	14.3	13.5	6.6	4.9	9.5	5.1	5.2	13.1	24.1	8.0	12.8	9.3	8.4	11.3	14.5	5.3	18.1	12.0	20.9	8.5	13.7	14.6	5.0	6.0	31.7	7.8	6.4	13.7	16.6	18.3	6.2	2.3	1.8	2.0	5.1	3.6	1.8	4.3	6.3	5.7	5.9	4.2	8.0	14.7	7.5	9.9	9.4	8.9	14.2	7.5	14.0	2.1	7.1	6.1	6.3	4.3	7.6	13.6	14.4	4.1	12.6	2.5	6.6	5.2	8.1	21.6	5.1	6.0	8.6	10.5	7.7	8.0	9.5	2.4	4.3	6.9	8.5	8.7	10.2	3.2	27.7	3.3	4.8	6.2	3.7	17.5	4.6	9.1	9.1	4.2	4.2	11.2	10.6	3.2	11.0	7.6	5.5	3.7	6.8	7.1	0.8	2.1	6.3	6.4	7.2	6.6	1.5	2.0	1.8	3.6	1.6	2.1	5.3	2.7	2.6	1.9	6.2	2.1	2.1	0.7	5.1	1.2	2.3	1.9	1.8	6.5	5.9	46.4	7.2	6.3	5.9	6.6	4.9	8.0	6.0	6.0	6.7	15.1	9.1	33.3	8.2	6.7	25.5	1.4	6.8	21.0	21.6	11.1	8.3	7.2	1.2	25.9	6.9	0.0	3.5	10.0	10.5	7.9	27.6	7.9	11.4	3.2	1.7	16.5	16.7	1.1	12.0	9.9	28.7	5.4	9.7	6.4	9.5	5.8	15.9	7.3	8.9	12.9	21.7	0.7	3.2	29.1	8.1	10.2	6.5	7.8
LRFN1	"KIAA1484, SALM2"	ENSG00000128011	"Leucine rich repeat and fibronectin type III domain containing 1"	Q9P244	19	39306568-39315336	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.5"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 22.8;Cone photoreceptor cells: 7.9;Muller glia cells: 7.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 14.9;HEK 293: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.92e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.36e-4)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.75e-2)"	"unprognostic (4.25e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.45e-3)"	"unprognostic (1.08e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.89e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.78e-1)"	1.6	0.3	5.5	1.3	3.4	1.1	0.6	9.5	9.0	0.4	0.6			1.0	1.2	1.4	0.2	0.6	0.3	0.2	5.2	6.6	0.3	0.5	0.9	1.0	2.9		0.3	2.0	0.2	0.1	0.5		1.1	0.4		2.0	0.3	0.2	1.4	1.5	0.7	1.0	3.8	0.7	0.6			0.3		0.6	0.2	0.0	0.3	0.4	3.2	0.8	1.8	1.0	0.0	1.1	4.7	0.1	4.1	0.0	0.0	5.1	0.1	0.0	0.3	0.1	14.9	0.6	0.4	2.0	0.0	1.2	0.2	1.9	0.1	0.1	0.4	18.2	0.8	0.7	0.6	0.1	0.3	3.9	0.3	0.2	0.1	0.0	0.4	0.1	5.5	7.5	0.4	0.0	2.4	1.9	2.3	2.0	1.5	5.0	6.4	0.0	1.6	0.0	0.2	1.4	7.3	1.6	3.1	1.2	0.4	1.5	1.5	0.3	1.7	5.9	1.4	0.1	0.7	0.2	1.8	0.1	0.9	0.5	1.7	0.3	3.2	1.0	0.2	0.9	0.1	0.4	1.0	0.0	0.3	0.5	0.7	2.6	1.8	0.8	0.4	0.3	0.0											0.0	0.0	0.0	0.1	0.7	22.8	0.8	2.5	0.0	0.0	0.0	7.9	0.4	0.0	0.2	0.0	1.0	0.0	0.0	0.6	0.4	1.0	0.4	0.0	0.8	0.8	3.2	0.0	2.5	4.0	0.0	0.0	0.7	0.0	1.0	0.0	7.5	0.2	0.0	2.5	0.0	2.3	0.0	0.1	0.9	0.7	0.4	0.7	3.1	0.0	0.1
LTBP4	"FLJ46318, FLJ90018, LTBP-4, LTBP-4L"	ENSG00000090006	"Latent transforming growth factor beta binding protein 4"	Q8N2S1	19	40592883-40629818	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Leydig cells: 900.3;Peritubular cells: 587.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015194	Approved				"Secreted to extracellular matrix"	NA	NA		7300000			"CAB015194: AB_2139064"	"unprognostic (3.29e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.09e-2)"	"unprognostic (9.94e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.41e-3)"	"unprognostic (2.67e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.83e-2)"	16.9	10.0	2.7	22.8	4.0	1.0	16.2	1.3	2.8	86.1	30.3	4.3	29.2	12.3	54.8	41.7	43.7	28.3	51.1	52.1	2.6	3.4	9.9	7.9	51.2	14.1	7.8	2.5	47.6	6.6	3.1	11.0	7.4	6.9	78.0	8.1	31.1	12.1	36.8	14.6	9.8	28.9	62.0	13.5	15.1	15.7	37.1	5.3	6.1	25.2	44.5	20.0	46.4	50.6	4.0	5.5	0.4	2.7	2.9	10.2	2.2	6.7	7.6	15.3	20.6	5.6	6.0	2.4	2.7	9.1	2.8	2.3	2.2	15.6	7.2	12.8	4.6	4.6	9.4	3.8	9.6	0.9	20.8	1.3	2.5	17.6	0.8	18.1	0.9	8.5	7.4	7.9	5.7	10.3	15.2	1.7	7.7	15.3	43.3	0.6	6.9	1.0	0.5	1.8	19.6	9.3	17.9	0.4	13.4	1.4	0.6	0.6	6.3	10.0	7.8	2.7	2.4	4.0	4.0	6.8	0.5	30.9	1.0	5.7	9.7	8.1	2.3	13.0	9.8	7.1	0.0	1.6	0.4	10.2	2.7	6.6	4.0	9.4	7.7	3.0	2.6	3.9	4.1	0.4	2.9	1.4	5.5	6.1	2.2	2.7	4.0	1.3	2.8	2.6	3.4	7.8	2.5	6.9	5.3	6.0	16.8	2.9	25.1	51.2	46.1	11.9	7.6	1.4	11.4	21.0	0.0	1.4	1.7	5.3	9.2	20.7	58.4	0.0	4.1	2.2	141.6	8.7	10.3	2.9	6.8	38.1	4.1	68.7	6.0	14.3	900.3	12.0	55.6	11.8	29.8	3.5	5.1	15.0	587.0	0.2	2.7	58.2	44.8	15.3	8.9	25.5	2.2	20.8	32.1	20.1
LYVE1	"LYVE-1, XLKD1"	ENSG00000133800	"Lymphatic vessel endothelial hyaluronan receptor 1"	Q9Y5Y7	11	10556966-10611689	"Plasma proteins, Predicted membrane proteins"	Transport	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 87.6"	"Group enriched"	"Detected in many"	26	"Hofbauer cells: 604.0;Ito cells: 335.7;Kupffer cells: 258.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.0;neutrophil: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	12	"HUVEC TERT2: 43.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB025860, HPA042953"	Supported					NA	NA		3000000000			"CAB025860: , HPA042953: AB_2678238"	"unprognostic (9.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (7.53e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.43e-3)"	51.8	28.6	3.3	7.4	4.2	0.4	23.0	2.8	2.8	7.9	26.4	2.4	2.9	5.3	5.3	20.8	17.7	17.2	8.0	19.8	3.8	2.0	18.0	31.1	15.7	47.7	3.2	1.6	11.0	5.4	1.6	3.6	56.6	6.2	15.2	8.0	6.0	4.8	4.7	15.4	5.1	17.8	25.5	2.9	87.6	8.4	11.9	2.5	0.0	21.4	9.1	2.7	25.9	10.9	0.7	0.0	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	43.2	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.3	4.2	2.8	1.8	3.8	2.0	3.2	1.6	6.2	2.5	0.0	3.2	7.0	0.0	3.3	0.0	3.1	15.3	2.7	0.0	0.0	0.0	4.6	0.0	0.0	0.7	11.4	0.0	0.0	0.0	4.4	4.4	0.1	1.1	1.5	604.0	0.0	0.0	335.7	258.9	0.8	3.4	8.5	6.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	12.9	5.1	0.0	0.0	2.9	9.3	0.0	0.0	0.1
MAPKBP1	KIAA0596	ENSG00000137802	"Mitogen-activated protein kinase binding protein 1"	O60336	15	41774434-41827855	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.1"	"Cell type enhanced"	"Detected in many"	18	"Basal keratinocytes: 48.5;Cone photoreceptor cells: 192.4;Suprabasal keratinocytes: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030832, HPA030833"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA030832: AB_10601869, HPA030833: AB_2673628"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.03e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	4.7	6.0	10.6	5.0	13.8	4.4	5.7	48.1	13.9	6.1	5.7	8.8	4.4	10.6	9.3	5.4	12.5	8.0	5.3	4.2	8.6	6.7	3.9	2.3	4.7	4.0	8.6	9.2	15.4	4.3	5.8	9.5	6.1	9.3	5.9	4.3	7.0	5.1	7.1	4.9	26.3	10.5	10.2	6.8	5.7	5.4	19.5	10.7	4.4	8.7	5.2	7.4	8.4	6.6	1.9	1.9	4.3	2.1	2.2	3.3	1.6	4.9	2.6	7.1	6.7	7.9	7.8	4.8	7.1	17.7	6.4	4.7	5.2	1.8	1.2	5.8	5.7	8.9	12.0	6.8	19.7	4.6	4.5	2.0	5.0	8.1	1.7	3.4	3.2	10.3	4.0	15.8	10.2	18.5	10.6	9.4	8.3	3.1	2.3	9.0	1.0	2.6	2.8	0.8	2.9	5.4	2.9	5.1	0.5	3.7	5.6	8.0	4.6	4.1	4.1	3.1	7.6	4.9	2.5	7.4	9.2	4.5	8.9	6.9	5.2	8.5	2.9	6.2	4.3	7.7	4.3	1.3	1.1	3.3	0.7	2.4	1.9	1.9	1.4	1.9	1.8	2.4	2.0	0.7	2.2	2.1	0.7	0.8	1.6	10.6	13.8	48.1	13.9	8.6	6.7	8.6	9.2	9.3	10.7	6.0	13.0	2.2	7.6	48.5	11.4	2.8	2.5	10.7	9.1	3.5	192.4	5.0	0.0	2.7	11.7	7.0	4.0	0.0	3.0	3.5	5.5	3.6	1.1	1.8	3.3	14.3	4.6	4.9	2.1	19.1	6.6	4.6	8.5	4.6	1.4	6.1	3.3	1.5	7.4	0.3	8.2	12.9	3.9	8.1	4.1	46.9	4.5	4.4	2.0	12.1
MFAP4		ENSG00000166482	"Microfibril associated protein 4"	P55083	17	19383442-19387240	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Fibroblasts: 593.8;Peritubular cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"eosinophil: 2.3;intermediate monocyte: 4.0;non-classical monocyte: 4.2"	"Group enriched"	"Detected in many"	15	"granulocytes: 2.3;monocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 60.2;ASC TERT1: 91.9;fHDF/TERT166: 41.1;HHSteC: 42.1;HSkMC: 63.7;MOLT-4: 52.6;SH-SY5Y: 52.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA054097	Supported		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		140000000	"Endoplasmic reticulum"		"HPA054097: AB_2682378"	"unprognostic (3.02e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.80e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (1.07e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.12e-4)"	41.5	10.0	1.3	37.3	4.1	0.0	34.9	1.3	3.7	62.5	44.8	5.1	18.1	12.1	64.3	58.7	64.2	32.2	150.2	46.9	1.8	1.3	15.9	12.0	106.1	10.7	2.4	5.8	57.6	8.5	0.0	15.8	43.3	6.8	102.4	17.2	102.5	16.3	16.6	18.7	25.9	43.8	88.9	3.2	7.6	31.4	26.2	1.3	8.4	20.3	55.3	39.0	79.2	73.7	0.0	0.2	2.3	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	60.2	91.9	0.1	6.5	23.5	0.6	0.4	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	42.1	2.0	0.0	63.7	0.0	0.3	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	52.6	4.8	1.0	0.0	0.0	3.7	3.7	0.0	0.0	0.0	5.3	52.5	0.0	0.0	0.0	0.3	0.0	11.8	0.0	7.6	0.5	0.3	0.0	0.0	0.0	0.0	7.3	2.2	0.0	0.0	0.3	2.3	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	1.3	4.1	1.3	3.7	1.8	1.3	2.4	5.8	6.8	1.3	3.0	15.5	0.0	0.5	42.2	0.7	9.5	0.0	5.3	5.7	1.8	0.0	5.9	0.0	0.0	0.3	4.4	0.0	0.0	0.0	3.1	593.8	1.2	1.1	0.0	8.2	0.0	0.0	19.0	0.0	2.0	72.5	2.4	64.1	0.0	0.0	71.0	0.1	0.0	225.6	0.0	2.9	19.4	95.8	0.2	0.5	35.9	16.2	0.0	0.0	0.4
MMP14	MT1-MMP	ENSG00000157227	"Matrix metallopeptidase 14"	P50281	14	22836557-22849027	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 216.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 96.4;HHSteC: 91.2;HSkMC: 92.7;hTERT-RPE1: 91.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009918, HPA051432"	Approved		Approved	"Intermediate filaments,Cytosol"		No	No		570000	Cytosol	"Intermediate filaments"	"CAB009918: AB_2250767, HPA051432: AB_2681484"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-3)"	"unprognostic (5.91e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.82e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (5.02e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.41e-3)"	60.9	10.5	2.4	16.6	4.7	0.2	64.2	2.2	3.2	56.3	35.0	8.2	12.7	12.0	53.1	24.1	47.0	21.9	39.6	17.5	3.4	1.8	16.8	9.0	29.8	16.9	5.8	2.9	39.3	11.2	34.4	4.7	73.5	16.4	39.1	11.3	27.1	24.4	16.7	20.4	37.0	22.9	28.5	20.7	22.5	18.2	26.3	4.6	5.4	22.3	14.6	16.7	52.5	53.9	0.1	0.7	0.0	0.7	0.0	0.0	0.1	7.8	0.1	2.4	0.1	96.4	61.3	44.3	24.7	49.8	7.5	13.4	2.3	29.4	0.1	13.8	26.0	2.3	20.0	0.0	25.7	9.6	0.1	0.1	3.6	0.1	0.5	91.2	0.0	0.1	92.7	15.5	31.2	26.8	91.6	45.3	0.1	0.0	0.2	17.6	0.1	0.0	8.8	1.4	1.7	4.3	0.3	8.5	0.0	6.8	13.5	0.0	0.0	16.1	0.0	53.5	10.8	0.1	7.9	40.0	60.9	5.2	17.7	28.1	0.1	0.1	0.1	37.1	0.0	35.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	4.7	2.2	3.2	3.4	1.8	5.8	2.9	16.4	4.6	11.9	4.8	3.7	19.4	30.2	0.0	3.6	53.5	2.7	3.4	7.0	0.0	83.6	10.0	61.2	0.4	13.5	16.8	0.0	24.9	216.8	65.7	13.9	3.5	2.9	79.3	0.0	7.5	41.1	18.3	0.7	66.7	26.5	35.4	34.3	32.5	17.1	102.2	28.5	51.6	13.0	0.8	38.8	34.8	0.9	0.7	29.9	102.6	1.0	17.1	28.7
MRC2	"CD280, CLEC13E, ENDO180, KIAA0709"	ENSG00000011028	"Mannose receptor C type 2"	Q9UBG0	17	62627401-62693597	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Alveolar cells type 2: 33.9;Early spermatids: 89.0;Fibroblasts: 61.1;Late spermatids: 54.5;Leydig cells: 66.4;Peritubular cells: 96.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 46.5;fHDF/TERT166: 31.6;U-138 MG: 47.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041991	Enhanced					NA	NA		28000000			"HPA041991: AB_10794166"	"unprognostic (3.22e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (7.70e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (5.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.93e-2)"	14.7	5.7	2.4	14.7	5.2	3.2	27.3	1.4	3.4	30.4	7.0	6.5	18.7	4.4	31.7	46.3	15.7	15.7	37.2	44.1	2.5	2.6	8.7	2.2	46.8	2.5	3.4	4.0	33.6	4.7	0.9	11.3	5.4	6.8	25.7	1.9	35.1	10.9	17.1	7.3	19.0	7.1	28.7	8.2	9.7	5.8	13.3	2.5	4.8	4.6	21.2	5.3	18.1	18.1	0.0	0.6	0.2	0.0	0.0	1.0	0.0	0.0	8.5	4.6	6.1	12.8	23.1	0.7	46.5	27.2	6.8	8.2	0.5	0.1	0.0	3.3	31.6	3.0	3.9	0.8	3.9	1.9	5.8	1.3	3.9	6.2	0.0	19.1	4.8	0.0	30.0	2.0	6.0	0.6	29.4	3.1	2.3	2.2	0.0	9.4	1.4	1.2	16.6	1.1	0.0	0.5	4.7	3.3	0.0	0.7	0.1	0.7	12.2	3.1	0.1	0.0	3.1	0.1	19.4	15.5	47.9	19.6	8.3	8.2	0.0	0.0	0.0	15.0	4.9	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	1.0	0.9	0.2	0.0	0.0	0.0	0.9	0.0	2.4	5.2	1.4	3.4	2.5	2.6	3.4	4.0	6.8	2.5	3.0	33.9	0.0	6.4	10.1	1.6	3.2	0.0	1.4	2.3	1.8	0.0	0.7	0.0	0.3	89.0	2.2	0.0	0.0	0.2	2.1	61.1	1.1	2.3	0.0	6.8	0.0	0.0	5.5	6.7	54.5	66.4	6.4	5.0	1.0	0.0	0.8	0.4	0.0	96.2	0.0	0.5	0.0	6.6	5.2	3.2	6.8	1.6	0.5	0.0	0.9
MTX3		ENSG00000177034	"Metaxin 3"	Q5HYI7	5	79976731-79991265	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047858, HPA062061"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA047858: AB_2680185, HPA062061: AB_2684672"	"unprognostic (2.56e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (5.08e-5)"	"unprognostic (4.02e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (8.58e-2)"	"unprognostic (8.46e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.28e-1)"	9.4	13.9	11.8	8.9	18.7	8.6	12.0	10.9	20.7	9.9	9.4	8.5	5.9	6.2	13.4	10.1	10.6	11.2	6.4	8.5	14.5	5.8	10.7	6.5	7.6	11.8	7.4	10.8	17.7	9.9	21.0	11.1	6.8	15.9	12.0	7.6	8.3	12.0	11.1	11.6	10.0	12.2	13.0	12.0	8.5	9.3	6.2	8.2	2.8	12.3	7.0	11.6	12.2	10.1	3.7	0.9	1.2	1.1	1.4	3.6	1.0	6.8	4.6	10.2	5.8	4.9	10.1	2.6	6.1	5.0	5.7	6.7	1.7	7.6	10.8	2.0	6.2	9.1	7.9	0.0	14.8	10.2	2.8	7.1	4.3	11.3	4.7	9.4	0.0	5.5	7.7	13.9	9.9	16.8	7.5	4.0	0.0	2.5	6.8	9.2	6.9	0.0	0.1	10.5	2.0	4.2	0.0	15.7	4.6	4.5	8.0	14.2	10.4	8.8	5.7	12.0	8.8	9.7	6.9	4.0	10.1	8.4	8.0	14.0	9.0	9.0	9.8	14.6	0.0	11.6	0.7	0.8	1.2	2.6	1.1	1.9	3.7	2.9	3.5	0.4	2.6	3.6	2.8	1.0	1.4	0.5	0.9	1.4	1.0	11.8	18.7	10.9	20.7	14.5	5.8	7.4	10.8	15.9	8.2	26.8	4.0	1.9	4.1	1.3	0.0	8.7	12.7	16.0	11.4	12.2	0.0	4.1	5.0	3.7	2.1	4.2	2.8	0.0	2.2	2.2	4.6	7.9	1.1	6.8	2.8	0.0	0.0	9.2	4.3	3.1	11.8	3.3	0.0	1.8	6.8	0.0	4.3	5.3	11.7	6.7	0.0	12.9	2.8	7.1	6.3	3.0	1.5	6.9	6.4	4.2
MYC	"bHLHe39, c-Myc, MYCC"	ENSG00000136997	"MYC proto-oncogene, bHLH transcription factor"	P01106	8	127735434-127741434	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 812.6;Basal keratinocytes: 900.0;Smooth muscle cells: 529.5;Suprabasal keratinocytes: 935.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 132.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000084, CAB010307, HPA055893, HPA066556"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000084: , CAB010307: AB_631274, HPA055893: AB_2682960, HPA066556: AB_2685691"	"unprognostic (1.45e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.94e-3)"	"unprognostic (2.41e-3)"	"unprognostic (8.14e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.80e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.19e-3)"	"unprognostic (9.86e-3)"	"prognostic unfavorable (5.49e-8)"	"unprognostic (7.85e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (4.96e-5)"	67.4	20.8	3.2	46.6	7.1	16.3	36.0	1.2	5.0	23.9	23.3	3.8	11.8	11.1	23.8	14.4	47.6	59.5	32.4	23.7	5.8	2.2	11.2	36.6	16.0	40.5	5.8	1.2	38.7	64.6	2.1	7.4	14.9	9.8	20.6	11.3	6.1	14.4	21.8	69.6	78.5	17.2	21.3	12.0	38.3	24.7	16.3	3.8	40.2	9.0	48.4	27.1	28.9	37.3	25.5	8.8	1.0	10.3	20.9	55.2	22.0	7.2	14.0	1.2	12.5	20.4	24.1	3.7	8.7	3.8	10.9	9.1	19.2	19.1	74.3	12.3	5.2	10.7	15.8	65.1	28.3	7.2	17.5	22.7	44.7	23.8	25.0	18.8	31.2	7.2	16.8	62.6	7.3	58.0	8.8	12.5	26.2	66.0	39.3	5.4	20.8	51.0	68.1	3.5	31.3	28.1	28.4	5.3	132.1	9.1	7.5	86.4	8.2	4.0	34.1	22.6	2.1	13.9	20.5	15.2	8.2	9.8	6.3	10.9	0.7	1.2	35.9	7.2	35.0	4.1	0.7	10.3	0.1	8.6	9.1	43.4	25.5	31.1	18.6	8.8	20.6	55.2	34.8	1.0	20.9	6.1	0.3	24.8	22.0	3.2	7.1	1.2	3.6	5.8	2.2	5.8	1.2	9.8	3.8	53.6	68.5	50.1	812.6	900.0	0.0	10.2	28.1	18.7	83.0	12.2	0.0	20.0	1.7	71.3	0.9	89.5	6.3	0.0	37.0	51.5	149.4	176.0	54.4	27.1	25.9	0.0	12.0	96.3	42.9	1.1	91.5	19.1	160.3	3.6	66.1	1.0	60.5	11.5	63.3	5.3	0.2	45.3	529.5	0.5	0.7	935.3	4.9	39.5	82.4	301.8
MYO18A	"KIAA0216, MysPDZ"	ENSG00000196535	"Myosin XVIIIA"	Q92614	17	29071124-29180412	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"skeletal muscle: 179.7"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 31.3;Club cells: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 29.3"	"Low region specificity"	"Detected in all"							HPA019646	Supported					NA	NA		80000			"HPA019646: AB_1854249"	"unprognostic (2.54e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.70e-2)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.95e-1)"	8.3	3.6	11.9	5.8	15.5	7.7	8.6	23.1	18.7	6.1	6.7	15.9	3.6	9.0	6.5	5.4	11.8	4.4	7.2	24.6	15.2	9.4	4.0	9.2	5.2	4.8	13.6	9.9	5.1	9.3	7.4	3.4	4.0	11.4	6.0	4.8	4.4	7.4	5.1	179.7	11.7	9.0	6.3	15.7	4.8	9.0	4.3	12.9	8.0	5.7	14.5	9.1	4.8	5.9	2.2	2.3	2.9	1.8	2.1	3.0	0.7	14.3	20.2	7.8	4.0	2.1	3.6	12.5	6.9	6.8	6.0	4.2	5.0	10.2	1.5	7.7	4.9	8.8	16.5	3.0	11.4	2.4	16.6	5.7	1.3	6.0	5.5	3.1	1.7	1.8	4.2	6.7	3.6	1.6	9.9	2.1	6.2	17.6	2.6	2.9	4.9	5.1	1.4	1.6	29.3	4.5	18.1	8.7	4.4	4.6	10.7	4.1	4.2	6.8	22.9	5.0	5.4	5.3	2.1	2.5	3.9	4.8	2.6	4.7	5.1	8.5	2.9	4.9	1.3	10.4	2.5	1.6	2.4	2.3	1.8	3.0	0.9	1.7	1.8	1.8	2.2	2.4	1.4	2.9	2.1	1.7	2.3	1.3	0.7	11.9	15.5	23.1	18.7	15.2	9.4	13.6	9.9	11.4	12.9	11.9	6.5	0.5	0.8	0.9	7.1	31.3	5.1	2.7	14.8	1.8	9.8	0.4	0.0	2.1	1.0	4.3	7.3	0.0	1.2	2.4	0.8	0.6	1.1	3.4	0.9	1.6	2.4	1.8	0.8	0.2	2.0	1.8	0.0	1.8	3.9	2.5	3.1	4.0	2.8	0.8	4.0	0.0	1.3	1.0	1.6	0.6	0.2	1.3	2.4	0.7
MYO9B	CELIAC4	ENSG00000099331	"Myosin IXB"	Q13459	19	17075781-17214537	"Disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, GTPase activation, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 192.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037190, HPA042043"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB037190: AB_477214, HPA042043: AB_10796897"	"unprognostic (1.92e-1)"	"unprognostic (1.79e-3)"	"unprognostic (4.35e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (7.97e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (5.66e-6)"	"unprognostic (1.97e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.53e-2)"	17.4	14.3	14.3	34.7	30.2	59.3	16.0	16.2	25.0	12.7	15.3	40.1	10.6	12.5	16.2	12.8	11.0	10.0	14.9	11.2	16.0	11.8	9.4	12.9	25.0	37.4	38.8	10.7	8.2	9.0	6.7	9.2	15.2	18.8	15.6	11.1	14.7	12.3	10.7	4.8	13.5	20.3	17.2	27.8	55.9	15.2	21.8	28.2	17.4	9.2	5.4	24.8	17.2	16.2	3.3	4.4	14.4	4.7	2.9	3.9	1.9	19.1	8.9	11.9	13.9	8.7	9.2	34.6	18.2	9.4	11.5	10.1	7.1	9.8	17.9	10.2	15.9	10.3	12.0	5.1	8.9	8.7	31.9	10.5	21.5	10.5	6.8	11.2	16.8	34.8	8.4	4.7	15.9	6.2	7.1	12.0	8.0	8.8	12.2	7.9	8.0	22.8	31.3	9.0	6.2	19.8	25.0	8.9	5.1	4.5	16.3	4.1	9.1	11.3	9.0	23.5	6.7	8.9	17.7	23.2	21.5	9.6	33.1	15.3	17.6	11.1	11.5	21.2	22.1	26.7	4.2	3.8	6.6	3.4	4.7	2.1	3.3	2.5	2.7	2.2	3.0	1.6	2.4	14.4	2.9	2.8	4.4	3.9	1.9	14.3	30.2	16.2	25.0	16.0	11.8	38.8	10.7	18.8	28.2	8.9	32.6	32.1	45.6	17.4	8.0	8.7	12.7	6.7	11.4	5.2	192.4	14.3	1.7	7.0	4.2	25.9	19.2	0.0	6.6	21.0	16.9	41.3	20.9	13.5	66.4	7.9	6.9	26.4	56.8	7.6	11.5	84.1	42.2	45.1	12.6	9.3	9.7	12.7	15.9	2.2	97.0	6.5	29.9	8.0	13.2	15.7	12.0	35.7	13.3	33.8
MYPOP	P42pop	ENSG00000176182	"Myb related transcription factor, partner of profilin"	Q86VE0	19	45890020-45902604	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 36.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 19.2;NB-4: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065307			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA065307: AB_2685460"	"unprognostic (5.13e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.94e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (8.67e-5)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-3)"	7.6	9.4	15.7	7.9	14.3	4.2	8.0	15.1	25.9	6.5	7.5	6.8	5.9	11.4	7.2	7.0	6.4	6.1	7.1	8.0	15.9	9.2	9.5	6.1	5.9	8.3	8.5	7.7	6.5	8.5	7.0	12.9	6.1	11.3	7.7	6.0	6.3	9.5	8.2	36.4	10.1	10.1	6.5	9.0	12.3	8.5	6.8	8.7	5.3	5.0	4.3	7.0	6.8	10.7	1.0	1.5	2.7	1.4	0.6	1.1	0.4	4.2	6.8	2.6	5.3	3.4	2.2	5.2	3.2	3.3	3.5	4.6	2.7	2.7	4.1	3.1	1.6	3.4	3.6	1.9	1.4	2.5	19.2	11.1	1.9	3.8	4.4	3.7	1.9	6.2	2.1	4.1	1.9	1.8	3.7	2.8	7.0	2.6	3.7	2.2	1.8	10.1	26.2	2.9	5.5	6.9	8.1	1.1	2.3	2.0	2.4	5.4	4.1	3.1	3.4	3.3	2.0	2.3	7.1	3.6	3.3	5.5	3.0	5.0	10.9	7.8	2.7	4.8	5.2	3.9	0.0	1.4	2.7	1.1	0.6	0.3	1.0	0.8	0.6	1.5	0.3	0.6	0.7	1.6	0.6	0.7	1.0	0.7	0.4	15.7	14.3	15.1	25.9	15.9	9.2	8.5	7.7	11.3	8.7	3.0	1.3	3.7	4.4	10.2	10.1	11.8	5.1	1.4	0.0	5.2	7.9	4.5	19.9	7.0	5.2	3.8	7.8	0.0	7.9	14.2	6.6	2.9	0.0	3.2	5.1	6.4	8.6	3.7	4.9	1.0	6.6	5.3	3.3	6.4	4.5	3.2	6.0	5.9	7.1	5.1	11.4	19.4	4.5	2.4	4.9	8.5	4.5	6.9	4.6	2.0
NDST1	"HSST, NST1"	ENSG00000070614	"N-deacetylase and N-sulfotransferase 1"	P52848	5	150485818-150558211	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Multifunctional enzyme, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 42.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"dendritic cells: 5.5;granulocytes: 7.2;monocytes: 6.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060532	Approved					NA	NA		1000000			"HPA060532: AB_2684310"	"unprognostic (1.36e-1)"	"unprognostic (5.54e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (4.97e-3)"	"unprognostic (6.92e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.08e-2)"	26.3	15.5	17.3	9.9	20.2	4.9	21.3	8.6	28.3	12.9	10.2	41.7	7.3	9.3	11.8	10.0	25.5	11.0	16.9	19.6	17.9	14.4	11.4	49.2	25.2	6.1	28.5	13.8	17.3	28.9	16.5	4.7	10.0	26.1	11.3	7.3	10.8	25.4	13.5	15.3	24.9	14.7	14.3	32.8	30.1	10.2	12.6	19.6	1.4	17.3	11.9	9.8	10.5	11.5	0.6	5.5	7.2	6.5	0.1	0.6	2.9	9.8	8.8	14.6	17.8	14.7	14.7	14.7	18.1	23.9	18.1	27.3	25.9	10.4	6.7	18.4	36.1	29.1	16.9	7.8	36.7	12.1	0.8	12.2	7.9	5.7	4.0	10.9	5.9	14.5	20.0	15.3	21.8	9.9	18.2	24.6	4.0	7.5	2.4	17.6	8.3	0.7	1.8	6.8	2.7	10.4	11.4	12.2	2.9	10.6	10.0	4.4	15.4	10.9	34.3	14.5	10.9	18.3	1.4	12.0	31.0	28.1	13.4	14.8	5.4	1.4	2.5	25.4	9.2	11.9	1.7	6.5	4.4	0.1	2.3	0.0	0.6	0.0	0.6	5.5	0.1	0.1	0.2	7.2	0.1	5.5	0.4	0.0	2.9	17.3	20.2	8.6	28.3	17.9	14.4	28.5	13.8	26.1	19.6	35.7	8.3	0.8	2.4	5.0	11.1	10.4	15.3	0.0	7.9	15.7	7.9	7.4	1.7	8.2	0.4	12.6	12.1	0.0	8.9	9.2	10.0	6.0	1.1	42.9	7.0	12.7	1.2	35.0	17.9	1.5	11.5	5.0	10.1	1.0	6.3	12.2	13.6	5.8	30.1	8.4	10.1	0.0	7.1	0.0	0.6	10.8	3.8	1.0	4.4	3.5
NOTCH2		ENSG00000134250	"Notch 2"	Q04721	1	119911553-120069626	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 129.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048743	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		67000000	"Nucleoplasm, Plasma membrane"		"HPA048743: AB_2680508"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.40e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.24e-4)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.86e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.35e-3)"	12.0	7.3	6.0	9.4	6.8	4.4	10.6	3.0	5.6	14.5	7.6	4.4	11.3	1.6	12.3	11.8	13.4	11.4	12.8	7.9	6.8	2.3	5.5	11.4	10.6	5.7	5.3	7.6	15.5	27.6	6.1	3.3	10.3	6.5	9.9	5.2	9.4	17.7	10.0	9.3	17.2	6.1	12.4	6.2	11.5	5.8	15.7	4.4	8.0	11.4	8.6	6.6	9.6	13.0	4.2	5.2	7.7	9.6	1.5	1.7	2.0	15.0	5.1	7.9	6.1	33.0	28.3	7.9	11.5	15.9	15.4	16.7	4.7	4.1	0.3	9.7	21.8	13.7	5.7	12.5	10.2	24.6	18.1	8.0	8.7	13.7	0.4	12.3	9.1	2.3	22.7	6.6	46.1	30.7	23.3	7.8	4.1	0.1	19.2	18.5	16.9	3.8	2.6	10.2	1.4	5.7	2.5	27.9	9.7	8.1	9.6	0.3	4.0	15.6	14.7	8.3	16.7	8.1	3.1	27.4	20.1	13.9	30.1	18.0	8.0	3.9	4.4	29.5	8.4	19.1	5.6	6.4	6.4	1.5	6.6	1.7	4.2	1.3	1.1	5.2	3.9	1.0	1.7	7.7	1.5	9.6	4.2	0.8	2.0	6.0	6.8	3.0	5.6	6.8	2.3	5.3	7.6	6.5	4.4	32.8	21.6	24.1	40.5	41.1	3.5	11.2	25.5	2.7	13.6	17.4	5.9	1.2	0.0	37.1	15.7	3.7	3.0	0.0	11.3	6.7	53.5	36.6	15.1	35.0	29.9	3.2	5.8	5.5	68.6	9.3	50.9	36.3	37.1	13.6	7.5	46.7	22.9	129.8	80.2	4.3	10.2	19.4	32.3	4.8	3.6	77.8	1.4	13.6	13.8	52.7
NRROS	"ELLP3030, GARPL1, LRRC33, MGC50789, UNQ3030"	ENSG00000174004	"Negative regulator of reactive oxygen species"	Q86YC3	3	196639686-196662004	"Predicted membrane proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 30.4"	"Cell type enhanced"	"Detected in some"	14	"Hofbauer cells: 61.8;Ito cells: 18.4;Kupffer cells: 33.8;Macrophages: 36.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 7.4;classical monocyte: 1.9;eosinophil: 3.3;intermediate monocyte: 2.0;myeloid DC: 2.5;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.5;granulocytes: 7.4;monocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"HEL: 16.4;HMC-1: 34.6;Karpas-707: 21.4;MOLT-4: 18.2;NB-4: 42.6;RPMI-8226: 21.2;THP-1: 18.8;U-937: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031586	Uncertain					NA	NA					"HPA031586: AB_10601543"	"unprognostic (5.28e-2)"	"unprognostic (8.92e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.20e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (2.32e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	17.0	3.6	3.8	9.3	4.4	30.4	12.4	1.6	3.1	4.7	3.3	4.0	1.0	3.0	7.6	7.1	2.7	4.2	5.8	8.5	3.1	2.7	4.3	3.4	13.4	23.0	4.3	1.3	2.6	2.6	1.2	2.3	12.4	3.4	4.5	2.2	5.7	3.8	2.2	3.1	3.1	6.9	4.9	5.2	22.5	3.4	2.8	4.8	15.6	3.5	2.4	8.8	6.3	3.5	0.6	2.5	7.4	2.0	0.6	0.7	1.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	2.2	0.1	0.1	0.0	0.3	0.0	0.0	1.2	0.0	16.4	0.0	0.0	0.1	13.4	34.6	0.1	0.0	0.5	0.2	0.6	1.3	15.5	1.6	21.4	0.4	0.0	18.2	42.6	1.4	0.0	0.0	4.9	0.0	21.2	0.0	0.1	0.1	0.0	0.0	0.0	8.6	0.3	0.0	18.8	0.1	0.1	0.0	0.6	0.0	8.6	12.9	3.8	1.1	23.7	0.2	7.4	1.9	3.3	0.7	2.0	0.2	0.6	0.5	0.4	2.5	0.5	0.2	0.4	0.0	0.6	1.9	0.3	0.5	1.2	3.8	4.4	1.6	3.1	3.1	2.7	4.3	1.3	3.4	4.8	0.0	0.3	15.9	0.0	1.3	0.0	0.1	0.0	0.0	1.2	0.0	3.9	0.3	0.0	0.0	0.9	3.8	0.0	0.0	0.0	0.5	0.8	0.0	13.9	0.0	61.8	0.0	0.0	18.4	33.8	0.0	0.6	36.2	8.5	3.6	0.0	0.0	0.0	0.0	0.7	0.0	0.4	6.5	0.5	0.5	0.2	0.6	0.5	13.1	0.0	0.0
NUMBL	"CAG3A, CTG3a, NUMB-R, NUMBLIKE, NUMBR, TNRC23"	ENSG00000105245	"NUMB like, endocytic adaptor protein"	Q9Y6R0	19	40665905-40690972	"Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 26.0;Leydig cells: 39.4;Peritubular cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058251, HPA058380"	Approved					NA	NA					"HPA058251: AB_2683653, HPA058380: AB_2683698"	"unprognostic (2.78e-2)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (1.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.56e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (7.55e-15)"	"unprognostic (1.91e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.69e-3)"	21.4	11.9	18.0	9.1	25.2	3.4	10.7	17.3	44.3	19.5	11.0	4.3	4.9	9.7	20.9	7.8	8.6	16.3	13.3	9.0	12.9	11.5	4.2	4.6	8.2	4.4	6.6	21.8	18.0	7.9	4.7	26.2	6.8	10.0	14.1	4.9	8.8	11.8	17.7	6.0	10.7	10.3	14.8	6.8	7.8	10.3	11.3	4.5	1.0	10.0	6.6	3.8	19.0	13.8	1.0	0.9	0.9	2.3	0.3	4.0	0.7	8.7	24.4	5.2	13.7	12.5	12.4	2.9	10.6	9.3	6.3	7.6	9.1	6.6	3.2	10.7	15.4	4.8	8.6	3.7	4.6	3.3	8.6	6.3	3.5	24.0	1.2	13.3	1.7	4.1	11.8	3.2	10.3	4.4	9.8	8.9	2.9	10.1	3.8	4.3	8.0	5.5	1.7	6.1	5.1	5.7	4.7	14.3	6.5	1.8	2.4	10.4	18.4	11.7	6.9	10.3	3.4	6.9	2.9	16.7	11.4	13.3	18.1	13.2	5.0	5.9	1.9	18.5	5.6	6.5	0.1	0.4	0.1	4.0	0.3	0.3	0.4	0.6	1.2	0.0	1.0	0.4	1.7	0.9	0.3	2.3	0.9	0.1	0.7	18.0	25.2	17.3	44.3	12.9	11.5	6.6	21.8	10.0	4.5	0.0	4.3	0.9	13.6	12.0	13.3	4.3	0.0	9.4	4.5	0.0	0.0	2.3	0.0	2.0	26.0	6.0	2.0	0.0	1.6	4.4	16.2	11.4	0.0	2.0	1.3	11.1	6.9	5.5	2.6	5.9	39.4	2.9	3.3	0.0	2.9	3.2	1.9	2.3	48.4	0.4	4.1	0.0	12.4	1.2	2.3	18.3	1.8	1.3	3.0	7.3
OGN	"mimecan, OIF, SLRR3A"	ENSG00000106809	Osteoglycin	P20774	9	92383967-92404696	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 68.7"	"Group enriched"	"Detected in many"	5	"Fibroblasts: 137.8;Leydig cells: 153.9;Peritubular cells: 199.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"T-reg: 5.1"	"Lineage enriched"	"Detected in single"	8	"T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 18.1;HSkMC: 8.1;JURKAT: 11.6;MOLT-4: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013132	Approved		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		190000000	"Endoplasmic reticulum"		"HPA013132: AB_1854825"	"unprognostic (2.31e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.86e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (2.03e-4)"	35.6	3.9	0.7	7.1	1.3	0.0	14.7	2.0	2.2	47.8	15.2	0.7	11.7	1.5	25.2	19.8	11.7	12.9	47.5	27.6	0.9	0.7	1.9	1.0	7.8	1.3	2.8	1.6	26.1	1.9	68.7	7.1	9.7	2.9	27.7	5.7	10.7	2.9	4.9	2.4	1.6	5.9	31.1	6.0	0.8	9.4	10.7	0.8	1.3	5.9	7.0	1.5	32.0	10.0	0.6	0.3	0.0	0.0	0.4	5.1	0.2	0.0	0.0	0.0	0.0	3.9	18.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	23.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.5	0.3	0.6	0.1	0.1	0.0	0.4	0.0	0.1	5.1	0.2	0.7	1.3	2.0	2.2	0.9	0.7	2.8	1.6	2.9	0.8	6.0	1.0	0.0	0.0	3.8	0.6	2.4	0.0	5.3	13.6	3.5	0.0	1.6	0.0	0.0	1.2	3.5	0.0	0.0	0.0	1.5	137.8	0.2	1.1	0.0	4.2	0.0	0.0	30.7	0.3	1.3	153.9	1.2	1.7	0.0	0.0	0.0	0.0	0.0	199.4	0.0	0.2	6.5	11.8	0.6	0.3	4.0	4.8	0.0	0.0	0.1
PABPC3	"PABP3, PABPL3, tPABP"	ENSG00000151846	"Poly(A) binding protein cytoplasmic 3"	Q9H361	13	25095868-25099254	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 50.9"	"Group enriched"	"Detected in many"	9	"Early spermatids: 131.2;Late spermatids: 106.4;Spermatocytes: 81.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	14	"U-266/84: 11.7"									"HPA045423, HPA067156"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA045423: AB_2679320, HPA067156: AB_2685793"	"unprognostic (2.17e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (8.00e-4)"	"unprognostic (5.26e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.61e-3)"	0.5	0.2	0.2	0.5	0.8	0.2	1.0	0.1	1.1	0.7	0.5	0.1	0.0	0.2	0.2	0.3	0.7	0.2	0.2	0.2	0.3	0.1	0.2	0.2	1.2	2.0	0.2	0.4	0.4	0.3	0.1	0.4	0.2	0.3	0.4	0.2	0.0	0.6	0.9	0.2	0.4	0.5	0.2	0.1	0.4	0.2	50.9	0.0	0.8	0.3	0.0	0.2	0.3	0.4	1.6	1.9	0.5	2.2	1.8	2.5	1.9	0.4	0.0	0.0	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.5	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.8	0.7	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.8	0.2	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.2	0.4	11.7	0.2	0.1	0.3	0.1	0.4	1.4	0.5	0.7	2.1	1.6	1.6	1.7	1.3	1.9	1.3	2.5	2.2	0.5	1.8	2.2	1.1	1.5	1.9	0.2	0.8	0.1	1.1	0.3	0.1	0.2	0.4	0.3	0.0	0.0	0.0	0.5	4.6	10.4	0.0	4.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	131.2	3.6	0.6	0.0	0.3	1.4	3.5	3.4	4.6	0.6	1.4	1.6	4.1	3.1	5.6	106.4	2.8	3.9	5.0	0.0	1.3	1.0	0.1	3.5	4.6	0.8	0.0	6.5	4.1	81.1	4.6	11.3	2.4	2.2	3.3	3.1
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848233-66958376	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 41.1;liver: 76.0"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 192.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		Yes	No		96000	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	41.1	10.7	11.1	2.8	14.6	3.1	12.9	13.1	14.9	2.4	3.8	10.7	21.4	5.6	2.1	2.4	5.0	2.7	2.9	4.0	11.3	8.9	18.7	76.0	2.1	1.6	15.5	11.5	4.4	4.3	19.4	4.0	4.1	10.9	5.4	3.1	3.4	24.2	24.4	5.7	2.8	6.7	1.8	9.4	1.5	3.3	6.1	13.1	0.6	4.2	2.5	2.5	2.2	2.1	0.6	2.6	0.0	3.8	0.3	2.9	2.0	2.9	9.1	3.4	8.3	13.9	5.5	3.5	1.9	7.9	3.6	3.5	4.5	3.3	0.0	3.8	2.9	4.8	3.9	3.8	21.0	1.1	1.8	5.3	4.5	28.3	17.3	10.9	0.0	5.9	21.0	5.4	2.9	6.6	2.3	2.9	7.9	8.5	0.0	1.2	19.4	5.1	2.4	6.4	7.7	7.6	3.8	7.0	1.8	3.3	0.9	7.4	10.5	17.6	9.4	7.2	2.6	7.7	1.2	3.2	4.0	3.7	4.7	2.1	2.0	2.3	0.0	4.1	2.9	3.4	0.0	3.8	0.0	1.2	0.9	1.4	0.2	0.5	1.9	2.6	0.6	2.9	1.6	0.0	0.3	0.5	1.0	1.5	2.0	11.1	14.6	13.1	13.6	11.3	8.9	15.5	11.5	10.9	13.1	0.0	4.8	2.2	1.1	1.1	4.7	3.7	10.2	0.0	1.2	3.5	2.0	15.6	1.7	3.1	15.2	1.4	18.6	0.0	1.6	3.5	1.9	2.4	9.2	192.6	11.2	0.0	8.6	4.3	6.9	39.9	0.6	1.6	5.0	32.5	4.2	9.2	2.3	7.0	3.9	37.8	4.7	0.0	1.4	6.0	4.2	0.5	21.3	1.3	6.0	1.1
PCDHGC3	"PC-43, PC43, PCDH-GAMMA-C3, PCDH2"	ENSG00000240184	"Protocadherin gamma subfamily C, 3"	Q9UN70	5	141475947-141512979	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 99.3"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 6.9;Horizontal cells: 11.1;Muller glia cells: 4.9"	"Group enriched"	"Detected in all"	6	"glioma: 55.0;melanoma: 20.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"plasmacytoid DC: 15.2"	"Lineage enriched"	"Detected in single"	22	"dendritic cells: 15.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 43.5;ASC TERT1: 41.7;HSkMC: 40.8;U-138 MG: 52.4;WM-115: 78.0"									"HPA008755, HPA010580, HPA077289"	Approved		Approved	"Plasma membrane"		NA	NA		74000	"Plasma membrane"		"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077289: AB_2686832"	"unprognostic (2.52e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (6.19e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (3.72e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (6.00e-4)"	14.9	15.0	52.8	7.0	49.0	0.5	11.2	30.1	99.3	28.0	8.7	38.9	2.4	3.8	20.6	27.6	12.8	15.7	14.6	11.0	40.2	25.2	7.1	8.0	20.9	4.2	32.0	24.9	16.6	4.4	18.8	7.9	17.7	25.8	17.1	10.2	17.3	8.4	20.1	5.8	18.3	5.6	19.8	28.1	5.3	6.6	4.8	24.1	0.9	5.4	6.4	7.1	8.6	11.1	0.6	15.2	0.0	0.0	0.0	0.1	0.0	2.8	1.6	10.8	2.9	43.5	41.7	0.1	14.2	37.9	7.0	7.6	0.0	2.7	9.4	9.2	24.7	26.5	10.3	1.4	4.4	6.7	0.0	4.3	0.0	0.2	0.2	13.4	0.1	0.3	40.8	6.8	10.6	8.7	25.8	4.7	0.0	0.0	0.3	17.7	5.2	0.2	1.0	0.4	0.1	0.0	6.3	21.9	0.0	3.7	3.0	3.5	15.4	3.8	0.1	23.3	4.0	8.8	13.1	5.7	52.4	2.7	10.2	15.3	0.0	0.1	0.1	12.5	0.0	78.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	15.2	0.0	0.0	52.8	49.0	30.1	38.9	40.2	25.2	32.0	24.9	25.8	24.1	0.0	0.0	0.0	0.4	0.2	6.9	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.9	0.6	0.0	0.0	0.2	0.1	0.7	0.3	0.0	0.0	0.2	11.1	0.0	0.6	0.3	0.4	1.1	0.0	0.0	0.0	0.0	4.9	0.5	0.0	0.4	0.0	0.9	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.5
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926066	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.2"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 71.4;Early spermatids: 99.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 39.5;hTERT-RPE1: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Nucleoplasm, Mitochondria, Cytosol"		"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavorable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favorable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	5.1	32.3	11.0	4.6	38.9	5.9	7.9	7.5	62.2	7.5	4.3	4.7	1.6	3.3	7.7	8.6	8.0	6.1	9.6	22.9	10.1	8.0	6.3	2.2	6.0	5.6	5.1	32.5	9.7	9.3	20.6	4.2	6.6	4.4	5.2	6.2	4.4	6.6	4.7	31.8	3.2	5.5	5.5	3.4	5.8	5.5	12.9	4.8	4.1	9.3	7.0	5.8	7.7	5.1	11.0	12.7	7.8	21.5	2.8	19.5	8.8	7.9	3.9	8.6	3.6	7.1	13.1	2.8	6.3	7.0	7.4	8.7	4.1	29.6	4.4	21.2	10.0	39.5	17.7	3.6	5.3	11.0	0.4	1.8	2.1	4.9	1.4	8.2	1.0	3.0	8.4	10.5	12.6	20.2	39.3	16.7	4.0	0.7	7.3	9.0	1.9	6.2	3.2	3.9	8.6	5.1	1.5	5.1	0.8	5.1	5.5	0.8	3.7	4.1	0.4	19.3	7.3	1.3	1.2	29.6	9.0	5.8	21.0	7.4	4.1	1.7	3.7	11.5	3.7	7.9	3.1	15.4	7.8	5.6	14.3	5.3	9.3	9.1	7.2	12.7	11.0	5.5	4.8	1.8	2.8	21.5	2.1	19.5	8.8	11.0	38.9	7.5	62.2	10.1	8.0	5.1	32.5	4.4	4.8	11.9	5.6	13.4	11.2	11.6	34.7	71.4	22.9	22.7	17.0	15.7	7.9	3.5	5.0	24.3	99.2	14.7	6.0	0.0	11.9	3.2	11.6	13.3	5.8	2.5	5.7	9.5	9.8	14.1	20.8	22.0	10.6	16.2	10.1	2.8	5.2	19.0	22.2	7.0	12.7	8.6	10.6	6.5	12.7	7.2	9.7	9.5	3.7	10.1	8.9	17.0
PFKL		ENSG00000141959	"Phosphofructokinase, liver type"	P17858	21	44300051-44327376	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 285.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030047	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA		1800000	"Nucleoli, Mitochondria"		"HPA030047: AB_10602815"	"unprognostic (6.21e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.98e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (5.69e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.01e-2)"	32.0	16.7	28.0	26.0	29.5	26.4	23.1	21.3	46.0	28.3	38.7	40.9	30.1	65.5	21.3	33.5	33.5	22.8	37.5	18.4	28.8	23.4	40.3	31.3	21.0	25.2	32.4	33.0	19.5	27.1	12.3	17.1	31.9	29.1	20.2	17.2	36.3	28.8	28.5	8.3	31.1	59.3	20.5	36.1	28.1	42.7	24.0	29.1	16.4	20.4	15.4	26.0	27.2	23.9	20.3	26.9	5.2	38.0	7.7	25.2	22.8	32.6	14.3	10.2	29.4	16.1	12.0	45.0	24.6	16.0	14.3	14.1	19.2	7.2	19.4	29.3	16.4	13.7	17.8	8.1	22.3	3.3	16.3	18.4	39.2	12.5	31.3	12.4	29.5	25.0	15.7	13.6	14.6	7.2	21.7	21.0	14.2	24.1	22.2	9.7	41.5	12.7	23.0	16.0	29.3	16.1	31.5	9.7	52.6	6.5	36.2	18.0	13.5	35.8	30.4	15.7	4.3	24.1	26.1	30.4	21.7	14.0	14.2	9.4	43.2	11.7	7.9	36.1	23.5	17.3	5.1	22.2	5.2	12.9	37.9	10.8	14.4	17.0	11.8	26.9	20.3	10.2	7.9	4.5	7.7	38.0	17.0	25.2	22.8	28.0	29.5	21.3	46.0	28.8	23.4	32.4	33.0	29.1	29.1	20.8	27.5	37.6	33.4	31.7	71.1	12.6	17.8	21.4	28.4	87.2	62.8	106.3	84.6	68.0	1.8	43.0	285.1	0.0	45.0	147.2	44.6	37.8	41.5	60.1	95.6	28.6	44.5	41.1	58.5	5.2	36.2	60.1	65.8	177.7	107.9	59.6	51.1	112.2	52.3	108.3	44.6	25.8	42.9	1.4	8.7	31.6	134.4	31.9	139.6	44.5
PGAP3	"CAB2, MGC9753, PER1, PERLD1, PP1498"	ENSG00000161395	"Post-GPI attachment to proteins 3"	Q96FM1	17	39671122-39696797	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"OE19: 133.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016591	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA016591: AB_1855203"	"unprognostic (1.29e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.53e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.68e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.57e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (5.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.94e-2)"	6.8	8.2	8.9	7.6	14.3	3.4	10.2	6.4	17.3	11.3	19.2	10.0	15.1	12.5	8.3	16.5	16.2	14.0	19.7	9.9	11.3	7.3	13.7	20.7	9.5	6.5	6.3	10.7	9.7	22.7	16.0	10.1	39.2	6.1	11.2	11.7	14.2	16.7	15.6	5.0	16.0	20.7	7.3	5.5	8.1	13.4	9.0	7.3	4.4	20.3	8.7	15.8	8.1	8.9	7.8	5.3	4.0	10.5	9.0	15.1	6.3	0.6	1.6	1.3	1.2	1.4	1.4	1.3	0.7	1.7	1.1	1.0	0.9	4.0	0.6	3.3	1.3	0.3	2.1	0.4	0.4	0.5	1.4	1.3	0.8	0.9	1.5	1.8	2.1	2.2	2.6	2.6	0.5	1.1	1.3	0.3	0.3	0.7	1.6	1.0	1.4	0.4	1.9	1.3	133.7	0.3	0.5	0.8	1.9	1.8	2.0	1.2	0.8	1.9	22.9	1.1	0.1	1.9	2.0	0.5	1.2	1.3	0.6	0.5	1.4	0.3	0.2	1.4	0.8	1.3	2.4	6.7	4.0	15.1	10.5	8.3	7.8	10.6	12.3	5.3	7.6	10.5	10.1	1.7	9.0	3.8	3.6	5.1	6.3	8.9	14.3	6.4	17.3	11.3	7.3	6.3	10.7	6.1	7.3	3.0	12.2	0.0	3.5	3.4	12.1	5.2	12.7	4.0	9.1	14.0	7.9	6.8	1.7	6.0	0.1	4.3	16.0	0.0	9.6	5.2	6.7	4.9	9.2	7.7	4.0	12.7	8.1	4.3	2.7	0.0	2.8	3.5	1.7	1.8	16.3	7.8	5.1	11.5	1.4	3.5	21.6	0.0	2.3	0.7	2.0	2.5	8.7	1.7	13.0	2.5
PI3	"cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14"	ENSG00000124102	"Peptidase inhibitor 3"	P19957	20	45174876-45176544	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 157.1;esophagus: 200.8;lymphoid tissue: 173.5;tongue: 468.6"	"Cell type enhanced"	"Detected in many"	21	"Enterocytes: 69.5;Exocrine glandular cells: 290.8;Pancreatic endocrine cells: 135.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2666.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1121	"neutrophil: 157.1"	"Lineage enriched"	"Detected in single"	1571	"granulocytes: 157.1"	"Group enriched"	"Detected in some"	5	"EFO-21: 26.6;HaCaT: 32.3;OE19: 29.6;PC-3: 55.0"									"CAB009449, HPA017737"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA		2100000	"Plasma membrane"		"CAB009449: AB_2252354, HPA017737: AB_1848107"	"prognostic favorable (6.94e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.20e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.84e-6)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (8.54e-3)"	"prognostic unfavorable (1.94e-8)"	"unprognostic (1.23e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.91e-3)"	0.4	0.0	0.2	8.8	0.2	0.0	0.7	0.2	0.2	85.3	9.3	0.2	0.4	0.1	7.7	0.2	200.8	0.3	4.8	0.6	0.2	0.0	0.3	0.6	3.1	0.8	0.2	0.2	0.3	0.4	0.0	0.2	0.6	0.3	1.0	3.7	0.3	35.6	0.4	0.2	6.4	3.2	0.6	0.2	1.4	0.7	5.1	0.2	23.4	0.2	468.6	173.5	1.6	118.7	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.9	0.6	0.4	26.6	0.0	0.3	32.3	0.0	6.6	0.0	0.3	0.0	0.1	2.0	0.2	0.0	0.2	0.0	0.0	6.3	5.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	29.6	55.0	0.0	0.2	0.0	6.3	0.1	0.0	0.0	4.5	0.6	0.0	0.0	0.0	0.0	0.2	0.3	3.2	0.0	0.2	0.1	0.4	0.1	4.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2	0.0	11.3	0.5	5.2	0.1	0.0	0.0	7.6	0.0	13.6	17.4	0.0	0.0	0.0	14.9	0.1	0.1	69.5	0.0	290.8	0.0	0.3	25.8	4.6	0.0	0.1	0.0	16.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.4	0.0	135.9	29.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.0	33.5	18.7
PIEZO1	"FAM38A, KIAA0233"	ENSG00000103335	"Piezo type mechanosensitive ion channel component 1"	Q92508	16	88715338-88785220	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 68.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047185	Uncertain					NA	NA					"HPA047185: AB_2679973"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (4.39e-2)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (3.51e-2)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (8.89e-7)"	"unprognostic (2.04e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.74e-1)"	34.6	7.3	5.7	19.2	9.8	24.2	59.0	5.7	6.5	13.8	25.2	7.4	20.3	7.5	13.6	8.2	16.5	12.4	15.4	7.2	6.7	4.3	15.8	18.1	21.2	14.7	10.3	2.5	9.1	6.9	7.0	2.1	17.8	9.1	15.9	4.9	11.9	15.7	16.7	4.2	15.4	12.9	29.2	8.9	18.6	13.2	3.0	7.5	6.7	10.5	9.9	13.3	17.8	39.3	2.5	9.4	3.1	11.6	0.9	8.5	3.6	10.5	10.8	1.7	8.2	7.4	8.1	41.0	25.8	11.5	9.5	3.7	15.6	17.7	8.7	18.1	12.4	4.7	22.8	3.6	9.3	1.9	8.5	14.5	14.7	18.8	12.3	11.2	6.6	2.4	6.6	5.1	7.4	6.2	5.6	11.5	14.6	19.9	11.2	5.5	68.2	8.1	23.0	3.8	5.0	6.7	19.6	2.4	21.8	4.3	15.6	3.3	0.9	33.7	17.8	4.5	1.8	24.3	19.4	30.9	22.9	13.2	15.3	13.0	2.3	5.1	5.3	18.1	11.9	13.5	1.7	5.1	3.1	8.5	9.3	7.9	2.5	6.1	5.5	9.4	2.5	1.0	2.7	0.1	0.9	11.6	1.7	4.7	3.6	5.7	9.8	5.7	6.5	6.7	4.3	10.3	2.5	9.1	7.5	68.5	20.3	5.2	12.3	16.9	0.8	4.5	15.3	4.0	11.4	55.8	15.7	4.4	0.0	30.6	1.3	34.8	7.4	0.0	18.7	24.2	14.2	35.0	8.1	17.8	20.8	3.2	20.2	47.9	19.0	1.0	5.2	15.0	15.1	10.0	23.0	1.1	57.8	14.8	2.5	3.7	3.3	0.0	8.9	0.4	2.7	13.9	4.2	10.2	8.0	13.9
PIM3		ENSG00000198355	"Pim-3 proto-oncogene, serine/threonine kinase"	Q86V86	22	49960513-49964080	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 46.5;SK-BR-3: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068758			Supported	Cytosol		NA	Yes			Cytosol		"HPA068758: AB_2686026"	"unprognostic (3.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.09e-4)"	"unprognostic (5.59e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.27e-3)"	32.5	15.5	6.8	19.9	16.7	62.4	50.5	7.6	11.9	16.4	22.6	11.3	20.9	15.9	14.4	17.6	25.0	15.9	37.8	23.6	7.5	7.9	29.1	25.7	38.3	29.4	21.1	4.9	13.9	36.4	4.8	14.9	31.4	15.1	28.4	7.6	9.7	27.6	22.7	39.9	31.3	20.9	12.2	10.1	25.4	33.6	13.0	13.5	9.7	19.1	19.9	19.0	25.6	18.3	6.1	5.7	16.9	4.0	1.2	4.5	1.9	7.3	4.9	3.3	6.2	2.6	1.9	18.9	4.6	7.5	5.6	4.0	8.1	6.3	13.2	5.9	1.2	11.3	6.3	6.3	3.5	2.0	9.9	26.2	5.4	11.7	9.8	12.2	11.7	10.5	3.7	11.7	3.4	5.8	3.0	18.0	9.0	7.4	46.5	1.6	16.5	5.9	20.9	6.9	7.7	7.9	27.7	5.5	15.6	2.9	5.6	11.8	8.2	9.0	41.3	28.9	3.2	5.4	15.6	4.7	3.5	15.0	5.7	7.5	23.9	15.2	11.2	8.7	6.6	9.4	0.0	3.1	0.1	1.9	3.2	2.3	3.4	4.4	3.8	2.5	6.1	4.1	1.7	16.9	1.2	4.0	5.7	4.5	1.9	6.8	16.7	7.6	11.9	7.5	7.9	21.1	4.9	15.1	13.5	59.6	91.3	64.7	240.2	201.8	30.4	27.9	68.8	20.1	45.5	76.8	2.0	51.0	71.3	44.7	2.1	87.2	56.5	0.0	46.7	226.7	51.4	225.9	70.2	37.5	64.3	58.8	93.7	59.5	30.8	4.1	30.0	74.6	102.9	46.9	56.5	11.1	57.1	46.3	10.6	48.8	15.3	25.8	117.4	19.9	37.3	178.9	326.1	26.6	49.6	261.0
PJA2	"KIAA0438, Neurodap1, RNF131"	ENSG00000198961	"Praja ring finger ubiquitin ligase 2"	O43164	5	109334709-109409994	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040347, HPA057636"	Supported		Enhanced	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA040347: AB_10795631, HPA057636: AB_2683485"	"unprognostic (5.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (4.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.94e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.00e-2)"	21.6	27.0	40.1	15.9	49.9	29.0	22.1	41.6	63.0	29.0	23.8	19.7	16.8	12.5	29.2	25.0	20.7	20.3	18.6	24.4	44.3	46.2	24.1	29.2	19.4	14.3	36.8	44.0	35.4	14.8	42.8	30.3	21.8	53.2	31.7	20.6	12.5	17.3	37.7	17.1	13.6	15.9	39.2	37.6	19.5	15.8	17.0	27.4	16.7	35.9	9.7	16.3	35.5	21.4	10.3	11.7	29.9	15.5	10.7	12.2	10.6	11.8	8.2	33.3	25.6	33.1	36.3	18.1	19.6	29.6	15.5	25.5	7.6	16.2	15.3	27.2	37.6	25.0	6.9	19.4	24.1	28.5	13.0	7.3	17.7	16.9	10.3	23.5	13.2	26.3	25.0	20.2	20.7	29.9	27.9	24.7	13.8	12.1	28.9	25.0	7.2	15.8	12.2	6.6	7.3	5.5	10.3	29.3	25.5	24.1	10.7	6.4	16.4	20.2	7.4	23.6	23.3	16.7	19.6	28.4	22.1	10.8	20.3	9.1	19.5	16.6	18.2	23.4	18.4	14.5	17.3	11.6	17.3	9.5	12.2	9.4	10.3	9.4	8.7	11.7	7.4	12.1	8.9	29.9	10.7	15.5	4.9	12.2	10.6	40.1	49.9	41.6	63.0	44.3	46.2	36.8	44.0	53.2	27.4	62.5	47.1	47.1	45.8	56.3	93.5	116.8	50.9	41.5	45.5	54.1	58.9	19.9	41.4	32.7	16.4	64.5	53.5	0.0	28.7	23.4	57.5	66.5	46.2	90.1	46.6	73.1	64.9	65.1	78.4	15.1	78.9	53.7	57.3	31.5	47.8	99.2	29.4	20.1	87.0	45.1	78.2	77.6	80.4	73.2	30.2	50.8	22.0	50.7	29.6	32.0
PLAC9		ENSG00000189129	"Placenta specific 9"	Q5JTB6	10	80131682-80145359	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Fibroblasts: 709.2;Leydig cells: 808.9;Peritubular cells: 620.2;Sertoli cells: 291.1;Smooth muscle cells: 378.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"eosinophil: 3.7;neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 41.2;ASC TERT1: 36.0;BEWO: 13.2;HSkMC: 11.9"					"Low region specificity"	"Detected in all"			HPA043469	Uncertain				"Secreted - unknown location"	NA	NA					"HPA043469: AB_10795770"	"unprognostic (1.72e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.57e-3)"	"unprognostic (5.88e-3)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.23e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-3)"	43.8	5.5	2.1	4.9	1.9	0.8	38.7	0.7	2.0	38.8	7.3	2.1	16.1	2.5	9.7	27.8	20.3	7.4	20.7	32.5	2.6	1.4	3.8	1.4	15.1	8.5	1.7	0.7	6.0	3.0	0.9	1.0	7.3	6.4	27.8	2.9	46.8	6.4	8.1	7.8	13.0	5.9	25.3	3.3	1.6	5.7	8.4	1.0	0.6	12.3	24.5	6.0	14.1	23.0	0.3	0.6	3.7	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	41.2	36.0	13.2	4.2	3.5	0.3	0.5	0.0	0.3	0.0	0.1	2.3	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	6.8	0.0	0.9	11.9	0.0	0.8	0.4	4.3	1.3	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.8	0.1	0.6	0.0	0.0	0.6	0.0	0.2	0.0	0.8	0.0	0.5	0.3	0.0	0.0	0.1	1.3	2.7	1.5	8.3	0.0	0.2	0.3	0.0	0.7	0.1	0.0	0.3	0.2	3.7	0.0	0.3	0.5	0.3	0.3	0.6	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.6	0.4	0.0	2.1	1.9	0.7	2.0	2.6	1.4	1.7	0.7	6.4	1.0	3.0	2.6	0.0	0.5	112.4	0.2	17.3	0.0	1.4	0.0	0.0	0.0	5.5	0.0	0.4	3.6	61.2	0.0	0.0	0.2	10.6	709.2	0.7	1.1	0.2	12.4	0.0	1.7	90.9	0.0	10.0	808.9	1.1	129.9	0.0	0.0	50.0	0.7	0.0	620.2	0.0	1.6	291.1	378.1	2.6	2.5	110.4	9.6	0.0	0.0	1.8
PLXNA1	"NOV, PLXN1"	ENSG00000114554	"Plexin A1"	Q9UIW2	3	126988594-127037392	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007499, CAB012483"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		2600000	Nucleoplasm	Cytosol	"CAB012483: , HPA007499: AB_1079637"	"unprognostic (1.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-6)"	"unprognostic (1.79e-2)"	"unprognostic (9.06e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (3.77e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (5.64e-5)"	"unprognostic (4.50e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	4.6	2.1	4.4	3.8	2.5	0.0	3.1	5.2	9.3	3.6	2.5	2.5	2.5	1.6	3.8	5.2	3.7	3.3	2.7	10.2	6.2	5.3	2.5	5.3	6.3	3.1	2.9	5.0	5.0	4.9	18.7	2.5	4.9	3.9	3.7	0.7	2.5	7.9	4.1	5.6	8.8	2.5	2.9	2.5	5.6	2.3	5.2	2.5	2.5	3.2	2.5	2.5	3.5	12.6	0.6	0.0	0.0	0.9	0.0	1.1	0.5	18.0	8.6	9.5	7.5	12.6	14.1	15.2	10.8	9.2	6.2	6.2	28.5	8.5	2.0	16.3	11.6	8.4	28.0	4.9	21.2	2.6	2.9	7.7	0.2	5.0	7.3	8.3	2.1	1.5	14.1	14.9	11.5	9.0	6.3	3.1	6.1	10.4	3.8	6.6	10.6	4.2	4.0	9.2	5.7	7.7	5.6	24.4	5.6	5.4	36.5	8.5	9.3	7.8	7.5	10.3	6.5	12.0	13.7	11.4	10.0	12.9	18.2	11.3	2.3	1.5	3.9	14.3	4.1	10.5	0.0	0.0	0.0	0.7	0.1	1.1	0.5	0.6	0.3	0.0	0.6	0.3	0.4	0.0	0.0	0.9	0.0	0.8	0.5	4.4	2.5	5.2	9.3	6.2	5.3	2.9	5.0	3.9	2.5	44.7	2.6	1.5	4.5	14.1	3.8	10.9	2.5	5.3	18.2	12.2	3.9	16.8	0.0	7.4	1.2	4.3	5.1	0.0	6.0	2.1	11.4	4.7	0.0	1.0	11.3	19.1	9.2	2.5	5.6	0.8	7.2	2.8	8.5	1.8	4.5	2.4	12.9	2.9	6.0	1.1	2.9	6.5	9.5	6.3	9.2	14.1	6.1	0.0	3.9	5.0
PLXNB2	"KIAA0315, MM1, PLEXB2"	ENSG00000196576	"Plexin B2"	O15031	22	50274979-50307627	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"classical monocyte: 7.2;intermediate monocyte: 14.3;myeloid DC: 6.0;non-classical monocyte: 16.1;plasmacytoid DC: 5.6"	"Group enriched"	"Detected in many"	30	"dendritic cells: 6.0;monocytes: 16.1"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 83.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003100	Uncertain					NA	NA		51000000			"HPA003100: AB_1079638"	"unprognostic (4.43e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.28e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (8.47e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.05e-2)"	"prognostic favorable (4.75e-4)"	"unprognostic (1.61e-2)"	"unprognostic (9.41e-3)"	"unprognostic (6.05e-2)"	14.1	27.0	10.8	13.9	9.6	5.5	14.4	43.5	12.8	23.1	19.6	15.0	39.8	22.2	25.9	28.0	27.8	26.7	56.2	12.0	11.9	5.8	31.6	20.3	21.0	18.6	8.3	9.3	32.2	23.3	10.5	19.6	29.6	11.6	27.7	7.7	26.5	26.7	31.0	5.0	24.7	23.6	22.5	9.5	33.6	39.5	19.3	9.5	3.4	45.9	19.6	20.2	23.2	21.9	0.1	6.0	0.3	16.1	0.1	0.3	4.5	17.9	27.8	14.0	19.8	7.8	9.4	24.4	26.5	12.7	8.4	8.5	18.5	25.2	12.9	29.7	18.0	5.3	35.0	2.2	17.5	1.9	2.6	11.8	2.2	44.7	13.9	20.6	0.4	12.8	16.0	25.7	8.5	6.4	15.5	7.4	0.0	3.6	3.6	8.0	29.6	0.2	5.0	3.9	11.2	6.9	15.0	24.0	4.5	9.4	49.7	6.6	12.5	24.1	83.2	6.5	3.9	31.0	17.8	14.7	19.2	28.9	9.6	9.0	1.8	0.3	2.3	15.5	0.7	25.9	0.0	7.2	0.0	0.0	14.3	0.1	0.1	0.0	0.0	6.0	0.0	0.0	0.1	0.3	0.1	16.1	5.6	0.3	4.5	10.8	9.6	43.5	12.8	11.9	5.8	8.3	9.3	11.6	9.5	59.6	55.7	8.6	19.2	20.4	15.8	14.2	66.2	62.9	60.3	129.1	15.7	2.3	3.3	84.0	6.6	14.8	107.0	0.0	50.4	26.5	19.8	53.9	4.7	48.9	32.2	12.7	47.7	20.9	40.3	3.2	22.5	36.1	13.5	18.0	64.7	44.4	86.2	68.5	18.0	32.7	9.3	25.8	21.7	1.7	1.6	22.0	5.4	3.8	43.4	34.0
POLR1A	"DKFZP586M0122, FLJ21915, RPA1, RPO1-4"	ENSG00000068654	"RNA polymerase I subunit A"	O95602	2	86020216-86106155	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010145, HPA031513, HPA049700"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"		No	No			"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.31e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (7.20e-2)"	14.3	12.9	10.1	12.4	16.5	9.7	10.3	12.2	20.3	11.1	11.0	17.4	8.3	9.4	19.5	7.4	13.5	12.3	11.7	12.7	9.0	9.2	11.5	15.1	9.4	9.6	9.0	9.4	12.6	14.3	18.2	15.9	11.4	13.8	10.7	11.8	13.9	11.2	12.5	22.5	12.3	8.6	16.0	8.0	11.2	10.4	14.9	10.9	14.0	10.3	11.4	14.2	10.9	9.6	2.6	2.6	1.8	2.5	2.0	3.8	1.2	9.4	21.6	9.6	18.5	9.5	7.6	14.0	8.7	5.8	12.6	7.8	27.0	7.5	21.7	9.3	8.9	12.2	11.0	24.7	12.9	11.2	9.0	12.8	18.7	9.2	18.1	6.7	17.7	10.1	5.8	8.1	18.6	14.5	4.8	9.7	10.1	24.7	5.5	8.6	8.4	13.1	7.5	17.5	12.7	14.3	15.8	21.1	10.2	5.6	15.5	15.0	7.8	9.6	12.8	6.9	6.9	7.5	6.2	15.4	15.3	12.1	13.0	17.5	7.8	7.5	19.0	7.9	15.3	13.4	1.8	1.5	0.2	3.0	2.5	3.8	2.0	1.5	2.5	1.8	2.6	1.4	1.8	0.7	2.0	1.9	2.6	0.7	1.2	10.1	16.5	12.2	20.3	9.0	9.2	9.0	9.4	13.8	10.9	3.0	7.8	6.1	2.9	3.8	11.5	7.8	15.3	6.7	3.4	8.7	15.7	5.7	3.3	5.9	2.4	5.7	4.2	0.0	4.0	4.4	3.8	4.3	5.8	7.2	10.2	11.1	9.2	4.9	2.8	1.5	5.8	3.1	5.0	1.8	6.1	2.9	5.0	0.0	4.9	3.0	10.1	0.0	4.7	4.2	7.5	2.4	3.2	4.4	9.0	3.7
PPIP5K1	"HISPPD2A, IPS1, KIAA0377, VIP1"	ENSG00000168781	"Diphosphoinositol pentakisphosphate kinase 1"	Q6PFW1	15	43533462-43590253	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 39.3;Rod photoreceptor cells: 42.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039380	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039380: AB_10673528"	"unprognostic (8.72e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.18e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.59e-3)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.85e-3)"	"prognostic favorable (7.14e-8)"	"unprognostic (2.67e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.95e-3)"	1.7	5.2	3.4	1.8	6.4	1.1	3.4	28.4	7.0	2.8	6.1			9.1	2.2	5.6	3.7	3.1	2.5	2.1	3.6	5.0	2.5	1.4	1.4	2.0	3.3		3.0	2.9	13.4	7.6	0.9		3.4	6.5		4.7	2.7	6.3	7.2	8.8	2.3	2.8	2.3	5.3	4.5			5.0		3.0	3.3	2.7	5.3	3.2	4.3	2.8	3.5	3.8	3.0	8.4	5.6	4.9	9.1	3.0	1.9	8.4	4.2	5.4	6.1	9.0	6.4	8.1	7.9	6.4	5.8	9.1	23.1	9.5	18.4	6.2	7.8	7.5	11.9	16.9	3.4	6.8	13.6	12.4	3.4	16.2	7.4	11.4	8.3	6.4	18.6	8.6	11.8	4.5	6.6	4.5	7.7	2.4	15.9	6.0	9.7	5.0	4.0	6.6	15.3	14.8	4.6	10.9	10.4	4.1	7.3	19.2	11.4	2.8	5.3	6.4	6.7	10.2	2.6	3.2	9.8	10.0	15.6	5.1	4.3	1.4	0.0	2.7	2.8	3.8	5.3	3.3	3.6	3.2	3.6	2.7	2.5	1.0	3.5	2.1	2.4	0.8	3.0											0.0	2.1	0.0	1.5	3.5	15.3	4.0	5.1	0.0	2.3	7.0	39.3	2.7	0.0	2.1	1.7	2.4	8.8	0.0	1.3	0.8	0.8	1.3	0.0	1.1	1.6	9.5	2.4	4.3	2.7	1.6	1.7	1.6	0.0	1.0	5.0	4.3	1.8	3.5	6.7	1.4	42.3	6.5	1.0	6.6	1.3	2.9	1.8	2.1	7.6	3.2
PPL		ENSG00000118898	Periplakin	O60437	16	4882507-4960741	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 126.9;lymphoid tissue: 60.9;tongue: 57.8"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 68.5;Collecting duct cells: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 27.2;HaCaT: 57.0;MCF7: 20.8;SiHa: 30.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA042550, HPA059859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		310000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA042550: AB_2678048, HPA059859: AB_2684145"	"unprognostic (2.12e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (2.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	10.8	0.7	2.2	1.4	0.7	0.2	6.8	0.6	3.0	23.5	2.9	0.2	4.1	1.7	2.6	5.1	126.9	2.9	5.8	1.8	1.8	0.2	3.0	3.3	4.7	0.2	0.0	0.9	1.7	2.8	1.6	2.8	2.9	0.5	4.6	1.0	0.7	24.3	3.3	3.2	30.7	2.0	5.0	0.0	0.2	2.1	1.5	0.0	0.5	7.2	57.8	60.9	5.0	39.9	0.1	0.0	1.6	0.0	0.0	0.0	0.0	6.9	2.5	0.0	0.0	18.7	27.2	9.0	0.0	0.4	0.0	0.1	11.6	17.8	0.1	4.1	0.3	1.0	57.0	0.3	6.8	0.0	0.0	0.4	0.0	13.8	2.0	1.2	0.0	0.0	1.3	6.3	0.0	2.2	1.4	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	1.8	9.2	5.4	0.0	0.0	8.7	13.6	11.1	9.4	0.1	30.5	10.2	0.1	2.8	5.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	3.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.2	0.7	0.6	3.0	1.8	0.2	0.0	0.9	0.5	0.0	68.5	23.2	0.5	33.9	31.1	7.7	3.5	30.6	12.0	30.7	54.1	5.9	1.6	1.7	15.3	0.6	6.4	4.5	0.0	4.0	1.2	11.0	30.6	0.0	10.9	0.6	1.6	37.8	4.3	0.8	0.2	51.2	1.8	16.9	1.8	3.9	5.3	16.8	5.8	3.9	0.8	11.2	0.0	5.6	3.9	2.9	44.8	1.1	0.7	5.0	47.5
PPP1R13L	"IASPP, RAI"	ENSG00000104881	"Protein phosphatase 1 regulatory subunit 13 like"	Q8WUF5	19	45379634-45406349	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 78.3"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 77.1;Syncytiotrophoblasts: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 35.6;hTCEpi: 52.2;hTERT-HME1: 36.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB005016, HPA041231, HPA059883"	Approved		Enhanced	Cytosol		NA	Yes			Cytosol		"CAB005016: AB_2168576, HPA041231: AB_2677376, HPA059883: AB_2684151"	"unprognostic (1.87e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.31e-3)"	"prognostic unfavorable (3.39e-5)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (5.40e-4)"	"unprognostic (2.52e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.69e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-1)"	6.7	6.6	2.5	3.6	4.1	0.6	14.5	3.5	3.4	13.2	6.2	2.4	8.5	2.9	5.8	8.2	51.6	3.6	4.7	37.2	4.0	1.2	8.0	5.7	8.5	1.6	3.9	2.5	4.4	12.4	6.6	6.6	38.7	3.9	11.5	3.8	5.1	17.8	15.7	3.8	78.3	7.1	3.8	3.3	2.5	4.4	1.6	6.1	2.7	10.6	24.4	25.6	13.2	22.9	0.6	0.7	0.0	1.5	0.0	2.3	0.2	21.2	3.0	1.2	1.0	1.3	0.8	18.5	3.8	0.6	4.8	6.7	6.0	19.8	2.5	1.7	3.0	9.9	28.4	1.0	35.6	4.4	6.5	1.5	0.3	9.8	2.2	2.8	0.2	0.9	1.1	52.2	7.6	36.2	21.7	8.9	2.1	2.1	0.9	0.3	17.4	0.4	0.4	1.4	9.7	5.0	1.9	1.5	0.4	6.2	25.5	0.6	2.2	19.7	18.9	0.4	8.5	16.5	0.5	13.6	6.1	18.7	0.4	18.7	10.6	10.9	1.6	0.9	0.7	1.5	0.0	0.0	0.0	1.5	0.4	0.7	0.6	2.3	0.4	0.2	0.2	0.1	0.7	0.0	0.0	1.5	0.7	1.3	0.2	2.5	4.1	3.5	3.4	4.0	1.2	3.9	2.5	3.9	6.1	32.8	8.8	0.5	77.1	61.0	2.0	34.3	20.4	8.1	22.7	19.2	9.8	69.5	5.0	28.4	0.5	11.2	15.4	0.0	13.4	33.0	6.1	31.1	4.6	2.1	6.7	0.0	6.9	8.0	2.6	0.2	5.5	2.7	11.8	1.8	6.2	2.2	35.6	14.0	11.7	2.7	25.6	6.5	10.4	2.9	1.9	62.0	107.4	0.7	7.1	62.2
PPTC7	TA-PP2C	ENSG00000196850	"PTC7 protein phosphatase homolog"	Q8NI37	12	110533245-110583320	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 53.8"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039335, HPA040614"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039335: AB_10805474, HPA040614: AB_10795526"	"unprognostic (2.44e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.43e-5)"	"prognostic unfavorable (6.76e-4)"	"unprognostic (1.09e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (5.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.83e-1)"	10.4	15.3	6.5	10.3	9.6	26.2	10.3	8.3	12.9	9.7	11.8	5.7	4.9	7.5	9.3	4.6	12.6	7.8	8.8	35.3	9.0	9.0	12.6	11.9	13.1	10.9	10.4	6.8	8.9	7.5	13.0	12.7	6.9	15.3	7.7	9.8	8.0	12.9	8.2	53.8	13.4	11.7	13.1	7.4	9.4	8.4	8.2	6.5	16.1	8.0	15.5	13.1	12.4	12.4	2.1	1.4	6.1	1.7	1.7	2.4	0.6	12.2	7.0	6.0	6.3	15.0	13.2	8.6	5.6	7.5	6.2	6.2	7.9	4.8	21.5	5.9	5.5	8.9	11.9	12.0	13.1	12.6	15.6	10.0	19.0	7.5	8.5	14.3	21.0	15.7	11.4	21.6	8.8	25.9	9.3	11.7	15.0	14.1	6.1	10.0	3.1	18.5	18.0	8.5	6.6	13.1	15.5	8.1	13.1	25.7	13.7	9.7	7.6	10.7	14.8	12.4	6.1	7.0	11.3	13.4	5.7	6.1	17.3	9.5	17.8	19.7	24.0	9.6	11.6	11.2	0.1	1.7	1.3	2.3	1.5	2.4	1.3	1.9	1.8	1.3	2.1	2.2	1.9	6.1	1.7	1.1	1.4	1.3	0.6	6.5	9.6	8.3	12.9	9.0	9.0	10.4	6.8	15.3	6.5	20.8	21.2	21.7	47.9	81.6	8.5	96.6	15.3	25.4	22.7	8.7	13.7	6.3	14.9	6.8	29.6	22.2	18.4	23.3	7.1	7.0	37.6	42.4	23.1	24.9	15.0	12.7	16.1	14.7	25.1	17.5	10.6	19.9	32.1	10.0	14.2	3.9	11.1	14.4	9.2	10.5	24.1	12.9	39.1	12.5	22.5	91.1	5.6	20.8	13.8	64.3
RAB11FIP5	"GAF1, KIAA0857, pp75, RIP11"	ENSG00000135631	"RAB11 family interacting protein 5"	Q9BXF6	2	73073382-73156721	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.4"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 64.5;Late spermatids: 127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"TIME: 25.4"					"Low region specificity"	"Detected in all"			"HPA036406, HPA036407"	Enhanced		Enhanced	"Vesicles,Centriolar satellite"		NA	NA			"Vesicles, Centriolar satellite"		"HPA036406: AB_2675105, HPA036407: AB_10669778"	"unprognostic (1.49e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (3.23e-3)"	"unprognostic (1.45e-1)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.66e-3)"	8.4	5.4	5.3	3.8	9.3	1.5	6.3	9.5	16.7	5.2	4.2	2.8	4.6	3.5	7.9	7.3	5.3	5.6	8.2	7.2	4.9	6.3	14.9	2.3	4.8	2.1	5.6	6.5	6.7	8.4	22.3	4.3	11.4	16.0	5.3	2.1	5.1	9.5	5.9	9.0	5.8	2.6	5.2	2.9	18.9	4.9	46.4	2.5	0.0	3.9	4.7	2.7	5.3	7.4	0.1	0.0	0.0	0.0	0.0	2.6	0.5	12.2	5.5	0.4	3.9	4.0	4.9	7.2	18.5	10.2	6.3	4.9	4.0	3.0	0.0	9.8	9.4	6.9	5.0	2.4	5.7	2.8	21.3	6.8	4.5	2.3	2.6	5.0	0.0	0.8	5.9	5.4	7.8	5.1	5.9	8.6	2.5	3.4	2.4	4.5	0.3	0.0	0.1	2.9	1.8	8.7	4.1	5.0	10.4	5.5	1.5	1.9	2.0	6.1	2.5	2.8	1.3	1.4	0.2	25.4	15.4	8.9	11.4	9.6	8.0	2.3	0.0	12.0	4.8	1.5	0.0	0.0	0.0	2.6	0.0	0.5	0.0	1.2	1.9	0.0	0.1	0.2	1.5	0.0	0.0	0.0	0.0	0.8	0.5	5.3	9.3	9.5	16.7	4.9	6.3	5.6	6.5	16.0	2.5	6.0	2.2	0.8	6.8	22.7	3.4	11.5	17.8	0.0	0.0	19.2	0.0	0.9	23.2	11.3	64.5	16.9	3.2	0.0	15.8	7.7	9.5	10.5	0.0	4.2	1.6	6.4	1.7	11.1	1.8	127.2	13.3	2.2	8.5	1.8	2.5	6.7	17.4	2.9	8.1	38.3	2.0	25.8	10.8	22.8	5.5	15.4	12.4	1.8	4.7	8.1
RAI1	"DKFZP434A139, KIAA1820, MGC12824, SMCR, SMS"	ENSG00000108557	"Retinoic acid induced 1"	Q7Z5J4	17	17681473-17811453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023898, HPA054906"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA023898: AB_10971089, HPA054906: AB_2682637"	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.28e-2)"	8.0	13.8	13.8	12.6	17.6	8.1	10.1	21.5	22.9	18.1	12.2	14.2	13.3	11.3	17.8	11.8	12.1	20.3	16.8	13.6	11.3	11.9	10.3	5.8	11.2	9.7	11.1	11.3	17.3	17.2	22.4	19.6	8.4	11.3	17.7	5.4	23.3	24.0	18.2	8.2	19.1	9.5	16.7	6.6	18.5	16.6	8.8	15.7	10.4	15.6	7.7	11.2	19.6	30.0	1.0	3.0	0.7	1.2	2.8	1.0	0.7	15.7	21.4	13.6	11.2	1.8	3.8	2.3	5.4	5.9	4.6	4.5	11.1	6.7	5.1	7.5	7.0	3.9	18.6	4.7	10.8	1.9	5.0	10.6	9.3	12.9	5.6	6.1	3.7	5.9	4.3	5.3	4.1	6.2	5.4	5.6	6.5	3.9	4.1	2.3	14.1	7.8	3.6	0.9	8.2	6.3	18.4	10.6	7.2	3.8	18.9	9.5	16.9	8.6	7.6	17.6	16.4	10.2	4.7	10.7	7.3	9.4	11.6	7.6	3.7	0.8	3.2	7.1	4.6	19.8	0.0	1.0	0.7	0.8	0.8	0.5	0.1	0.4	0.6	0.5	1.0	0.3	1.0	0.1	2.8	1.2	3.0	0.0	0.7	13.8	17.6	21.5	22.9	11.3	11.9	11.1	11.3	11.3	15.7	11.9	28.1	1.9	9.0	10.8	24.9	3.6	10.2	1.4	11.4	14.0	21.6	0.1	0.0	13.7	2.5	7.8	2.4	0.0	8.0	0.5	8.8	11.5	13.9	5.6	2.1	22.3	10.9	14.1	2.2	3.1	6.4	6.3	8.5	2.8	6.9	5.8	9.6	0.0	5.6	1.8	12.0	6.5	6.4	1.4	12.4	7.8	0.3	2.9	6.3	11.1
RB1	"OSRC, PPP1R130, RB"	ENSG00000139687	"RB transcriptional corepressor 1"	P06400	13	48303726-48599436	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000095, CAB016687, HPA050082"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000095: , CAB016687: AB_1622010, HPA050082: AB_2681008"	"unprognostic (4.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	19.6	21.5	14.9	23.2	18.4	14.7	28.1	25.6	19.4	18.0	13.2	11.5	19.0	12.3	16.8	19.5	27.9	12.7	15.3	19.5	15.4	15.3	18.1	12.1	25.4	30.1	17.0	11.8	15.2	11.6	12.8	17.2	21.5	16.0	15.5	15.3	11.6	20.0	17.4	27.9	20.3	14.3	16.8	23.6	29.4	13.7	14.4	15.3	39.1	19.9	15.8	25.3	17.4	23.6	20.5	10.3	13.2	12.2	3.6	4.6	4.0	9.1	4.9	13.5	14.5	6.7	7.8	6.1	18.0	15.0	19.0	16.2	4.2	16.2	11.8	4.2	12.0	10.5	12.7	17.5	14.5	29.0	16.5	6.7	21.7	10.2	7.2	7.1	18.6	20.6	4.3	8.9	12.3	15.8	15.9	13.1	29.2	7.2	9.7	21.7	4.3	58.2	9.4	6.6	20.8	5.4	25.0	13.5	13.5	19.7	8.9	0.6	13.8	17.8	8.9	14.7	12.5	9.7	24.3	10.1	11.8	7.7	14.3	16.2	4.3	1.2	0.1	6.2	11.7	15.9	11.0	9.7	5.0	4.6	12.2	3.7	17.4	3.8	4.6	9.3	20.5	3.2	3.8	13.2	3.6	12.1	10.3	4.5	4.0	14.9	18.4	25.6	19.4	15.4	15.3	17.0	11.8	16.0	15.3	3.0	18.7	56.5	18.3	25.2	14.4	15.9	17.8	20.1	14.8	29.6	27.5	5.9	13.3	15.8	20.6	33.6	15.9	0.0	10.4	8.0	15.4	21.4	11.5	14.7	64.6	17.5	16.8	38.6	83.9	10.6	24.2	88.8	25.3	107.4	18.5	21.8	13.3	9.9	26.9	21.1	18.5	19.4	20.6	27.9	14.3	33.4	3.7	20.8	15.0	14.4
RCBTB1	"CLLD7, CLLL7, FLJ10716"	ENSG00000136144	"RCC1 and BTB domain containing protein 1"	Q8NDN9	13	49531946-49585583	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 41.7;Cone photoreceptor cells: 60.9;Rod photoreceptor cells: 37.8;Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056783			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056783: AB_2683234"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.52e-2)"	"prognostic favorable (5.51e-5)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (1.17e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.49e-2)"	7.4	17.6	16.9	6.5	19.7	8.8	10.3	9.4	16.9	7.0	5.0	27.5	21.3	4.5	12.2	15.1	4.1	9.6	7.0	11.1	18.3	16.5	13.7	6.2	9.3	9.4	26.5	11.2	5.8	8.2	30.9	15.3	9.2	15.8	8.4	6.3	15.1	6.0	14.6	5.0	5.8	5.6	10.8	22.7	9.9	7.4	6.4	22.3	10.9	32.0	4.1	7.7	8.5	6.5	4.6	7.4	15.3	8.1	2.5	8.7	3.2	3.0	7.1	15.8	14.2	21.1	18.4	9.2	11.8	11.8	8.9	9.2	6.0	7.8	10.5	2.6	9.7	7.8	4.4	11.7	18.1	15.5	15.3	9.0	12.5	5.7	15.3	25.3	10.0	10.0	16.3	11.2	7.4	11.9	11.8	15.5	20.8	5.5	4.6	17.9	2.8	14.4	5.8	16.4	10.4	4.4	18.8	11.9	6.6	11.2	8.5	8.3	11.0	6.0	4.6	11.7	13.9	6.2	7.3	10.8	6.7	5.4	14.0	5.7	4.7	5.7	17.1	6.0	10.0	9.4	15.3	5.8	6.1	2.9	7.2	3.4	4.6	4.8	2.3	7.4	3.2	3.0	2.8	2.9	2.5	8.1	1.0	8.7	3.2	16.9	19.7	9.4	14.3	18.3	16.5	26.5	11.2	15.8	22.3	41.7	9.6	6.5	2.3	3.3	8.3	14.8	12.7	16.0	14.8	1.8	60.9	2.5	6.6	6.4	0.3	7.4	0.7	0.0	4.3	2.5	3.5	4.2	2.3	7.3	7.5	9.5	15.5	5.5	12.0	0.4	3.1	8.4	8.5	7.2	2.5	5.8	4.9	0.0	5.3	7.9	37.8	38.8	7.1	1.7	3.6	2.0	0.9	4.9	1.9	1.8
RECQL	"RecQ1, RecQL1"	ENSG00000004700	"RecQ like helicase"	P46063	12	21468911-21501669	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009743, HPA030960, HPA064259"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009743: AB_655306, HPA030960: AB_10794912, HPA064259: AB_2685230"	"unprognostic (9.70e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.89e-3)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (3.77e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.69e-2)"	32.7	15.8	10.0	22.0	12.7	10.8	18.2	10.9	11.2	18.0	16.3	9.4	11.0	7.5	19.8	14.4	18.7	14.6	14.1	17.9	11.2	7.2	19.6	18.0	19.5	25.7	15.3	7.6	16.0	11.9	8.0	14.8	17.1	12.0	14.0	12.7	6.7	13.1	12.4	15.0	12.4	15.5	20.5	19.5	34.0	12.9	10.8	13.0	27.4	17.4	14.3	25.0	22.6	13.0	19.3	15.2	11.3	20.7	23.1	28.0	13.8	17.2	17.5	13.3	9.8	26.9	33.8	15.4	33.3	28.2	21.5	25.2	19.1	14.4	20.7	12.9	22.7	27.3	12.6	14.2	16.6	30.7	34.6	9.4	25.3	19.4	8.1	10.4	17.5	19.1	18.8	8.6	30.5	22.4	19.8	24.1	14.6	8.8	10.1	28.3	8.4	19.1	20.4	22.1	5.3	11.9	15.8	53.9	16.0	8.3	11.9	3.6	10.6	24.9	6.7	17.5	48.0	17.0	11.2	32.5	30.3	19.7	26.5	30.9	4.1	12.2	45.4	25.6	10.3	22.2	9.3	11.8	11.3	21.9	20.7	21.3	19.3	20.5	21.0	15.2	16.0	13.6	18.8	5.5	23.1	18.8	11.6	28.0	13.8	10.0	12.7	10.9	11.2	11.2	7.2	15.3	7.6	12.0	13.0	20.8	19.7	38.7	12.7	20.9	10.9	7.3	12.7	30.8	25.0	14.0	13.7	9.7	8.3	16.8	0.5	36.0	3.2	0.0	21.6	23.8	30.7	7.0	50.8	11.9	25.0	14.3	9.4	28.3	30.7	2.0	20.4	35.9	28.7	49.5	6.0	17.7	24.4	5.5	35.3	9.5	10.9	12.9	25.8	6.0	8.1	37.5	3.0	41.7	6.9	8.2
RIPK4	"ANKK2, ANKRD3, DIK, PKK, RIP4"	ENSG00000183421	"Receptor interacting serine/threonine kinase 4"	P57078	21	41739369-41767106	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"naive CD4 T-cell: 1.5;neutrophil: 2.2"	"Group enriched"	"Detected in many"	17	"granulocytes: 2.2;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.9;GAMG: 20.8;HaCaT: 23.5;hTCEpi: 15.8;RPTEC TERT1: 14.2;RT4: 15.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030942	Enhanced					NA	NA					"HPA030942: AB_2732462"	"unprognostic (8.93e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.32e-3)"	"unprognostic (7.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.22e-5)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (9.98e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.78e-2)"	1.0	0.2	0.2	0.8	0.2	0.1	3.3	0.2	0.2	6.7	9.4	0.3	12.0	6.8	1.7	6.5	42.1	4.2	17.1	1.1	0.4	0.2	10.8	17.3	5.4	0.4	0.2	0.1	1.8	14.4	4.7	6.8	2.8	1.1	10.6	1.3	4.8	10.2	14.8	0.2	11.7	11.6	2.0	0.3	0.2	11.2	2.7	0.0	8.1	13.6	12.3	26.6	5.2	11.0	0.0	0.0	2.2	0.1	0.0	1.5	0.2	6.8	4.4	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.1	0.1	11.4	15.9	0.0	6.7	1.4	20.8	23.5	0.3	9.5	0.0	0.0	4.7	0.0	3.3	4.2	0.0	0.0	0.0	0.0	15.8	0.1	2.1	0.0	0.0	7.1	0.0	0.0	0.0	5.0	0.9	0.0	0.4	4.5	13.1	0.0	0.0	1.1	14.2	15.1	2.3	0.1	7.7	7.8	7.1	0.7	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.1	2.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.1	1.1	0.0	26.8	10.8	0.0	26.1	14.1	0.0	1.0	12.7	17.4	14.8	3.5	0.0	7.0	8.3	10.8	0.4	0.0	17.3	0.0	9.0	4.7	0.7	20.1	2.3	16.1	0.9	0.0	21.8	0.0	1.6	1.1	0.0	0.6	6.8	0.0	13.4	0.0	14.2	8.7	0.0	10.0	0.9	0.0	0.3	1.1	0.6	13.2	2.1	0.0	9.8	19.5
RPL7A	"L7A, SURF3, TRUP"	ENSG00000148303	"Ribosomal protein L7a"	P62424	9	133348214-133351426	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA046794			Approved	Nucleoli,Vesicles		NA	NA		160000	Nucleoli	Vesicles	"HPA046794: AB_2732534"	"unprognostic (5.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.07e-3)"	"unprognostic (4.17e-3)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (1.98e-1)"	"unprognostic (8.88e-2)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (4.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.89e-2)"	58.8	72.8	34.9	64.0	39.6	78.6	96.3	33.1	43.2	70.1	66.6	27.6	66.9	38.9	137.4	81.5	96.0	94.8	74.4	48.2	29.5	25.7	51.0	59.3	48.1	159.6	32.7	45.2	164.9	193.1	29.1	50.6	42.4	34.1	90.1	67.6	47.3	204.8	70.0	85.2	91.9	48.6	91.0	35.5	68.1	61.4	78.2	24.0	80.5	77.9	70.1	93.2	75.1	109.7	79.7	56.4	12.1	35.8	50.2	80.4	94.0	44.6	68.0	77.7	77.3	136.7	227.0	74.2	56.3	115.3	101.6	56.7	103.3	58.9	140.1	34.8	98.1	54.9	109.5	114.8	135.3	82.0	59.4	65.0	49.3	101.1	100.4	90.7	116.6	58.4	228.3	202.5	73.4	127.5	165.7	128.9	98.9	94.2	73.9	116.6	151.6	90.4	122.1	84.4	200.3	67.1	79.6	97.5	178.2	130.8	57.2	73.0	64.5	46.1	118.7	71.9	67.4	129.4	123.6	70.3	67.1	48.3	60.3	66.7	28.9	57.5	86.1	52.4	81.5	52.1	12.1	35.8	7.7	52.2	33.6	77.3	79.7	71.2	64.3	56.4	71.8	80.4	73.5	5.5	50.2	29.3	56.1	54.6	94.0	34.9	39.6	33.1	43.2	29.5	25.7	32.7	45.2	34.1	24.0	482.4	687.0	2813.3	3757.7	2882.1	278.7	355.9	1538.8	477.8	915.6	567.0	135.5	3181.9	1798.9	1584.8	1644.9	1944.8	1276.3	864.3	3823.0	4356.2	1751.6	3047.6	827.3	1030.7	2186.7	123.9	1445.6	1391.5	1793.3	3226.4	3459.6	1682.6	1434.0	2247.1	2534.7	429.4	2742.5	1749.9	1813.9	2011.8	362.0	950.7	1790.0	984.2	735.4	3479.5	2766.0	1939.0	3532.0	4275.0
RPS6KA2	"HU-2, RSK, RSK3"	ENSG00000071242	"Ribosomal protein S6 kinase A2"	Q15349	6	166409364-166906451	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 271.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"eosinophil: 17.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 17.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 48.4;ASC TERT1: 35.5;HHSteC: 35.9;HSkMC: 31.9;hTERT-HME1: 38.6;hTERT-RPE1: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026243, HPA045061, HPA054237, CAB069428"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425"	"unprognostic (8.71e-2)"	"unprognostic (3.14e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (8.68e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.86e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.01e-1)"	15.4	6.5	26.8	5.3	35.5	6.9	12.7	12.1	21.5	13.5	7.1	20.3	11.5	4.3	18.3	5.2	14.0	11.9	12.5	40.9	25.0	18.3	9.9	3.3	24.6	10.6	22.4	18.4	20.9	30.2	32.6	18.0	12.1	22.7	10.6	7.4	11.1	9.0	10.5	14.4	7.5	7.2	15.8	37.2	16.5	10.4	5.1	25.7	0.8	24.8	3.5	4.9	15.5	10.2	0.4	3.9	17.5	1.6	3.3	0.6	0.2	1.9	0.0	3.9	5.7	48.4	35.5	0.0	4.1	8.1	2.3	3.2	0.0	1.2	0.2	1.3	14.6	1.8	1.7	2.0	9.0	2.1	0.8	0.5	0.0	8.5	0.1	35.9	0.1	1.6	31.9	6.5	12.5	38.6	70.4	12.6	4.1	0.0	0.0	9.5	0.4	0.1	0.4	1.0	1.9	2.3	0.6	2.0	5.7	2.4	2.1	2.1	15.2	1.4	3.9	5.3	1.0	0.1	3.0	4.6	8.3	0.8	22.8	1.2	1.1	1.7	0.5	5.5	0.2	7.8	0.1	0.5	17.5	0.5	0.7	0.2	0.3	0.5	0.2	0.7	0.4	0.6	0.3	0.4	3.3	1.6	3.9	0.4	0.2	26.8	35.5	12.1	21.5	25.0	18.3	22.4	18.4	22.7	25.7	20.8	34.5	0.0	4.1	4.1	34.9	54.9	22.9	2.7	13.6	34.9	7.9	0.1	10.0	12.8	12.0	47.2	0.5	0.0	20.9	0.2	8.0	9.4	2.3	11.6	7.2	271.7	5.2	38.6	5.0	48.4	4.9	4.7	18.6	3.6	5.5	8.3	22.7	1.4	4.2	4.4	15.4	12.9	6.9	3.2	1.1	3.0	0.2	1.3	1.2	5.8
SCAF8	"KIAA1116, RBM16"	ENSG00000213079	"SR-related CTD associated factor 8"	Q9UPN6	6	154733325-154834244	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035601, HPA035602"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035601: AB_2674698, HPA035602: AB_10673220"	"unprognostic (4.60e-3)"	"unprognostic (3.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.11e-1)"	27.9	19.1	17.4	32.0	19.1	36.1	27.5	28.1	22.2	30.0	23.4	18.2	20.8	14.2	28.3	21.6	18.5	25.1	21.9	19.3	16.9	13.4	19.8	17.6	19.6	23.5	16.2	15.1	32.6	20.0	33.6	24.1	23.8	14.8	24.4	20.7	17.9	21.9	30.1	28.5	26.9	21.2	23.8	14.3	21.7	19.9	25.4	20.2	42.6	24.7	20.1	22.8	26.1	32.9	5.4	3.3	3.8	6.7	6.1	7.5	2.6	8.5	8.4	24.9	15.0	16.8	17.3	15.3	14.1	19.9	18.7	19.0	13.1	8.7	26.9	11.5	16.2	16.6	11.7	21.9	18.6	25.1	11.7	11.0	24.1	9.1	16.0	19.5	22.2	16.2	18.6	19.8	16.3	25.6	14.5	15.8	11.9	27.9	16.4	17.1	15.6	23.7	15.1	17.3	13.2	6.3	22.8	13.6	14.5	15.8	15.8	15.4	18.0	14.7	19.4	10.7	18.7	12.7	25.9	14.4	10.7	13.0	13.8	14.2	15.4	11.3	29.8	13.3	13.9	16.5	1.2	2.8	3.5	6.0	3.9	5.8	4.8	6.2	5.9	3.3	5.4	6.3	5.6	3.8	6.1	6.7	3.2	7.5	2.6	17.4	19.1	28.1	22.2	16.9	13.4	16.2	15.1	14.8	20.2	23.8	18.6	14.1	10.3	11.2	17.7	31.1	7.6	13.4	9.1	12.2	23.6	9.2	1.7	9.3	2.7	13.5	12.2	0.0	10.2	7.4	13.5	10.4	33.5	10.4	11.2	12.7	12.5	19.6	25.1	4.2	15.3	11.4	10.1	6.4	13.9	14.8	11.9	8.6	11.7	5.3	18.6	25.8	8.2	21.4	22.4	9.4	8.9	10.0	13.6	12.8
SCNN1A	"ENaCalpha, SCNN1"	ENSG00000111319	"Sodium channel epithelial 1 alpha subunit"	P37088	12	6346843-6377730	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 100.4"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 108.2;Mucus-secreting cells: 167.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"pons and medulla: 9.4"	"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 1.7;neutrophil: 4.4;plasmacytoid DC: 3.0;T-reg: 1.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.0;granulocytes: 4.4;T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 71.8;HBEC3-KT: 48.2;hTCEpi: 20.7;RPTEC TERT1: 25.2;RT4: 27.0;SK-BR-3: 23.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA012743	Enhanced					NA	NA					"HPA012743: AB_1856627"	"unprognostic (1.68e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.86e-4)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (5.56e-2)"	"prognostic favorable (9.21e-8)"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-2)"	0.9	3.7	0.4	7.5	0.4	0.0	10.1	0.4	0.9	22.0	20.6	2.2	60.9	5.6	8.1	15.7	47.3	19.3	7.0	0.4	1.1	0.1	100.4	2.2	53.6	0.4	0.5	0.4	5.9	14.2	0.0	10.2	1.6	9.4	15.0	21.5	6.2	53.1	55.5	0.6	14.4	11.8	1.0	0.4	0.4	20.3	2.8	0.4	0.9	74.7	21.1	41.3	10.3	13.8	0.0	3.0	4.4	0.5	0.0	1.7	0.3	5.0	0.9	0.0	0.4	0.0	0.1	4.3	0.0	0.0	0.0	0.0	1.4	71.8	0.0	0.1	0.0	0.0	3.3	0.0	48.2	0.0	0.0	0.0	0.0	4.0	0.7	5.2	0.0	0.0	1.2	20.7	0.0	15.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	4.2	9.1	0.1	0.0	0.0	0.1	25.2	27.0	0.3	0.0	0.5	23.3	0.0	4.3	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.0	0.0	0.2	0.6	0.5	0.0	1.7	0.3	4.4	0.0	0.1	3.0	1.3	0.3	0.4	0.4	0.4	0.9	1.1	0.1	0.5	0.4	9.4	0.4	68.5	63.0	0.0	21.9	1.6	0.8	0.8	68.8	26.8	47.8	108.2	3.9	1.2	5.0	41.1	0.4	1.4	57.4	0.0	30.8	0.2	2.4	31.3	2.3	2.4	0.3	1.6	26.0	0.6	1.9	0.2	1.7	2.1	0.0	1.8	167.5	0.3	24.0	47.5	1.4	4.2	1.6	0.0	1.0	1.4	2.1	7.8	1.4	1.9	31.6	33.3
SCRN1	KIAA0193	ENSG00000136193	"Secernin 1"	Q12765	7	29920103-29990289	"Enzymes, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.8"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 65.2;Muller glia cells: 76.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 69.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024517	Enhanced		Approved	Cytosol		No	No		110000	Cytosol		"HPA024517: AB_2184811"	"prognostic unfavorable (8.32e-4)"	"prognostic unfavorable (8.46e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.00e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (2.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (2.60e-4)"	6.8	14.8	32.0	6.3	31.5	3.6	7.6	62.8	55.4	12.4	8.1	23.2	4.5	3.4	13.3	8.8	10.0	13.9	8.5	9.8	26.6	30.7	12.8	1.5	8.3	6.7	42.7	26.6	17.5	18.5	42.9	12.1	8.0	26.3	15.0	5.6	7.8	8.4	20.2	1.0	5.7	5.0	17.7	42.9	5.2	7.1	11.4	23.3	8.2	7.1	1.5	10.6	9.4	5.8	10.4	7.8	6.9	16.7	4.8	8.1	2.2	21.8	15.8	25.8	10.4	18.3	28.2	0.1	20.4	27.4	22.2	24.0	18.2	17.4	2.7	18.2	26.1	49.4	9.9	29.3	8.7	32.5	0.1	6.1	9.0	10.6	11.7	23.4	0.0	0.1	23.5	12.6	20.1	10.8	30.3	20.4	5.9	0.1	7.1	31.2	12.3	3.1	0.0	23.5	0.0	17.0	0.0	27.5	0.2	15.5	10.8	9.4	22.4	21.1	13.7	23.6	33.9	18.5	1.4	22.5	28.9	24.9	0.3	25.8	2.3	35.4	0.2	13.6	0.1	69.6	2.2	2.3	6.9	0.6	10.2	8.1	10.4	0.1	0.8	7.7	5.0	0.6	1.0	0.4	4.8	16.7	7.8	0.0	2.2	32.0	31.5	62.8	43.1	26.6	30.7	42.7	26.6	26.3	23.3	26.8	13.1	8.2	9.7	2.7	63.5	12.6	20.4	21.4	22.7	31.4	43.2	0.3	13.3	18.8	49.3	5.8	0.0	0.0	21.5	1.6	7.7	14.1	8.1	0.5	4.8	65.2	11.6	2.5	10.0	48.7	12.7	10.6	6.8	4.6	0.9	76.1	21.8	17.3	19.8	1.8	39.0	6.5	8.5	2.3	12.3	1.5	0.8	4.3	1.0	17.0
SH3PXD2A	"FISH, KIAA0418, SH3MD1"	ENSG00000107957	"SH3 and PX domains 2A"	Q5TCZ1	10	103594027-103855543	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 34.5;BJ hTERT+: 32.3;fHDF/TERT166: 25.7;HSkMC: 25.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037922, HPA037923"	Approved					NA	NA					"HPA037922: AB_10697088, HPA037923: AB_10672612"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-1)"	"prognostic unfavorable (3.18e-4)"	"unprognostic (5.83e-2)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.62e-2)"	11.2	6.0	11.1	11.4	10.7	1.4	7.1	20.2	12.0	38.8	12.4	30.9	9.9	5.2	20.5	9.5	20.5	11.7	15.5	10.6	12.8	8.3	3.3	10.0	8.8	4.0	10.9	8.5	18.7	6.1	1.3	7.7	38.2	15.2	9.2	12.1	10.3	9.3	13.0	11.6	25.1	7.6	23.5	15.1	12.0	6.6	3.0	11.3	3.4	4.6	13.1	9.6	11.3	16.4	0.6	1.5	0.0	1.2	0.8	1.0	0.3	0.4	2.0	5.3	6.3	18.9	34.5	2.8	14.9	32.3	5.0	4.8	0.2	0.1	0.0	2.9	25.7	0.6	5.0	0.3	13.4	4.5	0.8	5.5	6.1	7.3	7.0	12.3	3.0	1.7	25.4	10.5	7.7	16.9	3.8	3.3	6.8	2.2	3.7	6.3	0.1	0.1	2.9	2.2	4.2	0.9	2.5	2.0	0.3	2.1	1.8	3.9	2.1	1.4	0.3	7.5	3.0	0.0	2.1	5.7	4.2	3.0	5.5	6.5	4.2	8.6	0.1	4.1	4.1	16.3	0.0	0.1	0.0	0.3	0.8	0.5	0.6	0.5	0.2	0.3	0.4	0.4	0.2	0.0	0.8	1.2	1.5	1.0	0.3	11.1	10.7	20.2	12.0	12.8	8.3	10.9	8.5	15.2	11.3	6.0	42.1	5.2	23.5	80.8	44.2	18.9	17.8	4.0	20.5	3.5	25.5	10.2	0.0	3.4	3.0	21.1	25.7	0.0	0.6	29.5	48.1	25.7	17.3	73.5	10.8	84.2	35.6	28.8	5.8	3.7	98.1	7.0	32.1	29.7	71.2	1.3	4.2	31.3	75.7	0.8	30.8	38.8	69.0	1.9	2.8	33.2	3.9	5.0	22.4	47.2
SH3RF3	"FLJ00204, POSH2, SH3MD4"	ENSG00000172985	"SH3 domain containing ring finger 3"	Q8TEJ3	2	109129348-109504632	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 9.0;Horizontal cells: 9.5;Ito cells: 9.2;Sertoli cells: 12.9;Smooth muscle cells: 10.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HHSteC: 14.1;RPMI-8226: 13.4;TIME: 15.6;U-266/84: 18.2"	"Low region specificity"	"Detected in many"							"HPA044822, HPA048444"	Approved		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"HPA044822: AB_2679103, HPA048444: AB_2680396"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-2)"	17.4	5.6	2.7	3.4	4.4	0.6	18.3	1.7	5.4	5.3	3.6	3.3	2.5	1.0	5.5	2.2	3.4	4.8	5.6	6.4	3.0	2.1	2.5	0.8	6.0	2.9	4.3	1.5	3.0	1.8	0.6	2.6	6.5	3.8	3.4	1.6	4.6	2.4	5.9	6.4	2.9	2.3	4.6	2.8	2.0	2.7	4.3	2.9	1.5	3.4	3.6	4.0	4.6	3.4	0.4	0.4	1.8	0.2	0.0	0.6	0.3	0.0	0.0	0.1	1.5	6.4	4.9	0.0	2.8	8.3	2.2	0.8	0.7	0.0	0.0	2.2	2.0	0.5	0.0	0.1	1.2	0.9	0.0	2.8	0.0	0.1	0.0	14.1	0.0	0.0	8.5	2.0	9.7	4.4	1.2	7.8	1.5	0.0	8.0	4.9	0.0	0.0	4.3	0.7	0.0	8.1	1.7	0.0	13.4	0.0	0.0	0.5	1.7	0.0	0.0	0.3	0.1	0.1	0.0	15.6	2.8	8.3	7.9	3.6	2.7	18.2	0.0	0.0	4.2	3.8	0.0	0.2	0.7	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.4	0.6	0.6	1.8	0.0	0.0	0.4	0.0	0.3	2.7	4.4	1.7	3.3	3.0	2.1	4.3	1.5	3.8	2.9	0.0	0.0	0.0	0.2	1.6	0.1	9.0	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.5	2.0	3.8	0.0	0.0	0.2	0.1	4.1	0.2	0.0	0.0	3.6	9.5	1.7	9.2	3.7	3.6	2.0	0.5	5.0	0.0	0.2	0.8	0.1	0.0	2.8	0.8	0.0	12.9	10.8	0.7	6.6	0.6	0.1	0.0	0.0	0.0
SLC12A9	CIP1	ENSG00000146828	"Solute carrier family 12 member 9"	Q9BXP2	7	100826820-100867009	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 72.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067536	Approved					NA	NA					"HPA067536: AB_2732768"	"unprognostic (6.53e-2)"	"unprognostic (3.65e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.11e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.38e-3)"	"prognostic favorable (5.97e-4)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.52e-2)"	"unprognostic (6.00e-2)"	"unprognostic (6.74e-3)"	"unprognostic (6.38e-2)"	11.3	12.1	10.6	13.4	12.7	10.5	9.0	7.3	14.2	11.0	12.8	26.8	12.7	12.4	11.9	7.5	11.8	10.2	18.2	6.3	11.7	9.8	12.0	9.2	12.7	16.3	18.3	9.6	10.2	16.7	12.5	6.2	21.8	13.8	11.1	9.2	7.6	11.8	11.5	3.7	11.9	13.2	10.3	19.8	19.5	10.8	4.8	13.9	8.8	9.5	6.5	14.5	13.6	8.5	1.3	5.1	2.9	4.0	0.3	0.8	1.6	8.1	6.4	2.1	17.6	6.5	4.0	22.5	4.2	7.8	6.2	8.7	9.0	13.8	5.7	13.5	7.6	9.9	8.7	3.7	8.9	1.6	6.2	6.2	2.1	5.9	6.4	8.1	2.6	9.2	9.6	5.2	4.9	4.9	4.9	11.9	4.6	5.1	3.1	8.6	25.5	2.8	12.6	4.2	16.7	12.9	6.6	2.2	9.0	6.1	7.2	3.6	8.4	4.5	32.2	8.5	3.7	4.0	9.8	7.2	7.6	7.6	12.5	7.3	1.6	6.6	1.9	5.3	8.9	9.1	0.0	2.9	0.0	0.5	3.8	0.8	1.3	0.2	0.3	5.1	1.3	0.5	0.3	2.9	0.3	4.0	2.5	0.6	1.6	10.6	12.7	7.3	14.2	11.7	9.8	18.3	9.6	13.8	13.9	3.0	17.3	13.7	10.7	9.7	4.9	2.0	5.1	2.7	11.4	17.4	2.0	72.5	0.0	11.9	0.4	10.5	12.3	0.0	11.6	19.9	8.9	8.6	1.1	5.5	27.7	6.4	10.9	11.6	16.2	0.6	8.3	23.4	8.5	10.0	11.1	20.0	11.7	23.0	6.0	11.2	6.0	12.9	7.5	1.4	8.2	9.9	42.0	11.5	16.2	10.2
SLC25A30		ENSG00000174032	"Solute carrier family 25 member 30"	Q5SVS4	13	45393316-45418455	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 38.0;skeletal muscle: 43.1"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 39.7;Hepatocytes: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA045260			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045260: AB_10962505"	"unprognostic (9.23e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (9.91e-8)"	"unprognostic (2.24e-1)"	"unprognostic (5.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (6.19e-3)"	7.7	6.3	6.2	4.7	5.7	5.3	7.1	3.6	6.3	6.5	4.2	2.1	9.7	2.5	7.7	7.2	5.3	3.9	4.5	38.0	5.8	3.8	24.6	19.5	5.9	9.3	5.4	4.3	10.8	7.5	2.4	5.7	3.4	8.1	8.0	3.5	9.5	6.8	9.1	43.1	4.4	3.5	9.4	7.6	6.1	4.0	5.0	4.9	1.2	6.5	6.7	4.4	6.6	9.0	1.6	5.3	4.3	3.4	1.7	2.7	1.1	2.3	5.1	3.0	13.1	15.4	9.8	1.0	10.9	6.4	9.5	5.7	5.3	6.3	0.0	9.6	11.1	7.0	4.5	7.0	11.0	11.3	7.6	5.7	8.6	3.3	14.1	9.1	12.3	11.7	6.4	7.5	13.9	10.4	11.2	16.4	8.7	5.2	0.0	19.1	2.7	4.5	8.5	4.5	2.7	6.5	11.2	5.1	4.5	20.5	1.9	0.6	3.1	6.1	9.4	8.7	5.5	7.3	16.6	6.0	8.9	5.1	9.8	7.5	2.3	4.5	0.1	9.7	11.7	13.6	0.0	2.8	4.3	2.2	3.4	1.5	1.6	2.2	2.2	4.0	1.5	2.7	1.2	0.0	1.7	1.5	5.3	0.8	1.1	6.2	5.7	3.6	6.3	5.8	3.8	5.4	4.3	8.1	4.9	6.0	2.1	1.5	1.9	11.4	1.7	39.7	10.2	0.0	1.2	14.0	3.9	0.7	19.9	2.2	7.6	4.1	1.4	0.0	1.2	0.8	2.2	2.8	4.7	38.9	3.7	0.0	2.4	7.4	10.0	2.3	4.6	5.9	5.0	6.4	3.9	0.8	2.4	0.0	6.0	22.1	1.1	6.5	2.2	0.0	1.4	5.4	0.5	4.4	3.3	1.1
SLC39A13	FLJ25785	ENSG00000165915	"Solute carrier family 39 member 13"	Q96H72	11	47407132-47416501	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"Early spermatids: 250.1;Late spermatids: 701.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043971	Approved					NA	NA					"HPA043971: AB_10959744"	"unprognostic (7.84e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (1.18e-1)"	"unprognostic (8.56e-3)"	"unprognostic (3.81e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (2.73e-5)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.96e-4)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.12e-1)"	17.0	19.2	14.1	19.7	17.0	6.3	15.1	25.6	21.8	17.8	18.6	18.8	12.4	12.1	32.1	20.2	17.1	18.5	19.0	35.5	16.1	10.3	39.9	17.6	23.2	14.8	18.5	15.0	21.3	20.7	19.0	21.0	34.5	15.5	20.5	6.3	23.8	20.0	24.9	19.8	27.1	12.0	22.8	10.6	15.3	16.1	25.9	16.4	9.8	18.7	9.3	10.4	19.5	15.7	5.8	5.0	6.5	14.4	6.7	13.2	5.2	7.4	6.6	7.8	8.7	19.1	26.8	2.2	30.0	22.2	16.8	19.2	2.6	5.1	2.9	8.2	22.5	16.6	12.6	2.3	20.1	4.7	8.4	8.8	1.5	15.7	5.3	28.7	2.5	3.7	22.3	14.5	10.6	8.7	21.1	17.9	5.6	1.4	6.4	18.0	6.6	5.4	3.7	3.7	6.3	9.9	6.6	11.4	2.9	28.4	3.6	6.9	12.5	9.0	16.1	8.4	3.0	10.7	3.8	24.9	25.7	11.9	29.3	13.6	5.0	1.6	1.2	28.4	3.6	18.6	2.0	3.6	3.0	13.2	13.7	8.8	4.5	8.7	9.3	4.6	5.8	8.3	6.8	6.5	6.7	14.4	5.0	4.5	5.2	14.1	17.0	25.6	21.8	16.1	10.3	18.5	15.0	15.5	16.4	8.9	5.4	2.2	16.0	16.3	23.6	15.5	10.2	1.4	5.7	27.9	11.8	8.4	8.3	29.6	250.1	17.6	4.0	0.0	18.1	14.1	34.0	9.3	5.7	5.0	17.2	30.2	9.2	19.0	4.8	701.9	30.5	10.7	18.6	44.1	7.3	15.8	25.0	6.2	37.8	7.3	15.8	45.3	20.3	12.5	5.7	3.6	16.4	8.6	5.5	6.7
SLC9A1	"APNH, NHE1, PPP1R143"	ENSG00000090020	"Solute carrier family 9 member A1"	P19634	1	27098815-27166981	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"Deafness, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 60.7"	"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022371, HPA048532, HPA052891"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981"	"unprognostic (6.18e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (3.44e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-2)"	7.1	11.3	7.5	9.9	10.1	7.3	8.4	11.7	18.9	8.7	14.0	5.0	26.9	20.7	10.6	6.8	10.3	7.1	24.4	13.4	4.6	5.3	7.3	2.4	11.2	5.8	5.0	6.7	6.9	6.4	13.4	8.0	42.5	14.8	8.5	10.2	10.1	60.7	55.4	3.8	9.2	24.7	8.1	3.9	10.5	45.6	8.3	4.9	6.0	8.0	6.5	9.0	18.8	8.4	0.9	0.6	5.5	1.5	0.4	4.2	1.8	13.7	4.7	4.5	4.5	10.2	7.4	27.6	11.3	17.3	9.9	10.8	5.7	9.0	6.2	9.7	14.7	4.8	17.2	4.4	28.0	6.2	7.4	4.1	9.5	3.1	2.4	31.1	5.5	7.2	9.2	13.6	16.7	23.3	7.2	16.4	4.4	2.6	6.1	14.5	8.2	2.8	2.9	6.2	17.0	9.8	5.1	4.0	2.9	5.2	20.8	5.2	1.6	9.5	13.0	5.7	4.8	6.0	3.5	17.6	10.6	4.2	9.8	6.2	5.5	3.5	1.8	11.3	6.2	6.1	0.1	1.5	1.5	1.9	0.9	4.2	0.2	2.2	2.0	0.6	0.9	1.4	1.7	5.5	0.4	1.5	0.1	0.8	1.8	7.5	10.1	11.7	18.9	4.6	5.3	5.0	6.7	14.8	4.9	6.0	17.9	5.2	16.2	27.7	6.3	11.3	10.2	0.0	3.4	10.4	0.0	30.0	0.0	8.5	26.9	7.1	52.0	0.0	10.9	16.2	11.0	8.8	26.5	1.0	11.5	19.1	12.0	8.0	4.9	9.7	8.6	6.6	6.8	1.8	12.3	10.8	19.4	22.0	12.4	1.3	3.6	6.5	8.7	1.4	3.4	22.0	44.3	6.7	14.3	16.3
SNX33	"MGC32065, SH3PX3, SH3PXD3C, SNX30"	ENSG00000173548	"Sorting nexin 33"	Q8WV41	15	75647906-75662301	"Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	20	"dendritic cells: 2.1;monocytes: 2.4;T-cells: 1.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040988	Approved					NA	NA					"HPA040988: AB_10794983"	"unprognostic (1.83e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (5.24e-4)"	"unprognostic (5.00e-3)"	"unprognostic (3.00e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.54e-2)"	20.9	11.3	7.4	10.9	6.1	0.1	16.7	7.0	8.0	25.1	20.1	4.5	16.4	9.8	21.1	11.0	26.0	14.0	23.6	12.5	8.6	3.2	8.5	17.8	12.3	8.3	4.3	3.4	18.6	24.9	9.0	4.8	10.7	6.1	20.1	8.3	14.6	16.8	15.4	6.7	18.5	15.2	18.1	7.9	8.9	12.0	7.8	4.4	4.1	16.5	11.7	14.1	26.1	36.5	0.0	2.1	0.0	2.4	0.0	1.5	0.9	7.0	6.4	6.3	6.7	24.8	16.2	6.9	7.0	14.6	7.8	7.1	4.0	7.5	0.2	5.1	15.4	11.2	17.1	7.7	18.2	4.2	7.8	2.6	2.2	7.3	7.2	16.5	0.2	2.3	16.6	22.2	7.6	10.7	18.8	4.9	0.7	5.1	0.9	9.0	1.3	0.0	4.5	6.0	4.4	3.6	1.1	4.9	0.3	7.9	10.7	0.5	4.3	10.3	11.3	8.5	12.2	6.7	5.0	7.1	11.1	5.3	8.3	3.7	0.1	0.2	0.0	11.2	2.6	2.9	0.0	2.4	0.0	1.2	0.7	1.3	0.0	1.5	0.0	2.1	0.0	0.8	0.3	0.0	0.0	0.3	0.1	0.9	0.9	7.4	6.1	7.0	8.0	8.6	3.2	4.3	3.4	6.1	4.4	6.0	6.4	0.5	3.2	10.8	0.0	3.2	2.5	5.3	4.5	7.0	2.0	2.5	0.0	6.7	0.1	5.3	10.5	0.0	5.8	3.5	7.8	5.7	1.1	10.6	4.2	0.0	8.7	6.7	2.6	0.2	12.0	2.3	3.3	2.8	8.3	3.9	11.9	7.0	14.2	3.1	0.0	19.4	7.5	0.1	0.4	9.8	1.1	0.7	7.0	6.4
SOCS5	"CIS6, Cish5, CISH6, KIAA0671, SOCS-5"	ENSG00000171150	"Suppressor of cytokine signaling 5"	O75159	2	46698952-46763129	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 45.7;fHDF/TERT166: 44.5;U-138 MG: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020884, CAB025510"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025510: , HPA020884: AB_1857356"	"unprognostic (1.69e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (4.52e-2)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	12.2	10.1	16.9	5.6	24.9	6.2	21.3	26.4	14.9	13.6	9.4	6.3	7.6	4.8	14.0	8.8	8.2	9.6	11.2	11.2	11.9	8.1	9.1	6.3	10.1	9.9	9.1	10.8	23.8	6.0	14.8	9.0	6.9	11.8	9.9	6.5	5.8	9.3	13.0	8.8	6.9	6.8	13.6	10.8	8.1	7.2	9.5	8.8	10.9	9.8	5.0	6.1	9.4	9.0	4.8	1.3	6.3	3.7	2.3	3.3	1.6	5.2	4.0	3.5	5.1	11.2	16.2	4.3	24.7	45.7	12.1	7.1	3.8	2.6	2.7	4.8	44.5	3.7	2.6	3.8	3.9	15.4	2.6	3.5	4.2	3.7	4.5	7.0	2.4	4.7	12.8	5.9	10.3	4.1	13.5	4.1	1.1	3.6	2.9	7.7	1.8	2.1	3.9	3.9	5.5	3.3	2.8	5.9	3.4	4.9	4.0	2.7	7.5	6.0	4.0	4.6	3.5	1.6	3.5	4.6	30.2	6.8	10.0	4.8	3.7	2.2	2.3	13.8	4.8	9.3	1.2	1.1	6.3	2.4	1.0	3.0	4.5	1.5	1.6	1.2	4.8	2.7	3.3	1.1	2.3	3.7	1.3	2.5	1.6	16.9	24.9	26.4	14.9	11.9	8.1	9.1	10.8	11.8	8.8	3.0	6.7	6.0	6.3	14.7	12.1	13.6	15.3	5.3	9.1	3.5	21.6	3.1	5.0	6.3	8.5	22.4	6.3	0.0	5.9	1.9	12.1	8.8	16.2	6.4	4.0	17.5	10.4	20.3	6.3	5.1	16.1	7.2	6.8	6.4	7.6	8.9	5.5	7.0	15.9	6.3	5.3	12.9	17.9	11.9	15.6	12.7	2.3	4.4	6.0	4.8
SOGA1	"C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA"	ENSG00000149639	"Suppressor of glucose, autophagy associated 1"	O94964	20	36777442-36863686	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 55.5"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043992	Approved		Approved	Nucleoli,Cytosol	"Secreted to blood"	NA	Yes			"Nucleoli, Cytosol"		"HPA043992: AB_2678762"	"unprognostic (2.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (8.28e-5)"	"unprognostic (1.09e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.45e-3)"	6.2	11.4	10.8	4.5	10.6	1.4	6.0	55.5	12.5	11.3	8.3	20.5	7.2	2.5	8.8	5.3	7.2	9.4	9.9	6.7	9.9	7.5	4.7	1.3	6.1	3.0	12.7	8.9	12.6	3.7	11.5	4.4	7.9	8.7	10.7	3.9	6.7	4.4	12.3	2.9	11.0	4.6	14.1	7.9	5.3	5.3	14.8	14.7	0.9	16.0	4.7	4.1	8.0	10.5	1.0	2.1	1.4	0.7	0.7	0.2	0.2	7.5	10.3	12.5	13.5	7.3	6.7	3.3	6.6	7.2	9.5	5.6	4.1	1.2	3.3	2.5	11.6	8.2	10.2	10.0	6.2	10.0	0.5	2.0	5.4	9.6	5.4	3.8	1.2	5.3	3.8	7.6	9.0	6.4	4.1	6.1	3.7	3.8	0.7	10.3	7.3	3.8	2.8	3.2	0.8	8.0	9.0	11.7	1.3	5.5	2.3	15.0	9.4	13.8	15.2	4.4	5.8	19.3	8.1	9.3	23.8	4.6	11.6	14.4	1.4	0.3	3.4	10.1	1.6	15.0	1.4	0.7	0.2	0.1	0.4	0.2	1.0	0.1	0.1	0.4	1.0	0.2	0.2	1.4	0.7	0.3	2.1	0.1	0.2	10.8	10.6	55.5	12.0	9.9	7.5	12.7	8.9	8.7	14.7	0.0	2.6	1.4	4.8	11.2	18.8	12.1	0.0	2.7	7.9	19.2	35.3	12.5	1.7	3.4	0.4	10.5	1.7	0.0	1.3	8.6	11.0	5.2	10.4	0.2	8.5	22.3	5.8	9.8	5.3	1.5	11.2	6.0	5.0	1.0	1.3	19.4	1.8	0.0	17.7	1.2	3.7	12.9	11.3	0.7	1.0	14.1	2.7	1.0	2.5	2.5
SORCS2	KIAA1329	ENSG00000184985	"Sortilin related VPS10 domain containing receptor 2"	Q96PQ0	4	7192538-7742836	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1"	"Cell type enhanced"	"Detected in many"	19	"Bipolar cells: 66.5;Muller glia cells: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.6;HaCaT: 16.6;HMC-1: 12.5;RPMI-8226: 7.4;SiHa: 12.0;THP-1: 7.0;U-937: 7.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061916			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA061916: AB_2684636"	"unprognostic (1.38e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.27e-3)"	4.9	2.6	12.0	6.4	16.6	3.3	1.8	4.8	22.4	13.8	4.0	32.1	3.2	3.1	6.0	8.2	4.7	3.5	7.1	3.2	10.7	6.9	7.4	5.2	8.3	2.0	9.9	11.2	7.4	1.7	0.8	2.7	0.9	11.2	7.5	2.6	7.5	2.6	5.3	2.4	1.9	4.2	11.5	11.2	1.3	1.9	3.4	11.3	0.8	6.2	2.2	2.7	5.2	3.7	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.9	1.1	0.2	0.1	0.0	0.0	0.2	0.0	1.4	0.4	0.1	0.5	0.0	6.6	4.2	1.1	16.6	0.0	0.0	0.2	0.0	0.0	0.0	2.5	0.2	0.1	0.0	12.5	0.2	3.7	5.2	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.7	0.0	1.3	7.4	0.2	0.0	0.7	0.6	12.0	0.0	0.0	0.7	0.0	7.0	0.0	4.3	1.3	0.0	0.1	0.0	0.0	0.0	1.4	7.3	0.2	0.0	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	12.0	16.6	4.8	17.7	10.7	6.9	9.9	11.2	11.2	11.3	3.0	13.7	0.0	0.2	0.1	66.5	2.0	0.0	2.7	7.9	5.2	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.2	0.2	1.6	0.0	0.0	0.3	10.2	11.8	0.3	1.7	0.0	0.0	31.9	0.7	0.0	7.4	0.7	2.4	0.0	0.5	0.1	0.1	0.4	0.0	0.0	0.0	0.4
SPIDR	KIAA0146	ENSG00000164808	"Scaffolding protein involved in DNA repair"	Q14159	8	47260575-47736306	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA027201, HPA041582"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027201: AB_10603774, HPA041582: AB_2677563"	"unprognostic (5.58e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.72e-3)"	"unprognostic (7.99e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (1.74e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.30e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.35e-2)"	21.1	21.6	24.0	22.4	20.7	15.6	23.8	47.5	32.1	18.2	18.9	15.5	17.1	12.8	29.7	18.9	28.6	19.5	25.1	14.4	20.1	17.5	15.3	16.3	21.4	18.0	15.9	18.7	28.4	20.5	19.4	39.8	21.4	22.4	20.8	18.5	19.9	20.6	15.8	15.7	24.0	15.1	21.4	18.6	23.3	20.2	16.7	15.3	12.7	23.2	10.5	25.2	21.0	24.8	7.9	9.6	5.2	11.1	8.6	11.4	5.5	8.4	14.3	9.0	14.2	10.4	12.8	7.4	10.8	8.0	8.6	12.4	7.7	19.9	17.0	13.0	9.5	8.6	4.6	9.4	8.2	13.0	5.0	8.9	11.8	12.5	14.5	11.2	8.8	7.4	7.0	8.0	6.8	10.3	9.5	6.3	10.7	8.6	6.1	8.5	20.7	16.5	22.0	11.1	18.8	3.5	8.2	5.2	0.9	11.8	31.8	4.6	10.8	16.0	13.4	6.0	9.2	12.8	16.5	11.0	6.9	10.0	8.4	7.3	7.3	12.9	11.9	7.2	12.1	6.6	4.8	11.1	3.5	11.4	7.2	11.3	7.9	5.1	6.9	9.6	7.4	5.7	5.1	5.2	8.6	8.2	1.6	10.0	5.5	24.0	20.7	47.5	32.1	20.1	17.5	15.9	18.7	22.4	15.3	32.8	28.9	6.2	14.3	9.5	10.9	16.1	15.3	25.4	14.8	12.2	17.7	15.1	6.6	7.0	7.4	14.7	6.3	0.0	7.7	9.5	13.0	15.5	11.6	6.8	9.7	12.7	11.1	11.6	29.4	6.6	13.6	18.6	8.5	1.8	11.6	8.2	6.7	8.5	13.8	3.7	10.7	6.5	13.7	22.3	29.5	7.5	13.7	13.8	11.0	15.9
SPOCK1	"SPOCK, testican-1, TIC1"	ENSG00000152377	"SPARC/osteonectin, cwcv and kazal like domains proteoglycan 1"	Q08629	5	136975298-137598379	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 92.2"	"Cell type enhanced"	"Detected in many"	19	"Cardiomyocytes: 54.3;Muller glia cells: 252.1;Peritubular cells: 141.1"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 83.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.5;myeloid DC: 1.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.6;monocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 75.8;hTERT-RPE1: 144.5;HUVEC TERT2: 75.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007450, HPA026770"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA007450: AB_10603116, HPA026770: "	"unprognostic (1.05e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (9.08e-4)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (9.09e-3)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.77e-5)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.90e-2)"	11.3	31.0	20.6	4.0	30.4	1.5	9.3	68.2	92.2	20.5	7.4	36.0	5.1	2.1	20.5	26.1	5.6	6.8	14.3	38.6	29.9	16.6	18.0	1.4	1.9	1.7	35.5	29.0	3.2	3.7	1.4	3.7	7.6	19.6	48.9	3.6	5.2	2.9	20.7	5.6	3.2	2.6	23.2	21.7	6.8	3.7	15.9	36.0	0.1	3.3	0.0	1.6	8.1	11.5	0.0	1.6	0.4	2.5	0.0	0.0	0.6	0.5	0.1	38.2	0.0	75.8	15.5	0.0	12.4	11.5	27.0	15.2	0.0	0.0	0.0	0.0	25.9	6.8	0.5	0.1	8.9	8.4	2.1	0.0	0.0	2.3	0.0	0.5	0.0	0.0	27.0	3.6	16.6	2.9	144.5	75.8	0.0	0.0	0.0	7.7	0.0	0.0	0.0	2.4	0.0	3.5	0.0	0.0	0.0	18.0	1.2	0.4	1.8	6.1	0.1	0.0	4.8	0.0	0.1	12.1	38.5	1.3	13.1	3.5	0.0	0.0	0.0	20.9	0.5	17.4	0.0	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	20.6	30.4	68.2	28.5	29.9	16.6	35.5	29.0	19.6	36.0	0.0	0.0	0.0	1.7	1.5	5.0	54.3	0.0	0.0	0.0	21.0	2.0	0.4	1.7	0.7	8.2	2.1	0.0	0.0	1.2	0.4	9.5	48.4	0.0	0.0	0.8	7.9	33.7	1.3	2.4	8.9	16.1	1.1	6.8	1.0	0.0	252.1	1.5	0.0	141.1	1.7	3.2	12.9	12.8	7.5	5.9	1.3	0.1	0.0	0.1	2.1
SPOCK2	"KIAA0275, testican-2"	ENSG00000107742	"SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2"	Q92563	10	72059035-72089032	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.1;brain: 70.7;lung: 52.1"	"Group enriched"	"Detected in many"	9	"Alveolar cells type 1: 268.0;Bipolar cells: 102.9;T-cells: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 27.5;MAIT T-cell: 47.1;memory CD4 T-cell: 27.7;memory CD8 T-cell: 21.9;naive CD4 T-cell: 21.5;naive CD8 T-cell: 21.2;T-reg: 37.5"	"Lineage enriched"	"Detected in many"	8	"T-cells: 47.1"	"Group enriched"	"Detected in some"	7	"Hep G2: 25.4;SCLC-21H: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044605	Enhanced				"Secreted to blood"	NA	NA		42000			"HPA044605: AB_10965991"	"prognostic favorable (4.05e-4)"	"unprognostic (3.11e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.18e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (4.72e-4)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (4.53e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.46e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.24e-2)"	4.2	29.8	31.9	24.9	47.8	27.9	2.0	70.7	63.2	2.5	4.2	9.8	0.0	6.2	2.5	2.7	2.8	4.7	9.9	4.7	27.5	49.5	18.8	2.5	52.1	36.4	36.0	32.1	3.7	1.5	1.7	12.8	2.9	47.9	3.0	4.1	5.4	2.8	4.5	3.6	1.9	9.3	3.4	22.3	16.9	8.3	13.6	9.2	43.4	3.3	0.6	27.0	8.0	1.4	5.6	0.7	2.9	0.2	2.8	47.1	10.3	0.1	0.2	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.4	0.1	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.4	0.1	0.6	25.4	0.9	0.2	0.6	0.1	0.2	0.0	0.0	0.1	0.0	1.4	0.0	0.4	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	36.2	2.2	0.0	0.8	0.2	0.2	0.0	0.9	0.1	0.0	0.1	0.1	0.0	0.4	0.8	3.8	0.1	0.0	0.1	0.0	0.1	0.0	27.5	0.2	47.1	5.6	27.7	21.9	0.0	4.5	21.5	21.2	2.9	2.8	0.0	0.7	37.5	10.3	31.9	47.8	70.7	42.0	27.5	49.5	36.0	32.1	47.9	9.2	268.0	14.3	16.4	0.2	3.4	102.9	2.5	0.0	2.7	5.7	14.0	5.9	0.1	0.0	0.4	6.3	9.0	0.7	0.0	0.7	0.0	2.4	0.4	3.5	0.0	0.2	3.2	4.7	6.7	2.6	8.2	4.9	2.0	5.0	0.0	0.3	3.8	0.0	0.0	5.6	0.0	12.4	0.0	4.2	3.6	0.6	3.9	0.3	96.9	0.0	0.3
SRGAP1	"ARHGAP13, KIAA1304"	ENSG00000196935	"SLIT-ROBO Rho GTPase activating protein 1"	Q7Z6B7	12	63844293-64162221	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 153.7;Muller glia cells: 159.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 17.4;hTERT-HME1: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052416, HPA078079"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA052416: AB_2681824, HPA078079: "	"unprognostic (3.05e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (3.54e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.41e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.56e-2)"	11.4	5.4	6.6	6.2	9.6	1.2	8.2	6.6	7.7	7.4	6.1	7.1	2.0	3.2	6.2	4.7	7.0	5.3	5.8	4.2	8.6	3.8	5.5	2.5	11.2	2.2	7.0	3.1	7.5	11.3	17.7	6.1	4.2	10.4	3.8	5.9	4.1	13.4	2.4	3.4	3.1	3.9	5.5	12.1	4.9	4.2	9.4	10.9	0.0	9.4	0.3	2.3	5.2	8.9	1.2	0.8	2.9	1.4	1.2	0.8	0.2	3.0	6.4	10.4	1.0	8.0	14.1	2.2	9.5	8.5	3.5	3.1	3.3	2.5	0.0	3.9	17.4	8.8	1.9	0.9	5.4	3.6	2.4	1.0	0.1	4.5	3.4	9.9	0.0	0.1	13.0	5.2	9.9	27.9	4.9	3.2	0.2	0.0	0.1	4.6	1.8	0.0	0.1	0.8	1.6	3.7	0.0	1.9	0.0	4.4	1.6	1.7	3.1	3.7	3.9	2.6	1.7	1.1	0.1	6.7	7.3	1.3	7.7	4.3	0.1	0.0	0.0	6.2	0.7	2.9	2.1	0.9	0.5	0.6	1.4	0.7	0.7	0.7	0.4	0.4	1.2	0.8	0.8	2.9	1.2	0.8	0.8	0.4	0.2	6.6	9.6	6.6	7.7	8.6	3.8	7.0	3.1	10.4	10.9	0.0	3.5	5.9	33.4	6.9	7.1	4.8	40.8	25.4	10.3	8.7	5.9	23.0	10.0	28.5	153.7	14.7	22.3	0.0	22.6	7.9	18.5	30.6	1.1	0.9	10.4	3.2	16.0	25.2	30.1	41.5	20.4	18.1	16.9	41.5	25.0	159.6	29.4	37.4	14.9	10.2	5.0	0.0	17.0	4.7	16.6	3.3	6.1	3.2	20.1	44.2
ST6GALNAC4	"SIAT3C, SIAT7D, ST6GALNACIV"	ENSG00000136840	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4"	Q9H4F1	9	127907886-127917038	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;pancreas: 61.0"	"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"plasmacytoid DC: 58.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 58.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.5;RPMI-8226: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009042			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA009042: AB_1079963"	"unprognostic (2.05e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (8.63e-7)"	"unprognostic (1.62e-2)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.30e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.03e-2)"	8.0	7.8	5.6	7.9	5.6	26.2	12.1	9.8	8.5	9.2	9.3	4.8	28.9	11.7	8.7	9.6	6.9	8.7	12.2	18.4	5.2	3.4	9.4	5.0	13.5	9.7	4.2	4.7	14.9	61.0	2.4	9.4	4.3	4.8	6.1	5.4	4.8	9.3	30.0	12.6	4.0	9.7	6.1	3.9	18.2	7.2	4.3	4.7	4.7	6.3	5.9	12.5	8.9	8.3	6.7	58.8	0.8	3.2	4.3	3.4	2.4	3.2	5.5	1.4	7.0	9.9	7.6	1.0	5.6	6.2	5.7	3.3	3.1	5.9	20.5	8.5	7.0	8.1	7.9	2.9	5.9	0.9	35.5	2.4	6.5	17.6	11.6	12.1	0.5	6.8	9.2	6.3	5.1	4.6	4.6	15.2	3.9	4.6	13.7	2.7	1.5	1.2	0.7	1.6	10.5	13.6	6.2	3.7	50.3	5.8	0.1	12.0	2.7	8.1	17.6	1.0	0.5	3.6	4.2	10.8	4.7	5.4	14.6	8.7	22.4	11.5	6.4	9.4	2.9	0.6	0.8	2.1	0.0	2.9	1.9	3.3	6.7	1.8	3.4	2.8	4.9	2.3	3.1	0.2	4.3	3.2	58.8	3.3	2.4	5.6	5.6	9.8	8.5	5.2	3.4	4.2	4.7	4.8	4.7	8.9	24.5	43.4	11.9	1.9	2.4	10.3	10.2	5.3	4.5	1.8	0.0	0.9	1.7	14.0	0.1	10.8	19.6	23.3	12.5	14.4	11.9	2.0	8.1	1.5	22.1	0.0	65.1	4.9	11.4	0.0	16.1	8.5	6.8	12.6	13.1	14.1	11.9	6.5	40.3	17.3	1.7	12.9	8.9	0.2	1.3	2.8	3.8	10.2	16.4	10.0
STAC2	24b2	ENSG00000141750	"SH3 and cysteine rich domain 2"	Q6ZMT1	17	39210536-39225872	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 94.0;seminal vesicle: 101.5"	"Cell type enriched"	"Detected in many"	11	"Muller glia cells: 446.6"	"Group enriched"	"Detected in many"	7	"breast cancer: 15.0;endometrial cancer: 3.2;glioma: 10.4;ovarian cancer: 4.2;renal cancer: 10.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 8.3;HeLa: 25.8;hTEC/SVTERT24-B: 3.8;U-87 MG: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076925			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA076925: "	"unprognostic (1.70e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (4.05e-5)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (1.42e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (1.12e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.17e-1)"	2.4	0.9	4.2	1.0	7.4	0.7	29.7	9.5	21.9	4.0	0.9	0.0	94.0	0.9	2.5	13.9	0.8	1.4	0.8	1.0	6.8	3.2	4.8	0.7	0.9	0.8	3.5	6.6	1.2	1.1	0.7	0.5	1.0	13.1	1.8	0.9	8.2	7.8	101.5	0.8	20.1	0.8	1.7	1.4	0.8	0.8	0.9	0.2	0.0	0.7	0.0	0.8	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	8.3	0.0	3.3	0.0	0.0	0.0	0.4	0.0	25.8	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.2	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	7.4	9.5	21.7	6.8	3.2	3.5	6.6	13.1	0.2	3.0	8.0	0.0	1.2	0.3	4.8	2.9	0.0	2.7	4.5	3.5	9.8	0.1	5.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.1	17.5	0.0	0.0	0.0	0.0	2.6	0.0	40.5	0.0	0.0	446.6	0.0	0.0	0.0	0.0	11.1	0.0	3.4	0.2	0.9	1.5	0.2	0.0	0.0	0.1
STRN4	"PPP2R6C, ZIN"	ENSG00000090372	"Striatin 4"	Q9NRL3	19	46719507-46746994	"Predicted intracellular proteins, Predicted membrane proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043051, HPA043527, HPA056706"	Supported		Approved	Cytosol		NA	NA		34000	Cytosol		"HPA043051: AB_2678290, HPA043527: AB_10959664, HPA056706: AB_2683214"	"unprognostic (3.57e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavorable (6.06e-8)"	"unprognostic (8.31e-3)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (1.56e-1)"	"unprognostic (9.41e-3)"	"unprognostic (4.86e-3)"	"unprognostic (6.74e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.84e-1)"	21.8	13.7	22.6	17.8	26.6	27.0	18.7	10.5	34.9	15.3	18.0	17.9	17.8	19.0	19.9	12.6	23.8	16.9	17.0	20.7	23.1	13.4	15.8	11.4	17.4	16.2	15.1	21.4	16.9	26.6	12.7	12.3	22.2	11.8	17.3	11.3	15.7	25.2	18.4	16.6	22.0	20.6	18.5	12.8	22.9	20.2	48.8	15.7	15.0	14.6	11.6	15.5	18.4	16.6	3.1	3.3	10.1	9.8	1.5	1.2	5.7	21.3	28.6	25.0	18.5	7.1	8.0	17.6	18.6	10.0	19.3	16.9	21.2	19.1	10.7	11.2	15.2	15.8	15.2	11.8	18.0	7.7	15.4	24.2	23.6	18.8	18.1	23.1	19.1	25.8	12.9	18.1	12.4	17.1	9.8	17.1	12.6	20.5	14.1	8.0	14.5	21.2	50.0	18.9	22.5	13.5	19.5	15.2	8.3	12.9	38.7	31.0	33.2	26.1	24.4	12.2	11.3	18.3	21.5	23.1	14.5	21.8	9.9	27.3	17.9	25.4	15.9	12.6	12.0	30.0	3.1	6.5	2.9	1.2	9.8	0.3	1.7	1.0	0.8	3.3	3.1	0.5	1.1	10.1	1.5	6.0	3.0	0.3	5.7	22.6	26.6	10.5	34.9	23.1	13.4	15.1	21.4	11.8	15.7	3.0	6.9	3.7	8.9	15.2	12.4	9.0	15.3	2.7	5.7	7.0	11.8	12.5	1.7	11.2	8.2	15.1	19.2	0.0	13.2	14.8	11.9	13.2	0.0	11.1	12.7	28.6	16.8	25.2	20.8	16.9	16.4	11.9	10.1	5.4	20.9	7.5	14.7	14.4	18.7	5.9	7.2	6.5	14.1	19.7	37.7	15.2	16.7	6.9	15.7	13.9
TBC1D22A	C22orf4	ENSG00000054611	"TBC1 domain family member 22A"	Q8WUA7	22	46762617-47175699	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001173	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA001173: AB_1080212"	"unprognostic (1.62e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (5.95e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.17e-2)"	"unprognostic (4.68e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.39e-1)"	18.1	17.6	18.3	36.5	16.0	14.0	16.4	10.8	18.5	14.6	23.1	22.4	16.5	22.8	20.6	17.8	24.8	19.6	22.1	15.1	16.1	15.4	18.1	14.8	18.5	26.6	17.3	17.0	16.1	20.5	18.8	15.9	23.2	16.9	12.5	15.3	17.0	23.5	15.5	23.7	22.6	26.3	13.0	18.4	27.2	22.8	14.2	18.2	21.1	17.8	16.5	36.3	16.5	17.3	11.7	10.8	13.2	15.0	4.4	8.6	5.6	13.4	9.4	6.0	7.2	8.7	12.3	7.3	9.2	12.6	10.5	11.4	10.5	10.5	11.8	10.4	14.0	6.6	15.0	5.1	14.4	7.4	5.1	14.3	6.7	8.2	20.2	13.4	14.5	5.4	14.3	17.0	7.2	10.2	12.7	17.3	7.5	4.3	12.7	9.5	6.9	6.4	7.5	5.8	12.7	10.6	8.3	7.0	12.7	12.2	7.0	4.9	9.1	8.5	3.2	14.3	7.8	7.7	9.7	13.9	8.1	11.6	8.5	5.8	8.5	2.7	7.6	20.1	7.5	5.0	2.1	9.0	5.3	5.9	13.0	5.7	10.8	5.5	5.5	10.8	11.7	3.6	4.0	13.2	4.4	15.0	5.3	8.6	5.6	18.3	16.0	10.8	18.5	16.1	15.4	17.3	17.0	16.9	18.2	23.8	16.5	38.9	10.0	5.7	16.7	6.9	10.2	16.0	21.6	7.0	17.7	19.9	10.0	21.8	10.3	16.1	28.0	0.0	20.6	15.8	9.4	9.0	16.2	7.8	29.2	20.6	3.5	20.9	20.7	2.2	9.2	25.5	10.1	51.3	15.2	12.9	26.2	21.2	11.0	16.5	28.1	12.9	7.1	4.9	9.7	6.9	24.3	10.2	16.6	10.2
TCF15	"bHLHa40, EC2, PARAXIS"	ENSG00000125878	"Transcription factor 15"	Q12870	20	603797-610398	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 11.4;heart muscle: 19.4;skeletal muscle: 18.0"	"Cell type enhanced"	"Detected in some"	19	"Cardiomyocytes: 8.5;Endothelial cells: 4.3;Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 10.9;HMC-1: 17.9;SuSa: 3.3;U-2 OS: 3.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050998, HPA060221"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA050998: AB_2681302, HPA060221: AB_2684225"	"unprognostic (2.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.11e-1)"	"unprognostic (6.99e-2)"	8.4	0.3	0.9	0.4	1.0	0.2	11.4	0.1	1.1	0.6	1.3	0.1	0.0	0.4	0.8	0.3	1.7	0.4	0.7	19.4	1.2	0.7	0.5	0.3	0.9	0.3	1.0	0.0	0.2	0.1	0.4	0.3	8.2	0.7	1.0	0.3	0.3	0.8	0.3	18.0	0.2	0.4	1.3	1.1	0.2	0.4	1.6	0.6	0.2	1.3	6.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.1	10.9	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.6	0.0	1.4	0.0	3.3	0.0	1.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.1	1.1	1.2	0.7	1.0	0.0	0.7	0.6	0.0	0.0	0.0	0.1	0.1	0.4	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.6	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	12.9	1.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0
TGFBI	"BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1"	ENSG00000120708	"Transforming growth factor beta induced"	Q15582	5	136028895-136063818	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Sensory transduction, Vision"		"Amyloidosis, Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Hofbauer cells: 254.4;Kupffer cells: 259.4;Macrophages: 225.7;Pancreatic endocrine cells: 363.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"pons and medulla: 19.7"	"Group enriched"	"Detected in many"	30	"classical monocyte: 41.9;intermediate monocyte: 27.0;myeloid DC: 28.6;non-classical monocyte: 20.6;plasmacytoid DC: 61.2"	"Group enriched"	"Detected in many"	43	"dendritic cells: 61.2;monocytes: 41.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 157.9;GAMG: 129.4;HSkMC: 164.8;hTCEpi: 114.6;LHCN-M2: 131.0;U-2197: 114.5;U-87 MG: 219.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA008612, HPA017019"	Enhanced				"Secreted to blood"	NA	NA		1400000000			"HPA008612: AB_1857970, HPA017019: AB_2669511"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (4.38e-3)"	"prognostic favorable (1.17e-4)"	"unprognostic (5.21e-3)"	"unprognostic (5.53e-3)"	"unprognostic (4.60e-2)"	"unprognostic (8.71e-3)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (1.42e-3)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (7.82e-10)"	"unprognostic (8.81e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-3)"	51.3	16.6	1.8	30.4	3.9	4.3	32.2	1.1	6.5	14.1	24.2	5.2	16.2	9.2	30.2	71.9	21.1	15.2	94.9	53.0	4.1	2.9	21.7	47.5	42.5	65.1	3.7	2.4	27.0	10.5	3.3	23.7	90.0	19.7	27.0	16.9	21.8	21.1	13.1	24.1	63.8	22.4	56.5	10.1	41.6	21.2	18.2	2.1	21.2	12.0	40.1	18.8	46.3	24.4	0.2	61.2	0.9	41.9	1.2	0.3	15.1	5.7	23.6	0.0	0.2	66.7	22.0	0.0	17.6	2.2	12.1	7.3	10.6	74.2	0.0	10.8	157.9	129.4	28.5	0.0	56.7	10.8	0.1	0.0	0.0	28.3	28.6	44.6	0.0	0.2	164.8	114.6	4.5	5.1	43.6	10.3	0.0	0.0	0.2	131.0	0.2	0.0	0.0	0.7	0.2	0.0	0.0	1.2	0.1	5.7	0.5	0.0	0.0	27.8	0.9	0.2	24.0	0.2	6.3	43.5	82.5	3.5	114.5	62.9	0.0	0.0	0.0	219.3	0.0	62.9	0.2	41.9	0.1	0.1	27.0	0.2	0.2	0.2	0.3	28.6	0.0	0.0	0.2	0.9	1.2	20.6	61.2	0.1	15.1	1.8	3.9	1.1	3.0	4.1	2.9	3.7	2.4	19.7	2.1	3.0	25.0	13.3	3.2	106.1	0.1	6.4	7.6	4.0	9.1	1.8	0.0	6.6	0.0	39.9	1.8	14.7	0.0	23.3	98.6	5.6	70.4	0.9	4.7	21.2	254.4	1.6	3.4	32.5	259.4	1.3	9.5	225.7	47.2	8.2	2.0	0.0	363.6	0.0	2.1	1.6	0.2	25.8	143.8	0.2	0.8	48.7	16.2	2.5	0.4	2.0
TIMP3	SFD	ENSG00000100234	"TIMP metallopeptidase inhibitor 3"	P35625	22	32801701-32863043	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision"	"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 392.5;retina: 247.1"	"Cell type enhanced"	"Detected in many"	10	"Leydig cells: 1295.0;Peritubular cells: 1818.1;Sertoli cells: 2289.5;Smooth muscle cells: 1077.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 2.2"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 57.0;BJ: 127.4;BJ hTERT+: 56.3;fHDF/TERT166: 115.8;WM-115: 97.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (4.98e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.53e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (3.92e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.11e-2)"	130.4	44.6	8.7	15.8	10.1	0.1	103.3	5.1	12.1	68.3	25.4	13.5	27.8	4.5	65.1	47.4	40.2	51.9	39.9	75.0	10.2	8.5	54.0	14.1	115.4	31.3	11.4	8.7	25.3	11.8	15.6	21.6	392.5	19.1	44.2	12.6	247.1	24.3	55.0	22.7	22.9	16.2	58.3	7.2	35.1	22.9	43.2	7.1	1.2	48.9	29.4	10.1	37.5	38.3	0.4	0.0	0.0	0.0	2.2	0.0	0.0	2.0	0.0	1.8	0.3	57.0	32.1	0.1	127.4	56.3	10.4	12.4	2.2	0.0	0.0	3.1	115.8	0.4	1.9	0.3	5.2	15.1	0.0	1.5	15.7	2.7	5.5	22.4	0.0	6.6	5.3	13.3	18.5	1.0	0.3	0.0	0.0	0.0	0.1	4.8	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.2	10.4	1.3	1.8	2.6	0.0	33.5	31.0	0.0	0.1	0.0	0.8	2.8	27.1	2.0	0.0	0.0	0.0	26.0	0.0	97.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	8.7	10.1	5.1	12.1	10.2	8.5	11.4	8.7	19.1	7.1	339.5	47.1	4.5	518.2	68.7	3.1	194.1	5.1	12.0	26.1	48.8	3.9	374.1	3.3	1.3	11.5	516.3	0.0	0.0	0.6	213.4	444.0	99.6	85.6	98.5	105.1	3.2	1.7	734.7	49.2	29.3	1295.0	27.8	72.6	1.0	0.0	169.4	1.1	0.0	1818.1	11.1	3.5	2289.5	1077.9	6.5	5.1	49.3	676.6	10.0	0.2	134.4
TMEM119		ENSG00000183160	"Transmembrane protein 119"	Q4V9L6	12	108589846-108598320	"Predicted intracellular proteins, Predicted membrane proteins"	"Biomineralization, Differentiation, Osteogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Early spermatids: 8.2;Fibroblasts: 21.5;Melanocytes: 8.5;Peritubular cells: 22.6;Smooth muscle cells: 8.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 107.3;ASC TERT1: 29.7;BJ hTERT+: 31.1;fHDF/TERT166: 14.9;HSkMC: 45.7"	"Low region specificity"	"Detected in all"							"HPA051870, HPA052650"	Enhanced					NA	NA					"HPA051870: AB_2681645, HPA052650: AB_2681901"	"unprognostic (4.90e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.84e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (1.29e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-2)"	20.3	4.4	8.0	18.7	10.3	1.3	28.7	2.1	7.4	36.4	6.7	13.2	2.8	8.0	14.0	8.0	4.7	9.0	19.4	11.1	6.9	4.3	6.7	0.8	25.6	24.2	11.0	4.2	1.8	5.6	3.3	4.9	3.4	8.3	10.7	8.4	13.7	4.2	15.0	1.2	9.7	12.2	9.2	10.2	10.4	5.7	6.1	10.3	0.8	15.8	4.9	14.2	18.7	14.3	1.5	0.8	4.9	1.4	0.8	1.3	0.2	0.0	0.0	0.2	0.1	107.3	29.7	0.1	2.1	31.1	0.0	0.5	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	1.3	0.0	0.2	45.7	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.8	0.0	0.3	0.2	2.5	0.0	2.1	0.0	0.5	0.5	0.1	1.2	0.1	0.0	3.1	0.9	0.8	0.8	0.3	0.7	0.8	1.3	0.9	0.4	1.5	1.3	1.1	4.9	0.8	1.4	0.8	0.4	0.2	8.0	10.3	2.1	7.4	6.9	4.3	11.0	4.2	8.3	10.3	0.0	0.0	0.0	0.1	3.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.2	0.3	0.0	0.0	0.0	0.2	21.5	0.0	0.0	0.0	1.2	0.0	0.0	1.3	1.0	4.7	3.7	0.9	8.5	2.8	0.0	0.0	0.1	0.0	22.6	0.0	0.0	0.0	8.1	0.0	0.0	3.1	0.2	0.0	0.0	0.0
TMEM181	"GPR178, KIAA1423"	ENSG00000146433	"Transmembrane protein 181"	Q9P2C4	6	158536436-158635428	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 49.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040189, HPA040228"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Nucleoplasm, Golgi apparatus"	"HPA040189: AB_10793959, HPA040228: "	"unprognostic (1.93e-2)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (9.87e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.36e-1)"	"unprognostic (3.26e-1)"	7.1	5.6	32.4	4.8	49.2	3.1	8.6	5.3	36.6	13.4	10.1	4.2	6.5	10.9	8.4	3.9	6.3	5.8	7.3	5.3	18.5	8.7	3.3	6.4	6.7	3.4	5.5	23.3	5.6	18.5	8.1	21.5	6.5	11.2	9.4	11.5	4.3	22.4	10.0	4.9	7.0	12.6	7.8	7.3	7.6	16.3	16.0	8.5	2.3	9.7	2.1	3.2	9.9	7.0	1.0	2.1	7.7	3.4	3.9	4.7	1.4	10.2	5.9	8.4	12.9	22.3	20.5	16.1	23.2	13.6	12.1	13.9	10.0	12.6	4.3	12.0	19.2	26.0	15.2	12.4	15.3	19.3	6.3	8.9	8.0	8.8	21.1	18.2	10.0	7.7	16.9	15.1	13.5	18.3	18.3	19.4	6.2	15.2	5.4	19.8	6.2	4.4	12.5	6.5	20.4	7.6	4.3	9.7	4.9	11.6	8.0	24.9	17.1	17.0	16.0	11.1	12.1	6.1	14.1	18.4	12.6	8.5	20.8	20.0	3.2	2.2	4.8	15.2	12.6	11.9	7.7	2.2	5.7	4.7	2.3	3.6	0.9	2.7	3.7	1.6	1.0	2.4	3.2	1.6	3.9	3.4	2.1	2.6	1.4	32.4	49.2	5.3	36.6	18.5	8.7	5.5	23.3	11.2	8.5	11.9	31.5	2.4	11.3	18.1	13.4	14.8	20.4	5.3	7.9	15.7	17.7	7.7	3.3	22.0	3.2	24.0	29.3	0.0	28.2	10.9	15.0	29.8	10.5	18.6	8.9	19.1	42.6	20.3	14.2	4.0	12.0	13.6	13.5	4.6	34.5	6.0	36.3	28.1	16.6	4.8	14.4	6.5	17.1	14.2	22.6	18.3	4.3	20.1	24.4	29.1
TMEM38A	"MGC3169, TRIC-A"	ENSG00000072954	"Transmembrane protein 38A"	Q9H6F2	19	16661127-16690029	"Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 158.8"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 21.6;Cardiomyocytes: 22.4;Cone photoreceptor cells: 80.5;Peritubular cells: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 20.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 20.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 12.1;U-266/70: 12.2;U-698: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048100, HPA050463"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048100: , HPA050463: AB_2681137"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.49e-1)"	"prognostic favorable (2.78e-5)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"prognostic favorable (2.99e-10)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.96e-2)"	1.3	1.6	3.6	1.1	7.9	2.3	1.2	5.1	12.2	1.3	1.4	2.1	3.1	1.3	1.1	6.6	3.5	1.8	1.0	5.4	3.0	3.8	2.0	2.7	2.1	1.3	5.2	3.7	1.2	1.3	1.7	2.2	0.9	4.8	2.9	1.5	8.3	2.7	2.4	158.8	1.0	1.1	1.1	1.9	1.0	5.3	1.6	1.4	0.0	1.8	30.1	1.9	1.1	0.4	3.9	0.5	20.3	2.9	2.1	0.5	0.6	3.0	0.6	0.8	4.7	2.6	0.3	0.4	1.1	0.6	0.7	1.5	0.9	4.4	12.1	1.9	0.2	4.2	2.5	6.2	1.3	0.7	0.8	1.8	0.0	1.8	1.0	0.7	0.1	0.2	1.1	4.8	0.9	0.5	3.6	0.3	2.2	0.1	1.1	0.5	4.6	0.1	1.2	1.2	11.3	7.2	6.3	1.1	3.2	4.6	2.3	7.8	5.4	3.3	0.4	1.5	0.4	2.3	1.0	0.0	0.9	2.3	2.9	0.5	12.2	8.8	20.3	1.1	7.2	0.9	20.3	2.9	8.2	0.0	1.1	0.0	2.8	0.4	0.0	0.2	3.9	0.1	0.1	1.6	2.1	0.7	0.5	0.5	0.6	3.6	7.9	5.1	12.2	3.0	3.8	5.2	3.7	4.8	1.4	3.0	1.0	0.8	2.8	1.0	21.6	22.4	0.0	1.4	1.2	0.0	80.5	0.0	1.7	3.1	0.0	3.3	0.7	0.0	2.2	0.1	2.1	3.6	0.0	6.7	0.4	12.7	4.1	8.0	5.6	0.5	9.8	0.0	3.3	0.0	5.8	12.1	7.1	0.0	21.2	1.0	10.2	0.0	2.8	0.5	0.4	0.3	0.1	0.0	2.4	0.9
TOM1L2		ENSG00000175662	"Target of myb1 like 2 membrane trafficking protein"	Q6ZVM7	17	17843511-17972422	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 81.5"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022541, HPA023304"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments"		NA	NA		66000	"Intermediate filaments"	"Golgi apparatus"	"HPA022541: AB_1858182, HPA023304: AB_1858183"	"unprognostic (2.32e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.29e-2)"	"prognostic unfavorable (2.58e-4)"	"prognostic favorable (1.92e-4)"	"unprognostic (3.19e-2)"	"prognostic favorable (6.21e-9)"	"unprognostic (7.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.51e-2)"	11.8	14.8	24.7	7.3	27.4	3.5	10.4	23.2	38.2	10.5	12.8	32.3	8.7	8.8	12.8	8.2	35.9	12.7	8.8	81.5	25.9	21.8	13.1	4.4	14.4	4.8	24.4	23.8	15.7	12.2	28.7	14.4	6.3	42.3	21.1	9.7	19.5	9.7	19.3	32.0	29.0	10.5	16.0	16.4	7.7	10.9	14.7	20.9	4.3	24.8	13.7	10.5	12.0	11.0	2.7	2.2	14.6	3.9	1.4	5.3	1.8	11.1	13.3	3.6	2.8	8.9	9.0	5.6	19.2	9.1	10.9	9.0	12.2	8.1	2.0	25.1	18.8	5.7	46.6	2.9	11.2	6.5	3.1	5.2	3.3	12.0	2.3	5.5	0.7	2.3	10.5	7.8	9.9	7.4	9.6	10.8	3.2	1.2	2.9	13.7	11.7	1.4	1.8	0.6	15.8	8.2	1.8	8.7	5.0	14.1	21.7	4.1	3.8	8.5	11.2	6.8	28.1	5.7	1.5	13.8	10.1	2.7	20.2	7.0	2.6	2.1	0.8	11.6	1.0	24.0	7.1	3.9	5.1	3.5	1.2	2.5	2.0	3.2	2.8	1.8	2.7	5.3	3.9	14.6	1.4	3.4	2.2	1.5	1.8	24.7	27.4	23.2	38.2	25.9	21.8	24.4	23.8	42.3	20.9	29.8	13.4	12.3	11.9	9.6	69.6	59.0	20.4	14.7	11.4	10.4	149.2	6.4	5.0	10.3	25.9	9.5	25.8	0.0	7.7	16.0	10.4	37.1	2.3	11.3	8.1	90.6	19.7	12.9	7.3	46.0	24.5	6.5	11.8	10.0	17.1	32.4	12.4	31.7	24.1	7.9	76.8	19.4	13.2	14.6	10.7	15.1	26.9	8.7	13.3	45.0
TPCN2	TPC2	ENSG00000162341	"Two pore segment channel 2"	Q8NHX9	11	69048897-69162440	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Melanocytes: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 21.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA016561, HPA027080"	Supported		Approved	Nucleoli		NA	NA			Nucleoli		"HPA016561: AB_1858207, HPA027080: AB_10600917"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (7.60e-2)"	"unprognostic (7.04e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-3)"	"unprognostic (5.01e-2)"	"unprognostic (4.88e-2)"	11.0	6.2	6.3	8.7	11.1	9.2	9.4	14.5	14.0	18.0	18.0	9.2	11.3	15.0	22.4	12.4	11.2	13.8	12.1	7.5	6.2	4.9	11.6	15.7	8.7	10.4	6.0	7.7	12.1	6.8	6.4	7.2	7.1	8.8	13.1	7.4	20.7	8.1	17.8	8.1	16.1	13.7	15.6	6.0	10.9	11.4	8.5	4.9	6.4	7.3	7.4	10.1	11.0	11.2	2.0	7.5	7.1	9.9	6.9	3.2	3.6	3.4	8.9	2.7	4.2	2.6	2.1	11.7	3.9	4.7	4.7	2.8	7.6	10.9	4.5	5.6	4.8	3.7	8.0	2.2	4.4	1.4	2.8	2.3	6.1	9.5	2.5	2.5	4.3	8.3	3.3	2.3	2.4	2.5	1.9	3.2	7.4	2.9	21.1	2.9	8.1	3.6	10.3	3.2	10.1	3.2	3.4	2.2	5.5	4.7	5.6	2.4	3.2	4.5	10.2	15.7	4.1	6.6	5.7	2.9	3.2	4.7	5.9	3.6	5.5	2.3	2.3	5.2	4.6	6.7	4.3	9.8	2.9	1.0	9.8	0.9	2.0	2.1	2.1	7.5	1.5	1.7	2.0	7.1	6.9	9.9	3.2	3.2	3.6	6.3	11.1	14.5	14.0	6.2	4.9	6.0	7.7	8.8	4.9	8.9	1.0	7.5	2.1	3.5	1.5	3.2	7.6	0.0	1.2	12.2	2.0	2.3	14.9	6.0	16.2	2.9	6.2	23.3	7.6	3.7	3.5	1.2	2.3	12.9	10.5	0.0	0.0	6.2	15.4	1.7	5.8	7.4	33.7	4.6	2.9	2.5	3.7	3.5	6.3	9.6	4.2	6.5	5.9	1.9	3.8	3.0	1.6	2.6	3.4	1.4
TRIL	KIAA0644	ENSG00000255690	"TLR4 interactor with leucine rich repeats"	Q7L0X0	7	28953358-28958292	"Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.7"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 11.9;Horizontal cells: 6.4;Muller glia cells: 13.7;Sertoli cells: 12.9"	"Cancer enhanced"	"Detected in many"		"glioma: 20.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 14.0;SH-SY5Y: 25.3;SK-BR-3: 22.4;T-47d: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.26e-3)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (4.27e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.07e-2)"	3.5	2.9	14.7	0.6	13.2	0.0	5.1	11.2	19.2	2.6	2.2	19.5	0.0	2.4	2.5	2.2	1.9	2.3	1.2	3.0	18.2		6.6	0.7	3.1	0.4	9.1	11.5	1.8	0.4	0.6	0.0	1.3	20.7	2.4	2.3	0.3	9.6	1.8	3.3	0.5	2.7	4.1	17.0	2.9	2.8	0.3	14.4	0.0	2.8	0.2	0.3	2.0	0.0	0.0	0.1	0.1	0.1	0.0	0.7	0.0	0.0	0.0	14.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.5	25.3	0.0	22.4	0.0	2.1	9.9	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0											11.9	4.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	1.2	1.8	0.0	0.1	3.3	0.0	0.0	2.1	0.0	0.0	0.0	1.8	0.8	0.0	0.0	0.2	0.1	6.4	0.0	2.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	1.6	0.7	12.9	0.2	0.2	0.7	0.0	0.1	0.0	0.6	0.1
TRPV4	"CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC"	ENSG00000111199	"Transient receptor potential cation channel subfamily V member 4"	Q9HBA0	12	109783085-109833401	"Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Charcot-Marie-Tooth disease, Disease mutation, Dwarfism, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 32.6"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 15.3;Cytotrophoblasts: 16.0;Syncytiotrophoblasts: 17.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	11	"pons and medulla: 15.0"	"Cell type enriched"	"Detected in single"	7	"classical monocyte: 3.0"	"Lineage enriched"	"Detected in single"	7	"monocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 9.0;BJ hTERT+: 9.3;EFO-21: 8.2;HaCaT: 14.8;HUVEC TERT2: 8.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA007150	Uncertain					NA	NA					"HPA007150: AB_1080393"	"unprognostic (2.98e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.20e-3)"	"unprognostic (6.25e-3)"	"unprognostic (1.09e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (4.12e-5)"	"unprognostic (1.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-2)"	1.3	0.9	0.3	0.9	0.4	0.1	3.3	0.2	0.6	2.3	0.4	3.2	0.0	0.6	0.8	3.7	9.5	5.6	5.2	1.6	1.3	0.2	11.6	7.8	2.6	1.8	0.2	0.0	0.6	7.1	0.1	4.3	11.1	15.0	6.2	0.3	12.6	32.6	1.4	0.2	6.5	0.3	0.9	0.3	3.5	0.9	0.7	0.1	0.2	0.9	2.6	8.7	2.6	1.7	0.0	0.4	0.0	3.0	0.0	0.0	0.4	2.6	0.1	0.0	0.0	1.9	1.9	9.0	4.3	9.3	1.3	0.5	0.0	6.4	0.0	8.2	5.5	0.0	14.8	1.1	0.0	0.3	0.0	2.1	0.0	0.0	3.6	0.7	0.0	0.0	3.3	2.0	3.3	0.0	0.5	8.4	0.0	0.8	0.0	0.4	5.4	0.0	0.0	1.7	0.0	0.3	0.0	0.5	0.0	0.0	5.2	0.0	0.0	0.3	0.6	2.6	4.1	1.2	0.4	5.1	0.0	3.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.0	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.2	0.6	1.3	0.2	0.2	0.0	15.0	0.1	0.0	0.0	1.3	8.2	3.0	0.0	1.1	15.3	5.3	6.8	10.4	0.0	16.0	3.3	2.2	0.2	0.5	0.0	0.0	8.4	4.3	0.7	3.7	0.0	6.4	3.6	0.0	0.0	0.6	10.7	0.0	0.9	1.6	6.8	1.0	0.0	0.0	1.5	0.0	0.0	11.1	0.0	0.0	0.8	0.2	1.3	3.3	17.6	0.0	0.0	2.0
TSC22D1	"MGC17597, TGFB1I4, TSC22"	ENSG00000102804	"TSC22 domain family member 1"	Q15714	13	44432143-44577147	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 989.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.7"	"Group enriched"	"Detected in all"	5	"dendritic cells: 8.9;granulocytes: 17.7;NK-cells: 7.9"	"Cell line enhanced"	"Detected in many"		"HEL: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077414			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA077414: AB_2686839"	"unprognostic (6.61e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.00e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.78e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (4.24e-2)"	"unprognostic (9.08e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (8.14e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.48e-2)"	43.1	38.6	71.6	23.7	82.3	6.6	56.6	32.6	94.8	73.7	49.9	27.9	14.1	27.3	68.3	62.5	46.4	67.6	49.7	54.1	64.2	63.9	46.3	36.7	37.7	14.1	71.2	49.2	63.7	15.5	44.7	36.4	40.8	54.6	72.6	47.7	56.6	31.0	39.5	49.6	20.4	48.6	64.4	46.0	11.1	36.7	27.9	38.6	31.7	38.2	24.3	17.4	39.7	31.6	1.1	8.9	17.7	2.3	7.9	2.5	24.6	5.1	16.4	16.1	6.5	10.2	12.8	18.7	5.7	23.5	6.3	6.7	18.4	18.4	8.5	12.0	13.6	13.6	13.1	6.9	46.5	8.8	1.6	5.4	58.6	30.0	5.6	9.5	3.3	7.5	19.2	20.3	16.7	40.8	48.9	14.0	4.7	1.6	0.0	11.7	5.2	10.5	2.7	11.4	35.8	15.4	7.6	3.2	2.5	12.4	8.6	8.4	11.3	15.7	15.6	4.5	17.4	7.6	4.7	12.2	7.0	6.4	14.5	8.3	0.1	1.5	2.7	17.7	2.8	16.2	17.7	1.0	2.7	2.5	0.9	2.4	0.7	0.8	1.1	0.9	1.1	0.9	1.3	4.8	7.9	2.3	8.9	1.5	24.6	71.6	82.3	32.6	94.8	64.2	63.9	71.2	49.2	54.6	38.6	110.2	291.2	23.4	328.2	392.6	138.9	236.4	86.6	290.4	395.8	413.5	108.0	484.2	313.4	140.3	674.0	250.8	383.6	0.0	140.7	189.0	164.9	477.0	312.3	64.8	94.3	120.8	215.8	101.3	19.7	989.9	84.8	43.1	381.3	11.8	181.4	229.5	176.7	143.7	128.3	121.8	134.1	439.8	322.5	50.2	24.5	533.2	978.5	27.4	139.7	385.5
TTC7A	"KIAA1140, TTC7"	ENSG00000068724	"Tetratricopeptide repeat domain 7A"	Q9ULT0	2	46916157-47076137	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.0"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 47.0;Late spermatids: 143.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036781, HPA036782"	Enhanced					NA	NA					"HPA036781: AB_10673665, HPA036782: AB_10671711"	"unprognostic (2.51e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.51e-3)"	"unprognostic (3.60e-1)"	"unprognostic (4.36e-1)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (3.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.30e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.15e-2)"	8.9	18.2	7.1	10.6	18.1	18.7	7.1	2.1	10.4	7.4	14.7	16.0	4.0	14.2	5.0	5.8	14.2	6.0	7.3	4.3	8.1	4.2	7.3	6.4	13.8	10.8	17.0	4.2	5.2	17.2	7.0	5.3	12.6	10.6	5.4	6.9	8.6	13.6	5.9	2.2	12.4	22.5	4.3	12.3	11.6	11.6	36.7	16.2	56.0	11.3	6.0	16.2	6.1	8.9	3.8	5.3	1.4	5.0	0.5	2.5	1.4	16.7	6.1	2.1	0.5	3.2	3.8	8.5	4.6	6.2	3.0	2.8	9.5	9.9	11.3	4.5	8.4	3.5	7.0	2.8	5.8	2.5	21.8	2.3	1.1	4.5	10.3	1.2	4.5	4.6	1.5	7.1	3.8	4.8	3.6	2.4	4.4	4.3	7.5	1.6	6.1	22.5	5.9	2.2	18.1	1.6	37.8	3.4	19.5	2.9	4.3	2.7	2.4	8.5	16.9	1.5	4.0	3.2	9.8	6.1	3.3	2.7	2.4	3.8	4.8	1.8	6.1	2.5	5.5	1.9	0.1	5.0	0.0	0.8	2.5	1.2	3.8	2.5	0.9	3.4	3.5	1.8	0.7	1.4	0.5	0.8	5.3	1.1	1.4	7.1	18.1	2.1	10.4	8.1	4.2	17.0	4.2	10.6	16.2	20.8	14.3	15.2	4.1	5.8	1.3	3.5	15.3	8.1	4.5	7.0	0.0	5.4	3.3	4.8	47.0	3.6	24.1	0.0	6.4	9.0	5.8	3.2	8.1	7.5	15.6	0.0	6.4	2.5	27.4	143.1	4.4	16.5	5.0	2.8	7.9	23.0	16.2	10.5	6.3	3.4	3.3	0.0	4.8	5.6	6.8	4.8	3.3	5.0	4.7	4.3
TYW1	"FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W"	ENSG00000198874	"TRNA-yW synthesizing protein 1 homolog"	Q9NV66	7	66995173-67239519	"Enzymes, Predicted membrane proteins"	"tRNA processing"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723"	"unprognostic (1.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.79e-2)"	15.4	19.1	10.2	12.3	15.4	11.9	15.1	14.9	15.3	18.8	12.9	21.2	18.2	14.1	22.7	15.3	12.0	15.5	10.8	12.9	10.8	9.8	15.2	17.7	11.1	15.5	14.1	10.8	19.4	23.9	22.9	28.0	13.2	14.5	14.9	16.5	17.8	15.3	14.7	26.2	14.4	12.8	14.0	13.9	15.1	12.6	13.7	13.4	19.7	19.0	13.6	23.3	15.3	15.2	9.6	8.3	3.6	9.1	11.2	11.8	5.3	10.6	13.6	8.3	17.2	12.5	8.7	9.7	11.4	8.7	9.0	8.5	15.5	13.9	18.5	17.5	10.5	12.7	12.6	17.2	14.0	13.1	14.5	13.2	8.0	11.3	10.5	12.4	18.4	10.6	8.9	14.2	12.2	18.8	7.1	8.2	13.5	21.0	11.2	10.3	10.5	11.6	15.5	14.6	18.0	12.2	13.2	11.6	23.3	12.2	10.8	12.8	12.7	13.7	26.6	11.4	16.6	18.1	13.1	9.6	10.4	7.4	8.2	15.5	11.3	15.9	22.3	8.5	17.4	14.3	2.0	7.0	3.6	8.6	7.8	11.7	8.5	9.4	9.8	8.3	9.6	11.5	11.8	2.0	11.2	9.1	6.6	6.8	5.3	10.2	15.4	14.9	15.3	10.8	9.8	14.1	10.8	14.5	13.4	6.0	15.4	4.5	4.9	9.3	9.0	8.1	10.2	9.4	4.5	10.4	3.9	16.5	0.0	6.6	5.5	6.7	4.7	0.0	6.0	10.7	7.7	4.9	33.5	12.5	6.9	3.2	4.6	6.7	4.3	3.1	7.8	8.9	8.5	10.0	12.1	7.7	6.1	3.5	7.8	2.1	11.7	19.4	7.1	17.0	22.7	14.8	12.7	8.5	9.7	2.8
UNC5B	"p53RDL1, UNC5H2"	ENSG00000107731	"Unc-5 netrin receptor B"	Q8IZJ1	10	71212570-71302864	"Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 43.7"	"Cell type enhanced"	"Detected in many"	14	"Horizontal cells: 106.5;Muller glia cells: 63.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.5"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 47.1;hTCEpi: 41.5;SH-SY5Y: 38.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA076687	Approved					NA	NA					"HPA076687: "	"unprognostic (3.98e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (3.01e-5)"	"unprognostic (8.82e-3)"	"unprognostic (6.79e-3)"	"prognostic unfavorable (3.80e-5)"	"unprognostic (7.70e-3)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (4.17e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.25e-1)"	3.8	12.4	9.1	4.6	19.8	0.5	2.3	23.1	12.5	5.7	8.3	29.5	33.6	3.2	5.4	7.5	14.2	9.1	10.5	13.8	12.2	6.8	6.6	2.1	9.3	3.9	27.1	9.7	4.5	5.2	1.5	5.3	6.0	15.0	10.1	6.0	7.1	4.5	43.7	3.0	5.9	4.5	5.5	17.5	8.5	9.9	6.0	20.4	2.2	4.6	5.2	3.6	9.6	8.9	0.0	0.2	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.2	1.2	3.7	6.1	0.1	2.0	6.0	0.0	0.1	1.1	5.5	0.0	2.1	12.7	0.1	14.3	0.4	0.8	0.0	0.0	1.3	3.2	0.2	0.0	47.1	0.0	0.3	5.2	41.5	0.5	2.6	0.5	0.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	3.2	2.9	0.1	0.0	1.4	0.0	0.0	6.2	6.4	38.9	0.4	0.5	0.3	6.0	0.6	0.2	2.4	0.4	1.9	0.8	0.8	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	9.1	19.8	23.1	12.5	12.2	6.8	27.1	9.7	15.0	20.4	0.0	3.5	0.0	15.5	2.7	1.5	7.3	0.0	6.7	3.4	5.2	0.0	0.3	0.0	3.6	0.4	9.5	13.4	0.0	1.4	0.3	10.6	9.4	23.0	0.0	1.2	106.5	2.9	8.0	4.5	0.8	0.6	3.6	1.7	1.0	7.0	63.8	7.4	20.1	0.7	0.1	3.7	0.0	3.6	0.5	4.4	3.8	0.2	0.0	1.5	29.5
UQCRFS1	"RIP1, RIS1, RISP, UQCR5"	ENSG00000169021	"Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1"	P47985	19	29205321-29213541	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.3"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 1206.2;Distal tubular cells: 877.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041863, HPA050339"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA041863: AB_10794638, HPA050339: AB_2681095"	"unprognostic (4.00e-2)"	"unprognostic (2.23e-3)"	"prognostic favorable (3.29e-4)"	"unprognostic (7.91e-3)"	"unprognostic (3.93e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.92e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-2)"	15.2	27.1	20.1	10.8	18.3	25.4	28.2	18.3	33.4	11.9	27.3	9.1	9.8	24.3	10.5	14.3	16.9	11.9	14.2	95.3	19.4	14.8	34.9	33.8	12.0	21.2	18.3	13.1	9.1	26.4	15.9	10.6	10.8	17.6	11.8	30.3	11.5	17.0	13.9	112.3	12.9	27.0	19.6	11.5	11.3	18.8	16.6	6.5	17.7	12.9	55.0	14.5	13.7	10.0	18.5	35.6	14.9	29.9	15.0	22.1	45.1	21.8	37.0	13.8	12.4	22.6	17.3	15.3	17.1	17.9	23.7	26.3	22.4	13.6	19.9	18.1	19.3	19.4	23.3	30.1	20.4	28.7	13.5	30.1	28.2	14.6	20.3	19.2	26.8	24.8	20.8	22.1	16.2	24.7	14.0	18.9	24.9	20.0	12.5	25.4	20.2	18.7	20.1	14.4	46.7	14.4	17.1	18.4	15.1	29.5	26.4	16.8	8.2	15.6	30.9	19.6	16.1	14.4	22.4	11.9	16.1	24.5	11.0	17.7	6.0	11.3	18.4	14.2	23.3	11.4	14.9	29.9	14.0	17.9	29.3	17.8	18.5	19.2	18.3	35.6	15.7	20.4	19.4	9.1	15.0	24.3	19.7	22.1	45.1	20.1	18.3	18.3	33.4	19.4	14.8	18.3	13.1	17.6	6.5	50.6	43.5	83.4	229.0	131.1	67.3	1206.2	170.7	48.2	45.5	108.2	15.7	255.3	877.0	208.2	176.6	94.4	303.4	70.0	204.7	204.0	122.3	162.8	88.9	250.4	234.4	49.3	153.7	93.9	135.6	102.8	85.4	113.1	156.9	178.5	238.4	96.8	186.1	196.4	76.7	532.4	58.7	97.0	163.6	296.9	77.1	140.0	319.3	108.3	325.0	307.9
UTP14C	"2700066J21Rik, KIAA0266"	ENSG00000253797	"UTP14C, small subunit processome component"	Q5TAP6	13	52024691-52033600	"Predicted intracellular proteins"	"Differentiation, Meiosis, Ribosome biogenesis, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047217, HPA054023"	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA047217: AB_2679987, HPA054023: AB_2682346"	"unprognostic (7.89e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.47e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (7.35e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.46e-5)"	"unprognostic (2.44e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.04e-2)"	4.8	4.8	5.3	3.4	5.9	0.5	6.2	6.6	5.9	6.8	5.3			4.6	6.7	4.6	3.6	5.2	3.9	5.5	5.1	5.2	8.0	7.9	4.5	3.5	5.5		6.1	5.8	8.9	4.8	6.6		7.1	5.9		5.7	5.5	5.3	2.9	4.5	5.3	6.2	4.4	5.7	2.3			9.1		3.8	4.6	4.2	4.1	5.8	6.7	4.8	3.5	6.8	3.1	4.2	6.8	14.1	11.1	14.5	10.5	10.9	12.3	9.6	8.3	7.7	6.7	9.0	10.5	3.3	11.6	10.5	10.0	12.4	6.8	11.0	10.7	8.8	20.2	4.8	6.5	9.9	17.9	14.0	9.2	13.0	6.4	12.4	10.9	6.8	12.5	11.6	5.3	12.4	3.1	10.9	10.0	12.8	19.5	4.9	10.7	9.9	4.5	14.1	6.9	4.6	9.5	7.3	11.0	8.4	13.5	9.8	14.2	10.3	7.7	8.0	8.6	8.4	5.4	7.8	12.7	4.1	6.7	14.4	6.7	3.7	5.4	4.6	4.8	3.9	3.0	4.9	3.7	4.4	4.1	6.8	6.7	2.4	3.5	3.9	5.8	5.2	3.1											6.0	17.4	11.2	5.0	5.3	13.0	18.5	20.4	12.0	13.6	15.7	3.9	8.5	0.0	6.0	0.3	10.6	10.8	0.0	6.6	8.1	10.8	11.1	11.5	28.1	7.9	23.8	17.9	12.3	14.8	0.0	9.8	6.7	8.5	2.8	15.1	13.6	6.8	14.0	13.4	5.0	10.6	6.5	7.6	6.6	12.2	7.3	5.8	6.9	12.7	5.4
WASF2	"SCAR2, WAVE2"	ENSG00000158195	"WAS protein family member 2"	Q9Y6W5	1	27404226-27490158	"Predicted intracellular proteins"	"Host-virus interaction"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022632, HPA045288"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		470000	"Plasma membrane"	Cytosol	"CAB022632: , HPA045288: AB_2679287"	"unprognostic (9.58e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (5.29e-8)"	"unprognostic (3.94e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.15e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.26e-2)"	36.9	23.3	22.0	23.8	30.0	30.0	28.6	13.6	24.0	31.9	28.8	33.2	13.2	15.7	36.9	16.0	55.3	28.8	22.3	20.5	22.8	13.1	20.2	11.6	29.4	31.1	32.5	12.6	38.8	24.0	21.3	14.8	29.7	23.2	26.4	23.3	22.2	25.6	26.1	11.4	35.1	26.7	42.9	31.5	34.0	26.4	20.7	32.7	32.3	21.6	22.2	35.2	39.1	30.3	18.9	21.8	36.9	38.4	8.5	12.9	16.8	24.4	11.7	27.3	24.8	19.9	26.1	15.8	20.0	18.6	22.1	19.9	10.1	26.5	17.0	19.4	31.2	15.0	19.7	21.9	32.8	26.5	23.8	13.8	37.1	20.8	11.9	26.8	29.6	21.4	23.8	35.8	24.0	45.0	24.0	27.6	19.0	29.5	8.9	29.9	8.8	22.0	13.6	21.9	12.5	18.1	46.1	33.5	17.4	15.8	13.9	13.6	15.0	34.9	15.6	26.1	17.3	13.0	18.0	36.2	18.4	19.1	38.0	15.7	18.3	24.1	22.8	21.7	36.8	20.6	14.8	23.3	18.5	12.9	29.1	10.5	14.1	10.2	8.9	14.8	18.9	10.7	8.1	36.9	8.5	38.4	21.8	10.2	16.8	22.0	30.0	13.6	24.0	22.8	13.1	32.5	12.6	23.2	32.7	62.5	51.0	92.0	173.5	131.5	24.5	30.1	86.6	64.3	69.4	85.5	13.7	174.6	53.0	89.1	42.3	188.8	120.0	46.7	88.6	107.9	114.2	242.5	56.7	41.4	133.0	19.1	104.2	120.3	180.2	47.6	152.8	97.4	72.6	162.3	79.4	56.5	119.6	91.2	171.5	37.6	19.4	135.8	119.5	121.8	114.1	170.0	120.0	87.1	89.2	299.4
WNK1	"HSAN2, HSN2, PPP1R167, PRKWNK1"	ENSG00000060237	"WNK lysine deficient protein kinase 1"	Q9H4A3	12	752593-911452	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046541, HPA059157"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA046541: AB_2679690, HPA059157: AB_2683935"	"unprognostic (1.40e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.67e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.30e-2)"	30.0	12.4	49.3	19.1	47.5	28.9	45.4	22.5	36.7	21.2	12.6	42.6	10.6	8.5	15.9	19.4	45.5	16.9	16.5	38.5	53.7	36.4	45.6	18.0	33.0	34.3	62.3	27.1	18.5	11.3	29.1	12.7	20.3	41.4	17.1	14.3	12.0	15.4	20.3	43.4	31.3	10.3	22.3	82.8	16.9	15.7	23.8	38.8	23.9	16.7	17.4	24.5	18.9	26.5	3.7	2.6	10.9	7.1	2.1	5.2	1.9	14.1	26.8	35.4	3.3	25.6	24.6	13.5	14.1	17.0	15.3	14.3	15.0	16.1	20.0	5.0	30.2	18.6	10.7	23.9	16.3	21.6	34.5	14.3	44.5	35.6	13.0	18.8	24.0	19.4	19.0	24.8	25.3	45.4	17.0	20.7	18.8	20.3	48.2	23.1	13.0	43.2	4.0	28.9	12.0	6.4	20.6	39.3	5.3	22.0	30.6	10.3	12.1	32.9	21.4	9.5	49.5	23.5	24.7	22.8	19.0	22.0	26.6	20.7	7.4	12.2	30.2	18.1	12.7	15.4	0.9	2.7	2.6	3.8	4.0	5.2	3.0	4.3	3.6	2.6	3.7	2.3	4.1	10.9	2.1	7.1	1.7	4.9	1.9	49.3	47.5	22.5	36.7	53.7	36.4	62.3	27.1	41.4	38.8	95.3	107.5	34.5	38.1	100.2	81.8	197.8	58.6	61.6	53.4	85.5	141.4	27.8	72.9	26.9	18.6	99.1	21.1	210.2	21.1	25.9	54.1	46.4	50.8	62.5	49.6	79.4	56.4	45.4	101.9	17.5	57.2	66.8	35.4	48.7	24.6	57.2	32.3	29.8	52.3	16.5	92.4	12.9	41.9	139.7	38.1	118.8	23.8	69.2	21.9	46.1
WNT9A	WNT14	ENSG00000143816	"Wnt family member 9A"	O14904	1	227918656-227947898	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 9.4;Club cells: 5.7;Leydig cells: 4.0;Peritubular cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 13.1;PC-3: 8.8;RH-30: 13.5;SCLC-21H: 12.3;SiHa: 11.9;U-2197: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.27e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.93e-2)"	2.4	1.4	1.0	13.1	0.5	0.2	2.6	1.4	1.0	4.0	14.1	2.6	2.2	1.9	6.3	4.7	9.5	5.4	15.3	14.6	0.7	0.9	0.8	0.4	9.2	2.1	0.8	0.1	8.9	7.5	0.8	4.3	4.3	3.1	4.7	1.6	4.9	4.9	4.2	20.2	1.0	6.8	8.3	0.6	1.2	5.7	1.8	1.0	0.6	1.8	10.6	4.0	7.1	3.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.7	2.6	0.3	0.1	0.3	0.6	6.7	0.9	0.8	0.1	0.0	0.0	7.1	0.0	3.9	1.2	2.7	13.1	0.3	0.6	0.0	1.3	0.5	0.0	4.4	0.2	0.3	0.0	0.4	0.1	3.3	0.1	0.1	0.2	0.8	0.0	0.0	0.1	1.5	1.7	0.0	0.0	0.8	0.0	8.8	0.2	13.5	1.3	3.7	0.8	12.3	0.0	11.9	5.4	0.0	4.5	6.8	1.4	0.5	1.8	1.1	8.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.5	1.4	0.7	0.7	0.9	0.8	0.1	3.1	1.0	3.0	1.1	0.0	1.1	0.8	0.0	1.1	0.0	9.4	5.7	1.8	0.0	0.1	0.0	0.4	0.1	0.4	0.0	0.0	1.2	0.1	1.8	1.3	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	4.0	0.0	0.0	0.0	1.8	0.0	1.6	0.0	4.2	0.0	0.0	0.0	0.4	0.0	2.3	0.3	0.0	0.0	0.0	3.3
WTAP	"KIAA0105, MGC3925, Mum2"	ENSG00000146457	"WT1 associated protein"	Q15007	6	159725585-159756319	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Basal keratinocytes: 372.2;Suprabasal keratinocytes: 398.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010550	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA010550: AB_1858866"	"unprognostic (9.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (3.01e-5)"	"unprognostic (7.92e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.32e-2)"	37.6	31.0	21.5	38.7	24.7	106.0	37.5	30.1	22.3	29.7	28.2	19.4	25.1	19.1	33.8	34.6	30.3	28.8	27.3	28.9	22.0	22.1	28.5	28.8	29.7	36.1	20.9	21.2	37.1	30.1	23.1	31.2	35.0	22.1	33.0	28.7	23.7	30.3	27.2	81.2	29.3	28.6	30.9	22.6	36.5	27.1	20.4	21.6	53.2	36.3	26.2	39.3	33.4	34.6	26.6	22.3	33.4	27.1	23.9	30.5	14.7	13.8	13.3	30.0	27.4	35.2	39.0	19.6	21.7	73.7	27.8	37.2	25.7	13.2	34.4	13.1	23.8	61.2	18.9	29.1	25.4	36.2	17.9	19.5	34.3	14.5	36.2	29.5	31.0	20.8	46.3	24.7	31.0	41.1	21.3	21.1	33.8	36.8	32.3	29.3	13.9	42.7	41.7	25.4	21.6	11.2	28.5	19.4	24.6	29.9	17.1	28.7	20.9	40.8	23.2	10.7	21.2	10.7	38.5	18.8	19.7	21.4	28.5	31.5	23.4	26.0	53.0	18.1	31.1	19.6	27.2	19.2	22.6	23.4	24.3	26.4	26.6	28.3	27.8	22.3	23.8	25.6	25.8	33.4	23.9	27.1	18.9	30.5	14.7	21.5	24.7	30.1	22.3	22.0	22.1	20.9	21.2	22.1	21.6	32.8	59.0	84.2	176.7	372.2	29.5	46.6	84.1	36.1	35.2	57.6	33.4	93.4	72.9	99.7	34.1	64.1	45.2	46.7	70.5	105.3	82.6	229.3	39.3	81.8	67.3	35.0	59.1	50.3	77.6	39.5	60.4	106.3	231.2	127.2	57.7	39.0	73.8	54.5	47.7	75.7	31.8	71.1	169.7	61.3	74.5	398.0	124.8	111.7	56.9	130.8
ZC2HC1A	"C8orf70, CGI-62, FAM164A"	ENSG00000104427	"Zinc finger C2HC-type containing 1A"	Q96GY0	8	78666047-78719765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 128.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 20.6;T-reg: 17.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 20.9;SK-BR-3: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024726	Approved		Approved	"Actin filaments,Cytosol"		NA	NA			Cytosol	"Actin filaments"	"HPA024726: AB_1846597"	"unprognostic (1.12e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.19e-7)"	"unprognostic (2.96e-1)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (9.00e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (2.34e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.05e-3)"	7.6	6.2	16.1	6.1	21.2	2.0	14.3	23.6	20.0	12.7	8.0	8.4	6.7	3.3	19.7	9.1	11.5	19.5	10.0	8.1	16.5	15.7	8.3	2.9	12.6	5.1	11.9	22.6	23.6	4.9	26.1	26.1	11.4	25.8	12.8	7.8	5.0	7.5	10.9	4.2	43.1	5.8	13.1	13.8	5.9	5.8	8.6	11.0	1.5	19.8	4.2	8.4	11.0	12.1	5.1	3.3	20.6	8.1	0.6	17.7	1.5	2.4	3.0	5.7	4.6	12.2	12.9	2.5	6.8	4.6	3.4	4.4	0.8	4.4	4.1	2.9	6.9	7.3	2.0	3.4	3.8	5.1	13.6	2.2	0.5	2.8	2.4	7.3	0.7	1.4	9.2	6.5	2.8	8.4	10.5	4.7	1.4	0.7	20.9	7.2	2.4	0.8	1.2	1.4	0.2	4.9	0.0	7.3	0.9	5.1	5.3	2.2	9.0	5.3	39.2	7.4	5.5	1.0	0.1	3.8	10.8	4.5	4.9	3.3	5.2	5.3	2.7	5.1	0.0	4.1	20.6	3.9	0.1	0.1	4.1	0.0	5.1	4.0	0.2	3.3	3.3	1.2	0.4	0.1	0.6	8.1	0.2	17.7	1.5	16.1	21.2	23.6	20.0	16.5	15.7	11.9	22.6	25.8	11.0	62.5	21.3	5.6	36.7	26.0	25.1	14.5	5.1	128.5	31.8	17.4	3.9	23.8	23.2	15.7	8.0	13.3	0.0	0.0	7.3	25.2	18.0	13.1	5.8	0.8	13.6	44.5	8.6	17.2	6.9	3.0	17.8	11.2	15.1	16.2	2.9	34.9	8.1	0.0	34.6	8.7	22.2	6.5	20.6	29.8	28.8	36.9	14.5	4.4	3.0	10.6
ZCCHC24	"C10orf56, FLJ90798, Z3CXXC8"	ENSG00000165424	"Zinc finger CCHC-type containing 24"	Q8N2G6	10	79382325-79445627	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 56.8"	"Cell type enhanced"	"Detected in many"	7	"Fibroblasts: 40.7;Hepatocytes: 44.7;Ito cells: 57.1;Leydig cells: 63.6;Peritubular cells: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 43.5;ASC TERT1: 37.4;BJ hTERT+: 28.5;HSkMC: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038348	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA038348: AB_10669538"	"unprognostic (3.47e-3)"	"unprognostic (8.70e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (5.35e-6)"	"unprognostic (1.84e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.95e-3)"	27.9	9.0	30.9	9.5	54.4	1.8	9.8	11.1	36.0	22.9	19.8	56.8	4.2	4.6	18.0	6.9	10.3	15.5	16.8	19.1	30.6	19.7	3.5	13.5	10.2	4.8	56.7	23.5	20.1	4.0	3.9	3.0	11.4	36.2	14.5	6.8	4.5	6.2	20.7	34.8	5.0	5.4	25.6	36.8	7.0	9.0	6.6	51.9	0.0	6.0	2.5	3.2	14.9	7.3	0.0	3.4	0.6	2.4	0.7	0.9	0.5	0.9	0.9	3.2	2.8	43.5	37.4	0.8	7.5	28.5	4.5	5.2	0.8	0.0	0.0	4.1	15.1	1.5	0.0	0.5	0.1	3.8	1.8	2.0	0.4	2.3	0.9	11.3	1.1	0.6	38.8	0.4	4.0	1.1	13.3	0.9	0.2	1.4	1.6	3.8	0.3	0.0	4.4	0.7	0.2	9.3	0.2	3.8	0.6	0.5	1.2	0.1	4.0	2.3	0.3	9.4	3.2	1.1	2.1	0.6	4.3	4.0	11.7	2.5	2.9	1.9	0.0	8.8	1.4	15.3	0.0	2.4	0.6	0.9	1.1	0.2	0.0	0.0	0.3	1.6	0.0	0.0	0.2	0.6	0.7	0.1	3.4	0.4	0.5	30.9	54.4	11.1	36.0	30.6	19.7	56.7	23.5	36.2	51.9	0.0	1.6	0.0	1.5	6.8	0.0	16.5	7.6	1.4	1.2	0.0	0.0	0.6	0.0	0.8	1.7	17.0	0.0	0.0	0.7	0.8	40.7	3.6	1.1	44.7	8.5	0.0	0.0	57.1	15.9	3.7	63.6	6.8	15.1	1.0	0.4	16.4	0.7	0.0	61.5	1.4	0.7	12.9	21.2	0.7	1.0	4.0	1.3	4.3	0.0	1.1
